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Abstract 
 
Despite numerous elegant advances in the formation of O-glycosides, many 
opportunities for improvement still remain. The site-selective incorporation of glycosides 
into complex polyfunctional molecules, as well as the need to synthesize the aglycone in 
a separate operation from glycoside formation still needs to be addressed. In an effort to 
overcome the current limitations in glycosylation chemistry a carbohydrate-bearing silane 
reducing agent has been developed to be used in synergy with catalysis for the site-
selective glycosylation of complex molecules. A variety of ketones were found to be 
directly converted into 1,2-cis glycosides by their reduction with sugar silanes, followed 
by glycosylation. This represents the first known example of the glycosylation of a 
ketone without directly going through a hydroxylic intermediate. Additionally the site-
selective glycosylation of hydroxyketones was demonstrated with sugar silanes using 
both a nickel- and copper-IMes catalyst system. 
 Sugar silanes were also utilized in the development of a mild, user-friendly 
method for the dehydrogenative silylation of alcohols. A bench stable, electrophilic 
triarylborane catalyst was used for the synthesis of silyl-linked compounds for the 
synthesis of 1,2-cis glycosides. This produces hydrogen gas as the only byproduct, and 
was demonstrated to site-selectively glycosylate secondary and tertiary alcohols in the 
presence of a ketone. Insight was gained into the site-selective glycosylation of diols by 
silylation with sugar silanes or a combination of a sacrificial silane and a sugar silane. 
xvi 
 
This led to a better understanding of the advantages, and limitations, of sugar silanes. 
Unreactive glycosyl acceptors, such as the 4-hydroxyl group of glucose, did not undergo 
glycosylation in an appreciable yield using silicon-tethered intramolecular aglycone 
delivery.  
 Aglycone synthesis was merged with glycoside incorporation when sugar silanes 
were employed as reducing agents in the nickel-catalyzed reductive coupling of 
aldehydes and alkynes, producing carbohydrates tethered to di- and trisubstituted allylic 
alcohols. Challenges encountered in the glycosylation of tethered allylic alcohols, due to 
the generation of sensitive intermediates, resulted in the production of the desired allylic 
alcohol glycosides in low to moderate yield. However, despite these limitations, this 
method highlights the utility of sugar silanes in the development of novel methods for the 
synthesis of glycosides. 
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Chapter 1  
 
Ketone Hydrosilylation with Sugar Silanes Followed by Intramolecular 
Aglycone Delivery 
 
1.1 Introduction 
1.1.1 Role of Carbohydrates in Nature 
Carbohydrates play an important biological role in virtually all living organisms. 
By their appendage to proteins, lipids, and other conjugates, carbohydrates affect a wide 
variety of essential biological functions.
1
 These functions include, but are not limited to: 
cell-growth regulation, protein anchoring, cell differentiation, inflammation, bacterial and 
viral infections, metastasis, and immunological response. One of the most identifiable 
examples of these characteristics is found in the glycoproteins of human red blood cells, 
which determine our blood type (Scheme 1.1). A molecular recognition event such as a 
blood transfusion containing mismatched blood types can result in drastic effects 
stemming from these seemingly minor differences in glycoforms. 
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Scheme 1.1 Human Blood Type Determined by Glycoprotein Structure 
 
Carbohydrates may be assembled into a plethora of different structures due to the 
variety of known monosaccharide units, as well as the positional diversity in which they 
can be assembled into larger building blocks. The possibility of regioisomeric 
connections at the 2-, 3-, 4-, and 6-OH, and the fact that glycosidic linkages have two 
different diastereomers, α and β, present an almost endless possibility of carbohydrate 
structures. 
Nature utilizes enzymes known as glycosyltransferases in late stage 
transformations to append carbohydrates to a variety of macrolides, enediyne, and other 
natural products classes. These carbohydrates often play a key role in the compound’s 
activity due to crucial interactions between the carbohydrate and non-carbohydrate 
functionalities.
2
 This is seen in the macrolide erythromycin A where the dimethylamino 
group of the desosamine sugar unit forms a salt bridge in the enzyme active site resulting 
in its antibacterial mode of action (Scheme 1.2).
3
 In the absence of the desosamine sugar, 
the compound loses all of its potent antibacterial properties. 
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Scheme 1.2 Glycosylated Macrolide Antibiotic Erythromycin A 
 
1.1.2 Importance of Carbohydrates in Biological Activity 
As seen with erythromycin A, carbohydrate-derived interactions can play an 
important role in the biological activity of a compound. This has provided scientists with 
an approach to the ongoing search for new and promising biologically active compounds. 
Modifying appended carbohydrates on small molecules is a popular approach to 
increasing biological activity. Glycosylated compounds provide an excellent platform for 
discovering new compounds, and one elegant application of this strategy came from the 
development of glycorandomization by Thorson and coworkers.
4
 
Thorson achieved the glycosylation of highly complex molecules in a very 
selective fashion with a variety of monosaccharides. This was done through the symbiotic 
use of nucleotide diphosphate sugars (NDP-sugar) and several glycosyltransferase 
enzymes. Known glycosyltransferases were subjected to directed evolution to decrease 
substrate specificity while maintaining high degrees of site-selectivity. This allowed the 
use of an array of NDP-sugars to selectively modify certain hydroxyl groups on natural 
products such as calicheamycin and vancomycin (Scheme 1.3).
5
 
While the use of enzymology allows for a rapid library synthesis of highly 
complex glycoconjugates of known active compounds, it is still limited by the need for 
available glycosyltransferases, as well as a strong understanding of their mode of action. 
4 
 
These glycosyltransferases must also be evolved to achieve enough promiscuity to accept 
a variety of NDP-sugars while still maintaining high efficiency for selective 
glycosylation of the desired hydroxyl group. 
Scheme 1.3 Glycorandomization Approach 
 
In addition to the glycorandomization method, the Thorson laboratory also 
developed a ligation approach to derivatizing glycosylated molecules, which is known as 
neoglycorandomization.
6
 In this method, the natural carbohydrate is excised from a 
compound, and the resulting alcohol on the aglycone is oxidized to a ketone, followed by 
condensation with methoxylamine to form an oxime. This oxime is then reduced to the 
secondary methoxylamine to give the desired ligation framework. This framework then 
reacts with a host of unprotected reducing sugars to form the ligated neoglycoside 
(Scheme 1.4). This methodology allows for the rapid synthesis of a library of 
neoglycosides for screening new front-line drug candidates. This technique was used to 
discover a more potent analogue of the glycosylated steroid digitoxin. In the process of 
developing neoglycorandomization, the investigators gained a better understanding of 
how minor changes in sugar structure can dramatically modulate the biological activity of 
a compound. 
Scheme 1.4 Neoglycorandomization Method 
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While both of these impressive demonstrations from Thorson and coworkers 
provided elegant approaches to the modification of compounds with unnatural 
glycosides, it would be beneficial to develop a purely chemical method to complement 
this work. This method would not depend on glycosyltransferases or developing an 
appropriate mode of ligation, instead selective installation of glycosides would be 
dictated by measures such as the reactivity of various functional groups with site-
selective catalysts. 
1.2 Glycosylation Methods and Challenges 
1.2.1 Glycosylation Background and Nomenclature 
The importance of carbohydrates in biological systems has resulted in a large 
body of literature focused on their synthesis. O-Glycosides are formed by the activation 
of a glycosyl donor to facilitate the formation of an oxocarbenium ion by assisted 
displacement of the anomeric leaving group. A wide variety of leaving groups have been 
developed and utilized in O-glycoside formation, most commonly consisting of: halides, 
thioethers, orthoesters, carbonates, trichloroimidates, 4-pentenyl alcohols, phosphates, 
sulfoxides, sulfones, and glycals.
7
 Upon activation of the glycosyl donor, a hydroxyl 
group of a glycosyl acceptor adds to the electrophilic oxocarbenium ion to form the 
desired glycosidic bond (Scheme 1.5). Additionally, 1-hydroxy sugars can be used as 
nucleophiles to displace an electrophilic species to form the glycosidic bond.
8
 
Scheme 1.5 Formation of a Glycosidic Bond 
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In order to achieve formation of the desired glycosidic bond, all potentially 
nucleophilic functionalities must be protected on both the glycosyl donor and acceptor. 
Formation of the O-glycosidic bond can occur from either of the two faces of the 
oxocarbenium ion, resulting in two different anomers of the same product. Since this 
dissertation will largely involve the use of the D-glucose and D-mannose sugars, the 
designation of α- and β-anomers will be defined by these sugar configurations. In the D-
series of sugars, an axial glycosidic bond is designated α, whereas the corresponding 
equatorial bond is β. Additionally, these sugars have positional numbers associated with 
their carbons, numbered one through six, starting with one at the anomeric position and 
going around the ring to the methylene carbon which is designated six (Scheme 1.6). 
This nomenclature will be used throughout the remainder of this dissertation. 
Scheme 1.6 Anomeric Designation and Numbering in D-Sugars 
 
1.2.2 Challenges in Synthesizing Glycosidic Bonds 
Great efforts have been devoted to developing methods where compounds are 
glycosylated with high anomeric selectivity. A common approach to the synthesis of 1,2-
trans glycosides utilizes neighboring group participation, or anchimeric assistance, in 
which a group located elsewhere in the glycosyl donor serves to shield the cis-face by 
through-space stabilization of the oxocarbenium ion. This results in high selectivity for 
addition of the glycosyl acceptor from the opposite face. A common way to employ the 
neighboring group participation strategy is to protect the 2-hydroxyl position with an acyl 
group such as an acetate or benzoate ester. This often leads exclusively to the 1,2-trans 
7 
 
product (Scheme 1.7) and is commonly used to synthesize β-glucose and α-mannose 
glycosides. 
Scheme 1.7 Neighboring Group Participation in Glycosylations 
 
The selective synthesis of 1,2-cis glycosides poses a much greater challenge. 
When considering the synthesis of α-glucosides, one can often achieve good to excellent 
selectivity for the axial glycosidic bond under thermodynamic glycosylation conditions. 
The kinetic product for D-glucose, even in the absence of a participating group at the 2-
hydroxyl position, is the β-anomer due to the steric repulsion from the 2-hydroxyl group. 
However, the thermodynamic product is the α-anomer due to the anomeric effect which 
provides stabilization of the axial C—O bond by lone pair delocalization from the pyran 
oxygen into the σ*-orbital of the glycosidic bond. Therefore, selectivity for the α-anomer 
of glucose can be observed under the appropriate thermodynamic conditions.  
The synthesis of β-mannosides provides additional challenges because the α-
mannoside product is both kinetically and thermodynamically favored. An elegant 
solution to the synthesis of β-mannosides was developed by Crich and coworkers.9 When 
utilizing Kahne’s method for sulfoxide activation, they observed a drastic difference in 
anomeric selectivity based on the order of addition of reagents. When sulfoxide 1 was 
mixed with glycosyl acceptor 2 and 2,6-di-tert-butyl-4-methyl pyridine (2,6-DTBMP) at -
78 °C, followed by addition of triflic anhydride (Tf2O) the glycosidic product was 
isolated with a 91:9 α:β ratio (3:4, 64% yield). However, when 1 was first mixed with 
2,6-DTBMP and Tf2O at -78 °C, and allowed to stir for two to five minutes, followed by 
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addition of glycosyl acceptor 2, a marked reversal in anomeric selectivity was observed, 
shifting to a 9:91 α:β ratio (3:4, 93% yield) (Scheme 1.8). 
Scheme 1.8 Crich's Method of β-Mannosylation 
 
Detailed 
1
H, 
13
C, and 
19
F-NMR studies showed that in Crich’s glycosylation 
protocol the observed selectivity is a result of the formation of an anomeric α-triflate.10 
This leaving group is displaced in a SN2-like fashion resulting in high selectivity for the 
β-mannoside. This method continues to be state-of-the-art for the formation of β-
mannosides despite the fact that it requires protection of all potentially nucleophilic 
groups on the glycosyl donor and acceptor. Additionally, modest β-selectivity is observed 
with some glycosyl acceptors lacking sufficiently nucleophilic hydroxyl groups. A 
method that overcomes these limitations would prove to be highly useful. 
1.2.3 Intramolecular Aglycone Delivery 
In the early 1990’s, a series of communications were published in an effort to 
overcome the challenges of synthesizing 1,2-cis glycosides, specifically β-mannosides. 
The unifying strategy in these reports was the use of a temporary linker to tether the 
glycosyl donor to the acceptor. The acceptor was tethered to the 2-hydroxyl group such 
that it was spatially oriented for delivery via a 5-membered transition state resulting in 
formation of the 1,2-cis glycoside exclusively (Scheme 1.9).
11
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Scheme 1.9 Intramolecular Aglycone Delivery Methods 
 
The first temporary linkage used for intramolecuar aglycone delivery was 
reported by Hindsgaul and coworkers.
12
 An isopropylidine ether was treated with acid in 
the presence of the desired glycosyl acceptor to form a dimethyl ketal linker (Scheme 1.9, 
equation A). Activation of the thioethyl leaving group with N-iodosuccinimide (NIS) 
resulted in good yields of the desired β-mannoside. The use of hindered glycosyl 
acceptors resulted in low yields for both the ketal and β-mannoside formation, and is a 
significant limitation of this methodology.  
An alternative design for intramolecular aglycone delivery was developed by Ito 
and Ogawa using a p-methoxybenzyl protected 2-hydroxyl group.
13
 Treatment of this 
compound with DDQ in the presence of an alcohol oxidatively formed the desired acetal 
linkage. Activation of the glycosyl fluorides with AgOTf and SnCl2 in the presence of 
water gave good yields of the β-mannoside exclusively (Scheme 1.9, equation B). This 
method was further improved by its development with thioglycosides which allowed a 
greater range of hindered glycosyl acceptors to be glycosylated in good yield.
14
  
10 
 
The Stork group used dichlorodimethylsilane to link the 2-hydroxy glycosyl 
donor to a hydroxyl group on the acceptor resulting in a dimethylsilyl-linker (Scheme 
1.9, equation C).
15
 The sulfur leaving group of the silyl-linked compounds is oxidized to 
the sulfoxide by m-CPBA, and subsequent treatment with Tf2O provided the β-
mannoside as the only isolated anomer. A report using the same dimethylsilyl-linked 
strategy was simultaneously reported by Bols in the synthesis of α-glucosides.16 All of 
these methods provided creative solutions to synthesizing the challenging 1,2-cis 
glycosidic linkage, however they are all limited by the necessity to protect any other 
nucleophilic functionalities. 
1.3 Development of Sugar Silanes 
1.3.1 Merging of Carbohydrate Chemistry and Transition Metal Catalysis 
Stork and Bols’ use of a temporary silyl-linkage to tether glycosyl acceptors and 
donors for the synthesis of β-mannosides and α-glucosides respectively, provided us with 
inspiration to develop a new method for the synthesis of these silyl-linked intermediates. 
Our research group saw this as an opportunity to impart our expertise in the field of 
transition metal catalysis and utilize the commonly employed silane reducing agent to 
synthesize silyl-linked compounds for intramolecular aglycone delivery. A variety of 
transition metal-catalyzed procedures use silanes to synthesize O—Si bonds either by 
hydrosilylation of ketones, dehydrogenative silylation of alcohols, or reductive coupling 
of carbonyl compounds with other π-systems (Scheme 1.10).17 
Scheme 1.10 Transition Metal Catalysis Utilizing Silanes 
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Transition metal catalysis has many advantages such as the ability to finely tune 
reactivity of a metal complex by altering the choice of ancillary ligands. The opportunity 
to achieve high levels of chemoselectivity in complex systems comes with the ability to 
fine-tune the reactivity of metal complexes.  
Stork and Bols’ use of a silyl-tether to afford high levels of anomeric selectivity 
provided an excellent solution to the synthesis of 1,2-cis glycosides. However, we felt 
that the way in which the silyl-linked tethers were synthesized could be greatly improved. 
Instead of using a dichlorodimethylsilane to tether a glycosyl acceptor and donor, we 
proposed using chlorodimethylsilane to synthesize a carbohydrate-bearing silane 
reducing agent (Scheme 1.11). This would allow us to synthesize the desired silyl-linked 
compounds while benefitting from the tunable reactivity of transition metal catalysis, 
thereby allowing the synthesis of O-glycosides from the standard alcohol oxidation state 
by dehydrogenative silylation. This strategy would also allow the unconventional 
synthesis of O-glycosides from ketones by carbonyl reduction. Additionally, C—C bonds 
can be formed in the synthesis of aglycones by the silane-mediated reductive coupling of 
two π-systems. These new opportunities utilizing carbohydrate-bearing silanes could 
provide useful new avenues for the selective incorporation of glycosides in complex 
settings and provide a purely chemical method for the rapid discovery of new 
biologically active compounds. 
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Scheme 1.11 New Opportunities for Glycosylation with Sugar Silanes 
 
1.3.2 Synthesis of Carbohydrate-Bearing Silane Reducing Agents 
Carbohydrate-bearing silane reducing agents were unknown at the time of our 
proposal, so we envisioned synthesizing a 2-hydroxy glycosyl donor that could be 
converted into a silane reducing agent, which we have termed a ―sugar silane.‖ These 
silane reducing agents can be synthesized from the commercially available 
chlorodimethylsilane. A robust, large scale synthesis of sugar silanes was designed 
starting from inexpensive starting materials, to allow us to explore their applications 
(Scheme 1.12).
18
  
To begin the synthesis of the desired glucose variant of a sugar silane reducing 
agent, the commercially available glucose pentaacetate 5 was treated with a mixture of 
hydrobromic and acetic acid in methylene chloride to generate the glycosyl bromide 6. 
Refluxing 6 in methylene chloride in the presence of methanol, and tetrabutylammonium 
bromide with 2,6-lutidine as an acid scavenger, yielded the orthoester 7, which serves to 
protect the 2-hydroxy position. Treatment of 7 with an ammonia solution in methanol 
13 
 
removes the acetate groups to produce triol 8. Perbenzylation of 8 is achieved by 
treatment with sodium hydride in the presence of benzylbromide to yield orthoester 9. 
The thioglucoside 10 is next synthesized by the mercuric bromide catalyzed opening of 
the orthoester in the presence of a thiol and 4Å molecular sieves. The 2-hydroxyl position 
is deacylated in basic methanol to give the 2-hydroxy silane precursor 11. At this stage in 
the synthesis, the only chromatographic purification is performed to give the pure 2-
hydroxy sugar. It was also found that the purification of 2-hydroxy glucose compounds 
could be achieved using only a short plug of silica gel to remove non-polar impurities 
followed by elution of the impure 11 away from the highly polar impurities. 
Recrystallization from a mixture of methylene chloride and hexanes gave 11 as a white 
crystalline solid. This can then be silylated with triethylamine and chlorodimethylsilane 
to give the desired sugar silane 12. Purity of 11 is paramount as the desired dimethyl 
sugar silane is not stable to column chromatography; rather, it is obtained pure upon 
aqueous workup. The sugar silane compound can be stored for months frozen in benzene, 
or neat under reduced pressure, and used with comparable results to freshly prepared 
silane. Alternatively, the corresponding 2-hydroxy compound is stable to bench top 
storage indefinitely.  
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Scheme 1.12 Synthesis of a Glucose Sugar Silane 
 
The synthesis of a mannose sugar silane begins with peracylation of D-mannose 
13 in a mixture of acetic anhydride and pyridine to give peracylated mannose compound 
14. This is then treated to the exact same sequence as described for the synthesis of the 
glucose sugar silane, with the exception that in the orthoester forming step, no 
tetrabutylammonium bromide is required (Scheme 1.13). Despite repeated efforts, all 
attempts to crystallize the 2-hydroxy thiomannosides failed, requiring careful flash 
chromatography to yield the desired pure 2-hydroxy compound as a colorless oil. 
Treatment of the mannose alcohol with triethylamine and chlorodimethyl silane produces 
the desired mannose sugar silane 15.  
Scheme 1.13 Synthesis of a Mannose Sugar Silane 
 
 Both the glucose and mannose sugar silanes are readily prepared on multigram 
scale in seven or eight steps respectively, and begin from widely available inexpensive 
reagents. The syntheses are robust, generally yielding the desired compound in an overall 
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40-50% yield (~90% yield per step), with only a single chromatographic purification. 
Although both the β-thioglucosides and α-thiomannosides are isolated exclusively in this 
sequence, it has been shown by Stork that the anomeric stereochemistry of the sulfur 
leaving group is inconsequential in intramolecular aglycone delivery.
15
 The first 
syntheses of sugar silane reducing agents has been now completed, it was time to test our 
hypothesis for the formation of silyl-linked compounds by employing transition metal 
catalysis. 
1.4 Glycosylation of Ketones 
1.4.1 Ketone Hydrosilylation Background 
The reduction of carbonyl compounds with silanes has been extensively studied 
due to the ease of handling silane reducing agents, and wide variety of  known catalysts 
are available to catalyze this transformation. Extensive studies of both asymmetric and 
non-asymmetric carbonyl hydrosilylations have been reported using ligand-metal 
frameworks of the metals: gold, silver, copper,
19
 platinum, nickel,
20
 titanium,
21
 
rhodium,
22
 ruthenium,
23
 iridium,
24
 iron,
25
 and zinc.
26
 Additionally, electrophilic borane 
reagents have been utilized to reduce carbonyl compounds with organosilanes.
27
 Each of 
these catalyst classes has their merits, as well as disadvantages, in various aspects of 
synthetic utility. The wide variety of options allow one to select the ideal catalyst system 
based on chemoselectivity, mild reaction conditions, high catalyst turnover, cost of 
reagent, or generality. Despite all the known ketone hydrosilylation methods, there still 
remains the need for new synthetically useful methods that expand the utility of this well 
known transformation. 
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1.4.2 Developing Conditions for Ketone Reduction by Sugar Silanes 
The synthesis of O-glycosides generally proceeds through the addition of a 
nucleophilic alcohol into the electrophilic oxocarbenium ion, or by displacing an 
activated leaving group, to form the desired glycosidic bond. We were interested to see if 
glycosylation could be approached from a higher oxidation state through a 
hydrosilylation/glycosylation sequence utilizing sugar silanes. A variety of nickel(0)-
ligand combinations were screened in the hydrosilylation of ketones. Of the various 
phosphine and N-heterocyclic carbenes, it was found that a nickel(0)-IMes catalyst 
system was most ideal. A screen of additives also found that reaction rates and yields 
were improved by the addition of Lewis acidic titanium tetraisopropoxide (Ti(OiPr)4). An 
optimized procedure was developed by treating 1.0 equivalent of ketone with 1.1 
equivalents of sugar silane, 1.1 equivalents of Ti(OiPr)4, and 10 mol% of a Ni(0)-IMes 
catalyst in a 0.1M solution of dry THF. 
Treatment of benzylacetone with the thioethyl glucose sugar silane under the 
optimized hydrosilylation procedure resulted in a 97% isolated yield of 16. It should be 
noted from the 54:46 dr of 16 that the chirality of the sugar silane does not transfer well 
to the facial selectivity of the reduction. The silyl-linked compound is then activated for 
glycosylation with NIS, trimethylsilyl trifluoromethanesulfonate (TMSOTf), and 2,6-
DTBMP, followed by addition of nBu4NF to produce the desired α-glucoside 17 as two 
readily separable diastereomers in an excellent 97% yield (Scheme 1.14). To our 
knowledge, this was the first demonstration of a ketone being directly converted to a 
glycoside without going through a hydroxylic intermediate.  
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Scheme 1.14 First Example of the Glycosylation of a Ketone 
 
The Ni(0)-IMes catalyzed hydrosilylation of ketones was mild enough to tolerate 
cyclic ketals in high yield to produce compound 18 in 96% yield. This was converted to 
the corresponding α-glucoside 19 in 82% yield. A ketone bearing a tertiary basic amine 
also performed well in the hydrosilylation producing 20 in nearly quantitative yield. The 
silyl-linked compound was activated using the NIS/TMSOTf procedure to give the α-
glucoside 21 in 70% isolated yield (Scheme 1.15).  
Scheme 1.15 Functional Group Tolerance in Ketone Glycosylation 
 
A limitation of the method was realized when trying to reduce the sterically 
hindered (-)-menthone using the Ni(0)-IMes conditions, as the desired silyl-linked 
compound 22 was isolated in 20-25% yield. A survey of the literature led us to a Cu(I)-
IMes catalyst developed by Nolan and coworkers for the efficient hydrosilylation of 
hindered ketones.
28
 When the Cu(I)-IMes catalyst was used in the reduction of (-)-
menthone with the thioethyl glucose sugar silane, 22 was produced in a synthetically 
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useful 68% yield with a 2:1 dr. Unfortunately, upon activation with NIS/TMSOTf, the 
desired α-glucoside 23 was only isolated in 20% yield (Scheme 1.16). It was proposed 
that by switching from thioethyl, to the more active thiophenyl leaving group, a better 
glycosylation yield could be achieved. The thiophenyl glucose sugar silane and (-)-
menthone were treated with Cu(I)-IMes to give 24 in a 64% yield and 2:1 dr. The silyl-
linked compound, with the thiophenyl leaving group, was treated with the NIS/TMSOTf 
glycosylation conditions, resulting in a synthetically useful 72% yield of 23, with a 5:1 
dr. The enhancement of the diastereomeric ratio from 24 (2:1) to 23 (5:1) is the result of 
the major diastereomer undergoing glycosylation at a much faster rate than the minor 
diastereomer, producing the observed enhancement of diastereoselectivity. 
Scheme 1.16 Glycosylation of Hindered Ketones  
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Having now demonstrated sugar silanes as effective reagents for the 
hydrosilylation and glycosylation of ketones to synthesize α-glucosides, we now wished 
to explore mannose sugar silanes for the synthesis of β-mannosides. The thioethyl 
mannose sugar silane and ketal-bearing cyclic ketone were treated with the Ni(0)-IMes 
catalyst system in the presence of Ti(OiPr)4 to give 25 in 86% yield, which upon 
treatment with NIS/TMSOTf gave the β-mannoside 26 exclusively in a modest 58% yield 
(Scheme 1.17). Additionally, the utilization of Nolan’s Cu(I)-IMes catalyst resulted in the 
reduction of the hindered ketone (-)-menthone with a thiophenyl mannose silane to 
produce 27 in 75% with a 2:1 dr. Glycosylation of 27 proceeded in 74% yield to give the 
β-mannoside 28. However, in this case there was a drastic difference in the rates of 
glycosylation of the major and minor diastereomer resulting in a 10:1 dr. 
Scheme 1.17 Synthesis of β-Mannosides from Ketones 
 
As we continued to explore the scope of the glycosylation of ketones, we tested 
the selective reduction of a ketoester. Using the Ni(0)-IMes catalyst resulted in selective 
reduction of the ketone. However, Ti(OiPr)4 catalyzed a transesterification of the ethyl 
ester. This reaction, stopped before completion, gave the desired ketone reduction 
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product 29 in 60% yield of which approximately 85% of the isopropyl ester was present 
(Scheme 1.18). This undesired background reaction could potentially be masked by using 
a titanium Lewis acid with the same alkoxide group as the ester. Additionally, treatment 
of p-cyanoacetophenone with a sugar silane and the nickel catalyst resulted in no desired 
product. The aryl nitrile presumably coordinated to the nickel irreversibly, or oxidized the 
Ni(0) catalyst, leading to an unproductive reaction. 
Scheme 1.18 Functional Group Incompatabilities in Ketone Glycosylation 
 
1.4.3 Proposed Mechanism for Ni(0)-IMes and Cu(I)-IMes Hydrosilylation 
We have now reported the use of sugar silanes in the hydrosilylation of ketones 
with Ni(0)-IMes and Cu(I)-IMes catalysts. While both of these species are isoelectronic 
d
10
 metal-ligand combinations, it is proposed that they operate with fundamentally 
different mechanistic pathways. We proposed that the Ni(0)-IMes catalytic cycle goes 
through a Ni(0)-Ni(II) cycle which is interchanged by the sugar silane reducing agent 
(Scheme 1.19). The Ni(0)-IMes catalyst presumably is oxidized by addition to the silicon 
hydride bond of the sugar silane to form Ni(II) species 30. Coordination of 30 to the π-
bond of a ketone forms complex 31, which can undergo migratory insertion to produce 
Ni(II)-alkoxide 32. Reductive elimination from 32 produces the desired hydrosilylated 
product 33, and the active Ni(0)-IMes catalyst for re-entry into the catalytic cycle. 
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Scheme 1.19 Proposed Catalytic Cycle for Ni(0)-IMes Catalyzed Hydrosilylation 
 
While the sugar silane serves to shuttle nickel between oxidation states, Nolan 
and coworkers proposed that the copper catalyst remains in the Cu(I) oxidation 
throughout the entire cycle (Scheme 1.20). They proposed that displacement of chloride 
from copper with sodium tert-butoxide occurs to make 34, followed by σ-bond 
metathesis with the organosilanes, producing the active copper hydride 35. This 
coordinates to a ketone to give copper complex 36, which is proposed to undergo 
migratory insertion across the π-bond (37), producing copper alkoxide 38. Another σ-
bond metathesis with the silane generates the desired hydrosilylation product 33, and 
regenerates the active copper hydride 35 for additional catalytic turnover. 
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Scheme 1.20 Nolan's Proposed Cu(I)-IMes Hydrosilylation Catalytic Cycle 
 
1.4.4 Site-Selective Glycosylation of Ketones 
We have now demonstrated that ketones can effectively be glycosylated by 
hydrosilylation with a Ni(0)-IMes catalyst to generate 1,2-cis glycosides. We ultimately 
hoped to exploit high levels of selectivity so commonly associated with transition metal 
mediated processes with an eye towards achieving site-selective glycosylations of 
polyfunctional substrates. When contemplating how we could apply sugar silanes to 
improve current methods for glycosylating molecules containing multiple hydroxyl 
groups, we considered how one would synthesize the glycosylated compound 39 
(Scheme 1.21).  
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Scheme 1.21 Retrosynthetic Approach to 39 Using Current Methods 
 
Using standard methods for the synthesis of 39, one would need to consider 
several different factors. First, the relative stereochemistry of the aglycone must be 
preassembled prior to any attempts at glycosylation. Second, one must choose a suitable 
set of glycosylation conditions and protecting group array on the glycosyl donor to ensure 
high selectivity in forming the desired anomer. Third, and most important, one must 
block the more nucleophilic primary alcohol in order to glycosylate the less reactive 
secondary alcohol. This dependence on a protecting group strategy adds two additional 
steps to the synthesis, as the blocking group must be put on and then removed at a later 
stage, thereby reducing the efficiency of the synthesis of compound 39.  
In order to overcome these limitations, we proposed approaching the 
glycosylation from a higher oxidation state with a sugar silane. By doing so, site-
selectivity could be achieved between a ketone and an alcohol, relative stereochemistry 
could be imparted on the aglycone by reduction, and complete control of anomeric 
stereochemistry could be achieved (Scheme 1.22). 
Scheme 1.22 Retrosynthetic Approach to 39 Using a Sugar Silane 
 
With the hope of testing our ketone hydrosilylation strategy in the synthesis of 
glycoside 39, hydroxyketone 42 was synthesized and subjected to the Ni(0)-IMes 
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conditions with 2.2 equivalents of Ti(OiPr)4.  Gratifyingly, this led almost exclusively to 
the ketone reduction product 43 in an 86% isolated yield with a 5:1 dr (Scheme 1.23). 
The silyl-linked compound was then activated using NIS and TMSOTf to yield the 
desired α-glucoside 39 in 97% yield. Not only was complete control of anomeric 
stereochemistry achieved, relative stereochemistry of the aglycone was set during the 
same hydrosilylation step. Glycoside 39 was synthesized without the use of protecting 
groups to mask the reactivity of the more nucleophilic primary hydroxyl group, 
highlighting the utility of sugar silanes in streamlining the synthesis of glycosides. 
Scheme 1.23 Site-Selective Glycosylation of a Hydroxyketone 
 
In our continued efforts to explore the role of catalyst-derived selectivity, we also 
subjected hydroxyketone 42 to the isoelectronic Cu(I)-IMes catalyst conditions. In this 
case, a complete reversal in site-selectivity was observed. Now dehydrogenative 
silylation was favored to form compound 44 in 57% yield. This could be converted to the 
α-glucoside 45 in a moderate 62% yield (Scheme 1.24). In addition to the 
dehydrogenative silylation product, 7% of the bis-silylated compound was also isolated. 
This diminished selectivity is a function of the increased reactivity of the Cu(I)-IMes 
catalyst system.  
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Scheme 1.24 Copper Catalyzed Reversal of Site-Selectivity with Sugar Silanes 
 
The observed reversal in selectivity in the glycosylation of hydroxyketone 42 is 
exactly the type of catalyst controlled site-selective glycosylation we hoped to uncover 
when introducing sugar silanes. Rigorous mechanistic studies have not been conducted to 
determine the origin of site-selectivity with hydroxyketones between the Ni(0)- and 
Cu(I)-IMes catalysts. However, we speculate that the catalyst’s preference for ketone 
hydrosilylation or alcohol dehydrogenative silylation is related to the active hydride 
species of each catalyst (Scheme 1.25).  
Scheme 1.25 Proposed Difference in Site-Selectivity for Ni- and Cu-Hydrides 
 
Despite the isoelectronic nature of the nickel and copper catalysts in their inactive 
species, the active metal hydride species are quite different. The active hydrosilylating 
species with Ni(0)-IMes is proposed to be the d
8
 nickel-hydride species 30, whereas the 
active copper-hydride species is a d
10
 Cu(I)-catalyst that lacks the silyl ligand. It is 
possible that nickel-hydride 30 preferentially binds to the π-system of a ketone, while 
copper-hydride 35 complexes with alcohols. This is our proposed explanation for the 
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observed selectivity differences between catalysts reacting with hydroxyketone 42 and a 
sugar silane.  
The other main difference in comparing the nickel and copper site-selectivity 
respectively, is the presence of Ti(OiPr)4 in the ketone hydrosilylation of 42 and its 
absence in the dehydrogenative silylation. This raised the question about what role the 
Lewis acid was playing in the ketone reduction. We set out to understand if it was 
actually acting as an in situ protecting group for the primary hydroxyl group, ultimately 
leading to the observed selectivity for ketone reduction. In order to probe this question, 
we subjected 42 to the Cu(I)-IMes conditions, in the presence of 2.2 equivalents of 
Ti(OiPr)4, to see what effect it would have on the selectivity of the silylation (Scheme 
1.26). If the selectivity reversed from favoring dehydrogenative silylation, to ketone 
reduction in the presence of Ti(OiPr)4, it would provide evidence for the in situ protection 
of the primary alcohol by the Lewis acid. When the reaction was conducted, very little 
silylated 42 was observed. The major product was derived from the dehydrogenative 
silylation of adventitious isopropanol from Ti(OiPr)4 to form 46. This provided further 
evidence for the ketone hydrosilylation selectivity in the Ni(0)-IMes catalyst system with 
sugar silane reducing agents. 
Scheme 1.26 Determining the Role of Ti(OiPr)4 in Site-Selective Glycosylation 
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In order to further understand the selectivity in the nickel mediated reduction of 
hydroxyketone 42, the oxidation states of the ketone and alcohol were interchanged to 
make hydroxyaldehyde 47. This was done to explore the possibility of any silyl- or 
glycosyl-transfer between the primary and secondary alcohol. Treatment of 47 with the 
Ni(0)-IMes catalyst and 2.2 equivalents of Ti(OiPr)4, resulted entirely in carbonyl 
reduction to produce 48 in 44% yield (Scheme 1.27). This was isolated predominately as 
the trans-diastereomer, because the cis-diastereomer presumably formed an unreactive 
hemiacetal under the reaction conditions. This was then glycosylated to give the α-
glucoside 49 in 95% yield with no evidence of silyl- or glycosyl-transfer.  
Scheme 1.27 Exploring Silyl- or Glycosyl-Transfer Pathways 
 
With a more thorough understanding of the site-selective glycosylation of 
hydroxyketones, we explored additional substrates. The steroid dihydrotestosterone was 
reduced with the thioethyl glucose sugar silane and the Ni(0)-IMes catalyst system to 
afford 50 in an 89% yield and 5:1 dr with no detection of dehydrogenative silylation 
(Scheme 1.28). This was glycosylated to give the α-glucosylated steroid 51 in a 95% 
yield and no change in the dr. Similarly, treatment of dihydrotestosterone with the 
thioethyl mannose sugar silane under the same conditions yielded 52 in 80% with a 6:1 
dr, with no detection of dehydrogenative silylation. Treatment of 52 with NIS and 
TMSOTf gave β-mannoside 53 in 87% yield (6:1 dr). This again demonstrated the utility 
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of the site-selective glycosylation of hydroxyketones with transition metal catalysts and 
sugar silanes. 
Scheme 1.28 Site-Selective Glycosylation of Dihydrotestosterone 
 
1.5 Future Directions and Ketone Glycosylation Summary 
1.5.1 Developing Asymmetric Ketone Reductions with Sugar Silanes 
In order to improve the utility of ketone glycosylation, an asymmetric reduction 
of ketones must be developed. As demonstrated in the reduction of benzylacetone with 
the thioethyl sugar silane and Ni(0)-IMes, which resulted in a 54:46 dr. The reduction of 
cyclic ketones such as 42 with Ni(0)-IMes, generally resulted in approximately 5:1 dr, 
favoring an equatorial approach of the metal-hydride (Scheme 1.29). This is most likely 
due to the nickel-hydride species also containing the moderately bulky sugar component 
of the silane. Generally, as steric bulk of a hydride reducing agent increases, the 
equatorial delivery of the reducing agent to cyclic ketones becomes more favored, 
resulting in the axial C—O bond.29  
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Scheme 1.29 Diastereoselectivity Observed in Ketone Reduction with Ni(0)-IMes 
 
Although each diastereomer can often be obtained in pure form upon 
chromatographic purification after glycosylation, it would be more synthetically useful to 
have an asymmetric catalyst that could produce high levels of diastereoselectivity. 
Ideally, a catalyst system would not only selectively reduce prochiral ketones, but also 
maintain high levels of site-selectivity in polyfunctional molecules similar to that 
demonstrated by the Ni(0)-IMes catalyst. In order to find a ligand that provided 
diastereocontrol in ketone reduction, a quick study was devised with chiral N-
heterocyclic carbenes (NHCs) developed in our lab for the asymmetric nickel-catalyzed 
reductive coupling of aldehydes and alkynes.
30
 In order to simplify the determination of 
selectivity, the less complex triethyl- and triphenylsilane were used as the reducing agent 
(Scheme 1.30).  
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Scheme 1.30 Asymmetric Ketone Reduction Ligand Screen 
 
In an attempt to quickly assay several ligands for asymmetric reduction of 
ketones, acetophenone was chosen, and chiral HPLC conditions were developed for the 
separation of enantiomers from a non-selective sodium borohydride reduction. Chiral 
NHCs 54-57 and Ni(cod)2 were used with Et3SiH and Ph3SiH to reduce acetophenone, 
followed by addition of nBu4NF, to probe the enantiomeric excess of the alcohol 
reduction product. It was found that NHC 54 gave 6% ee with Et3SiH and 1% ee with 
Ph3SiH. The bulky C2-symmetric ligand 55 and Et3SiH gave a slight increase in 
enantiomeric excess up to 12% ee, Ph3SiH resulted in a lower 3% ee. Switching to non-
C2-symmetric NHCs, 56 and 57, did not improve the enantiomeric excess any further.  56 
gave a 6% ee with Et3SiH, whereas 57 did not react with Et3SiH and produced nearly no 
facial selectivity when using Ph3SiH. It was determined at this point that the chirality 
transfer from these ligands, designed for the asymmetric reductive coupling of aldehydes 
and alkynes, did not relate to prochiral facial selectivity in ketone reductions. Therefore, 
future efforts must focus on expanding the ligands to be screened in order to better 
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understand how the spatial features of the asymmetric catalyst will transfer to selective 
ketone reduction. 
1.5.2 Ketone Glycosylation in Complex Molecules 
  The ultimate goal of developing sugar silanes to merge the fields of carbohydrate 
chemistry and transition metal catalysis is to have the ability to selectively incorporate 
glycosides into complex molecules based on the functional group, without protecting 
groups. This would provide the purely chemical complement to the glycorandomization 
approach of Thorson that was mentioned earlier in this chapter. After developing the 
glycosylation of ketones and gaining a better understanding for the site-selective 
glycosylation of hydroxyketones, we wished to push the limits of our method by testing it 
in a highly complex setting. Erythromycin A was chosen as a target due to its high level 
of complexity, known biological activity, and single ketone in the presence of many 
hydroxyl groups (Scheme 1.31).  
Scheme 1.31 Attempt at Site-Selective Glycosylation of Erythromycin A 
 
When attempting to hydrosilylate the ketone of Erythromycin A with the thioethyl 
glucose sugar silane and Ni(0)-IMes catalyst system, no desired product was observed. 
Additionally, no dehydrogenative silylation of the macrolide was observed. It appeared 
that solubility of Erythromycin A in THF as well as having 5.5 equivalents of Ti(OiPr)4 
were detrimental to the reaction. In order to better understand how polar solvents would 
affect the Ni(0)-IMes catalyst system, control experiments were conducted with 
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benzylacetone and THF containing 5% DMF or DMSO. The reaction was completely 
tolerant of DMF, but DMSO reduced the yield and efficiency of ketone reduction. These 
solvents would play an important role in the solubility of polar molecules, and their 
compatibility with the nickel-catalyzed hydrosilylation was important to determine. It 
would also be beneficial to develop conditions that do not rely on the addition of Lewis 
acids as complex molecules often contain many Lewis basic sites. This will require the 
addition of a large excess of the Lewis acid, possibly causing undesired side reactions.  
1.5.3 Summary of Sugar Silanes in the Glycosylation of Ketones 
This chapter has focused on the development of sugar silanes and their utilization 
with transition-metal catalysis. An orthogonal glycosylation strategy has been developed 
in which ketones are directly converted to O-glycosides for the first time. This method 
generally produces high yields in both the reduction of ketones and glycosylation of silyl-
linked intermediates which exclusively generate the desired α-glucoside or β-mannoside 
products. Additionally, the catalyst-controlled site-selective glycosylation of 
hydroxyketone 42 was demonstrated (Scheme 1.32).  
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Scheme 1.32 Catalyst-Controlled Site-Selective Glycosylation of a Hydroxyketone 
 
The introduction of sugar silanes as new reagents for glycosylation provides many 
opportunities for novel, site-selective methods in which compounds can be glycosylated 
in a more efficient manner. 
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Chapter 2  
 
Dehydrogenative Silylation with Sugar Silanes: Progress Towards 
Streamlining the Synthesis of Disaccharides 
 
2.1 Introduction to Dehydrogenative Silylation 
2.1.1 Transitioning from Ketone Hydrosilylation to Dehydrogenative Silylation 
The conversion of ketones directly to glycosides without going through a 
hydroxylic intermediate was a fundamentally new advance in the synthesis of O-
glycosidic bonds.
18
 However, it would be useful to develop complementary conditions 
for the site-selective dehydrogenative silylation of alcohols. Many substrates of interest, 
such as carbohydrates, exist in the alcohol oxidation state, and it would be laborious to 
oxidize then reduce the compound to form the desired glycosidic bond (Scheme 2.1). 
Scheme 2.1 Ketone Hydrosilylation vs. Dehydrogenative Silylation with Sugar Silanes 
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When exploring the glycosylation of carbohydrate alcohols such as 58, the 
dehydrogenative silylation pathway is much more practical. Oxidizing the alcohol 
followed by reduction with a sugar silane would add additional steps as well as erase the 
existing stereochemical information. With this in mind we wanted to apply sugar silanes 
to a method aimed at the dehydrogenative silylation of alcohols. Ideally this method will 
be user friendly, mild, and utilize catalyst derived selectivity for the glycosylation of 
hydroxyketones as well as diols. 
2.1.2 Advantages of Dehydrogenative Silylation with Silanes 
Silyl ethers are most commonly synthesized by the nucleophilic addition of an 
alcohol to an electrophilic silylchloride or silyltriflate species in the presence of an amine 
base.
31
 While this is an effective method for the synthesis of the desired silyl protected 
alcohol, it requires an aqueous work up to remove the stoichiometric production of 
ammonium salts. This was used in the synthesis of silyl-linked compounds by Stork and 
Bols by the sequential addition of two different alcohols to dichlorodimethyl silane.
15,16
 
Not only does this require the removal of stoichiometric byproducts and purification of 
sensitive intermediates, but it also requires careful control of addition in order to avoid 
undesired homocoupling of the alcohols (Scheme 2.2, equation A). 
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Scheme 2.2 Differences in Silyl Ether Synthesis 
 
On the other hand, when silylhydride reagents are utilized with a catalyst to form 
silyl ethers, the only byproduct is hydrogen gas, which simplifies purification of the 
desired product. Instead of synthesizing the silyl-linked compounds from 
dichlorodimethyl silane, we use chlorodimethyl silane to make the sugar silane. The 
sugar silane is then coupled to the desired alcohol by dehydrogenative silylation to form a 
silyl-linked compound without any issues of homodimerization (Scheme 2.2, equation 
B). 
2.1.3 Choosing a Dehydrogenative Silylation Catalyst 
Dehydrogenative silylation of alcohols, similar to hydrosilylation of carbonyls, 
has been studied by with an extensive variety of metal catalysts. Complexes of the 
following metals have been utilized: copper,
32
 gold,
33
 iron,
34
 platinum,
35
 nickel,
36
 
iridium,
37
 rhodium,
38
 and ruthenium.
39
 Additionally, the electrophilic tris-
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pentafluorophenyl borane has been utilized to silylate alcohols.
40
 As demonstrated in the 
previous chapter, we discovered that Nolan’s Cu(I)-IMes catalyst, designed for the 
hydrosilylation of hindered ketones, was also an effective catalyst for the 
dehydrogenative silylation of alcohols.
18,28
 In addition to this catalyst system, a wide 
variety of catalysts for dehydrogenative silylation have been reported in the literature. As 
mentioned previously, we hoped to select a catalyst system that would allow for the user 
friendly, mild, and selective silylation of alcohols with sugar silanes. One such catalyst 
that fits this description was tris-pentafluorophenyl borane (B(C6F5)3), developed by Piers 
and coworkers. It was particularly attractive because B(C6F5)3 is bench stable, requires no 
ancillary ligands, operates with low catalyst loading, and proceeds effectively at ambient 
temperature. In addition to these attributes, B(C6F5)3 demonstrated selectivity for 
dehydrogenative silylation of hydroxyketones as well as chemoselectivity in 
differentially substituted alcohols. These attributes provided more than enough 
motivation for us to explore its utility with sugar silanes in the hope of streamlining the 
synthesis of disaccharides.  
2.1.4 Proposed Dehydrogenative Silylation Mechanism with B(C6F5)3 and Cu-IMes 
Piers and coworkers proposed a mechanism where the highly Lewis acidic 
B(C6F5)3, in the presence of an alcohol, is in equilibrium with complex 60 (Scheme 
2.3).
40
 Although the equilibrium between the free borane and alcohol and 60 lies further 
towards the complexed species, the small amount of free B(C6F5)3 can interact with a 
silyl hydride species to form 61. This produces a positively charged, highly electrophilic 
silicon species similar to a silyltriflate, which, in the presence of a free alcohol, forms the 
ion pair 62. This consists of a protonated silyl ether and a borohydride, which quickly 
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liberate hydrogen gas, producing the desired dehydrogenative silylation product, and 
regenerating the active B(C6F5)3 catalyst species. 
Scheme 2.3 Proposed Mechanism of Dehydrogenative Silylation with B(C6F5)3 
 
Alternatively, the Cu(I)-IMes catalyzed dehydrogenative silylation of alcohols is 
proposed to go through a fundamentally different mechanism than that of B(C6F5)3 
(Scheme 2.4). Similar to the mechanism discussed in the ketone hydrosilylation chapter, 
sodium tert-butoxide displaces chloride from copper to form 34, followed by σ-bond 
metathesis with a silane to generate the active copper hydride species 35. This 
coordinates to an alcohol, forming complex 63, followed by σ-bond metathesis (64) to 
liberate hydrogen gas and form copper alkoxide 65. An additional equivalent of silane 
will undergo a σ-bond metathesis to form desired product 66, driven by the strength of a 
Si—O bond, and regenerate the active copper hydride species to re-enter the catalytic 
cycle.  
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Scheme 2.4 Proposed Mechanism for Dehydrogenative Silylation with Cu(I)-IMes 
 
2.2 Dehydrogenative Silylation of Alcohols with Sugar Silanes 
2.2.1 Developing Conditions with B(C6F5)3 and Sugar Silanes 
Piers and coworkers found that B(C6F5)3 effectively catalyzed the 
dehydrogenative silylation of alcohols with a variety of silanes, generally using toluene 
or methylene chloride as the solvent of choice. In order to gain an understanding of the 
reactivity, an initial screening of conditions was carried out with triethylsilane and (-)-
menthol in both of these solvents (Scheme 2.5).  
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Scheme 2.5 Exploring Solvents in B(C6F5)3 Catalyzed Dehydrogenative Silylation 
 
It was found that the dehydrogenative silylation proceeded much faster in 
methylene chloride, so the initial development of conditions with sugar silanes in the 
borane-catalyzed dehydrogenative silylation was carried out in methylene chloride. It was 
found that switching from triethylsilane to the thioethyl mannose sugar silane, the yield 
was much lower. Upon addition of B(C6F5)3, vigorous hydrogen evolution was observed, 
and undesired byproducts indicative of silane decomposition were observed as well as the 
desired product. The sugar silane was considerably more reactive than triethyl silane 
under the same conditions. The observed increase in reactivity when switching from a 
trialkylsilane (67) to a dialkylalkoxysilane (68) was not surprising considering the 
stabilization of the transition state proposed in the borane-mediated hydride abstraction 
operative in this reaction (Scheme 2.6). It was found that switching back to toluene, or in 
some cases a toluene: methylene chloride mixture, resulted in higher yield of the desired 
product. 
Scheme 2.6  Explanation for Increased Reactivity with Sugar Silanes 
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2.2.2 B(C6F5)3 Catalyzed Dehydrogenative Silylation of Alcohols 
With a better understanding for the reactivity of sugar silanes in the B(C6F5)3 
catalyzed dehydrogenative silylation of alcohols, we wanted to apply the method to a 
variety of alcohols. Using 4 mol% of B(C6F5)3 and a thiophenyl glucose sugar silane, (-)-
menthol was silylated in 97% yield to give 69 (Scheme 2.7). Activation with 
NIS/TMSOTf gave the α-glucoside 70 exclusively in 98% isolated yield. Treating (-)-
menthol under the same conditions with a thiophenyl mannose silane produced 71 in 82% 
yield. This was then glycosylated in nearly quantitative yield producing only the β-
mannoside 72. The use of B(C6F5)3 in the dehydrogenative silylation of (-)-menthol with 
both sugar silanes was directly compared to the Cu(I)-IMes procedure, which produced 
69 and 71 in 89% and 77% yield, respectively. Based on these results, it was determined 
that, for the silylation of secondary alcohols, B(C6F5)3 is the catalyst of choice.  
Scheme 2.7 Comparison of Methods for the Dehydrogenative Silylation of (-)-Menthol 
 
An advantage of using the 2-hydroxy group as a tether is that upon glycosylation, 
the alcohol becomes liberated, allowing further manipulations. Taking 72 and silylating 
with an equivalent of thioethyl glucose sugar silane gives 73 in 68% (Scheme 2.8). 
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Activating the tethered carbohydrates with NIS/TMSOTf then produces disaccharide 74 
in 89% isolated yield, highlighting the utility of iterative glycosylations using B(C6F5)3-
catalyzed dehydrogenative silylations to form this complex disaccharide in an efficient 
manner with complete control over the stereochemistry of both anomeric positions.  
Scheme 2.8 Iterative Synthesis of a Complex Disaccharide 
 
Attempting to silylate the 6-hydroxy galactose compound 75 with the B(C6F5)3 
catalyst and thioethyl glucose silane produced very little desired product 76. Increasing 
catalyst loading, reaction time, and reaction temperature did not lead to synthetically 
useful yields of 76. Piers and coworkers reported similarly sluggish, low yielding 
reactions with primary alcohols. They proposed the more Lewis basic primary alcohol 
binds strongly to the B(C6F5)3 catalyst, rendering it inactive. In order to remedy this 
limitation, we reverted to the Cu(I)-IMes catalyst system, which reacted with 75 to form 
76 in 84% yield (Scheme 2.9). This was glycosylated to form disaccharide 77 in 84% 
yield. Therefore this demonstration of dehydrogenative silylation established Cu(I)-IMes 
as an excellent catalyst for the dehydrogenative silylation of primary alcohols. 
Scheme 2.9 Dehydrogenative Silylation of Primary Alcohols with Cu(I)-IMes 
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A limitation of sugar silanes was discovered attempting the dehydrogenative 
silylation of phenol, when no desired product was observed. Instead the only product 
observed under the standard Cu(I)-IMes conditions was silyl-dimer 79. This presumably 
formed as the increased acidity of phenol led to desilylation of the sugar silane, resulting 
in a 2-hydroxy sugar, which was then silylated by the sugar silane (Scheme 2.10). It was 
found that by adding a solution of phenol dropwise to a mixture of the sugar silane and 
Cu(I)-IMes catalyst system, 78 could be formed, but still in low yields (~30%). Control 
experiments showed that stirring the sugar silane and copper catalyst did not lead to 
formation of 79, as stirring the two together for 5 minutes followed by addition of 
methanol resulted almost exclusively in dehydrogenative silylation of methanol with little 
to no formation of 79. This limitation must be overcome in future efforts as phenolic 
glycosides represent an important class of biologically active glycoconjugates.
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Scheme 2.10 Limitations in the Dehydrogenative Silylation of Phenol 
 
2.2.3 Site-Selective Dehydrogenative Silylation of Hydroxyketones 
One of the main goals of developing sugar silanes was to improve the current 
state of carbohydrate synthesis. In order to achieve this goal, site-selective silylation of 
polyfunctional molecules is very important. Having already demonstrated catalyst 
controlled site-selective glycosylation of a hydroxyketone with Ni(0)- and  Cu(I)-IMes 
catalysts, we wanted to explore how B(C6F5)3 performed with polyfunctional molecules. 
Reacting the thioethyl glucose sugar silane with a polyfunctional steroid and 4 mol% 
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B(C6F5)3 resulted exclusively in dehydrogenative silylation of the alcohol to give 80 in 
93% yield (Scheme 2.11). This was important to demonstrate, as the aglycone contains an 
olefin and a ketone, both of which have been shown to be reduced by a combination of 
silanes and B(C6F5)3.
27,42
 Silyl-linked compound 80 was activated to yield the α-
glucosylated steroid 81 in 96% yield.  
Scheme 2.11 Site-Selective Glycosylation of a Polyfunctional Steroid 
 
To this point, only primary and secondary alcohols have been glycosylated with 
sugar silanes. We wanted to explore the site-selective glycosylation of hydroxyketone 82, 
which contains a tertiary alcohol, with B(C6F5)3. Not only would this site-selectively 
glycosylate a hydroxyketone, but it would show the ability to glycosylate a hindered, 
nonnucleophilic alcohol in the process. Treatment of 82 with the thiophenyl glucose 
sugar silane and only 2 mol% of B(C6F5)3 produced silyl-linked 83 in 91% yield with no 
detection of ketone reduction (Scheme 2.12). This was readily converted to the 1,2-cis 
glucoside 84 in 96% yield. Not only did this demonstrate the high reactivity of sugar 
silanes with hindered tertiary alcohols in the dehydrogenative silylation, but also in the 
glycosylation process.  
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Scheme 2.12 Glycosylation of a Tertiary Alcohol with Sugar Silanes 
 
Hydroxyketone 82 was also treated with the thiophenyl mannose sugar silane and 
2 mol% of B(C6F5)3 to give 85 selectively in an 81% yield. When this was subjected to 
NIS and TMSOTf, the desired β-mannoside 86 was isolated in a 70% yield, 
demonstrating that the site-selective glycosylation of a tertiary alcohol performed well in 
both the glucose and mannose sugar silanes. 
2.2.4 Additional Applications of Sugar Silanes in Dehydrogenative Silylation 
Intramolecular aglycone delivery has many advantages, such as the highly 
selective synthesis of 1,2-cis glycosides.  This is especially true when the silyl-linked 
compounds are synthesized in a site-selective manner. However, despite these 
advantages, intramolecular aglycone delivery is a two pot procedure, in which a linked 
material is first synthesized and isolated. This is followed by a second step where the 
linked material is activated to give the penultimate glycoside. This is unlike most 
traditional glycosylation methods that proceed in a single operation. We therefore opted 
to investigate a one pot dehydrogenative silylation/glycosylation sequence. The B(C6F5)3 
catalyzed hydrosilylation was viewed as an ideal scenario for glycosylating in a one pot 
procedure as the only byproduct of dehydrogenative silylation, hydrogen gas, bubbles out 
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of solution during the reaction. Additionally, the only species remaining is a catalytic 
amount of B(C6F5)3, as other metal or ligand derived byproducts are not present. Control 
experiments showed B(C6F5)3 had no detrimental effects when added to a NIS/TMSOTf 
catalyzed glycosylation.  
With this understanding of how a catalytic amount of B(C6F5)3 would affect a 
glycosylation sequence, (-)-menthol was selected as an ideal target to test the one pot 
procedure due to the fact that it was high yielding in both the dehydrogenative silylation 
and glycosylation step with thiophenyl glucose sugar silane. It was shown that allowing 
the sugar silane to react with (-)-menthol and 4 mol% B(C6F5)3 for 1.5 h, then diluting to 
0.02M with CH2Cl2 and cooling to -40 °C, followed by treatment with the standard 
NIS/TMSOTf glycosylation conditions, produced the desired α-glucoside 70 in 80% 
yield (Scheme 2.13). This shows the possibility of utilizing a one pot dehydrogenative 
silylation/glycosylation sequence for the synthesis of 1,2-cis glycosides. 
Scheme 2.13 One Pot Dehydrogenative Silylation/Glycosylation of (-)-Menthol 
 
Thus far the development of all sugar silane related procedures has utilized a 
glycosyl donor containing a thioether leaving group, a dimethylsilyl group linked to the 
2-hydroxy group, and benzyl protecting groups at the 3-, 4- and 6-hydroxy positions. 
While this protecting group array has performed well in all methods without having any 
detrimental side reactions occasionally associated with protecting groups, it would be 
nice to develop a sugar silane with a different protecting group array. This would prove 
highly useful in a scenario where one wishes to further modify the donor sugar after it is 
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appended to the glycosyl acceptor. Designing a silane with a protecting group array that 
would allow for selective access to all of the sugar’s hydroxyl groups would be 
advantageous. With that in mind, a new sugar silane 87 was designed with a tert-
butyldimethyl silyl (TBS) protecting group on the primary 6-hydroxyl group and a Ley 
acetal linking the 3- and 4-hydroxyl groups together.
43
 Using silane 87 and the Cu(I)-
IMes catalyst system, the dehydrogenative silylation of (-)-menthol produced 88 in nearly 
quantitative yield (Scheme 2.14). Compound 88 was treated with NIS and TMSOTf to 
yield α-glucoside 89 in 60% yield with selective deprotection of the 2-hydroxydimethyl 
silyl group in the presence of the primary 6-OTBS protecting groups. Protection of the 2-
hydroxyl group of 89 followed by standard protecting group conversions will allow 
selective access to any of the 3-,4- or 6-hydroxyl groups for further manipulations.  
Scheme 2.14 Design of a New Sugar Silane for Selective Manipulation 
 
2.3 Site-Selective Glycosylation of Diols 
2.3.1 Mechanistic Implications of B(C6F5)3 Catalyzed Dehydrogenative Silylation 
The use of catalysis and sugar silanes has now been demonstrated in several 
examples where either a ketone or an alcohol can be selectively glycosylated based on 
catalyst choice. While these are useful in the site-selective synthesis of O-glycosides, we 
would also like to extend this selectivity to diols. An area where this would be 
particularly useful is in the synthesis of disaccharides in which the glycosyl acceptor has 
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two free hydroxyl groups that could be selectively glycosylated by judicious choice of 
reagents and catalyst. Aside from the user-friendly nature of B(C6F5)3 and mild reaction 
conditions, another intriguing feature is its proposed mechanism of action in the 
dehydrogenative silylation of alcohols. 
A revisit to the proposed mechanism reveals why B(C6F5)3 is most reactive with 
tertiary alcohols, and least reactive with primary alcohols (Scheme 2.3). As the Lewis 
basicity of the alcohol increases, the equilibrium between the free borane and 60 lies 
towards the complexed species. This prevents formation of any appreciable amount of the 
electrophilic silyl species 61 when attempting to silylate a primary alcohol. On the other 
hand as the Lewis basicity decreases with secondary and tertiary alcohols, more free 
B(C6F5)3 is present in solution, allowing formation of the reactive silicon species 61 and 
then the charge separated 62 which ultimately delivers the desired silylated product.  
With the understanding of different rates based on the nucleophilicity of the 
alcohol, Piers designed a competition experiment between a primary and secondary 
alcohol. Cyclohexanol and 1-decanol were chosen as the substrates, due to the marked 
difference in their reactivity. In standalone dehydrogenative silylation experiments, 
cyclohexanol took 2 hours to go to completion, whereas 1-decanol took 24 hours. In the 
competition experiment, 1.0 equivalent of both alcohols was treated with 2 mol% 
B(C6F5)3 and 1.0 equivalent of Ph3SiH (Scheme 2.15). Surprisingly, 1-decanol was 
silylated almost to the exclusion of cyclohexanol. 
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Scheme 2.15 Competition Experiment between Differentially Substituted Alcohols 
 
When reevaluating the proposed mechanism of this reaction, this result was readily 
explained. More Lewis basic alcohols, like 1-decanol, cause formation of the inactive 
complexed borane species 60 (Scheme 2.3). However, this is only present at a maximum 
of 2 mol%, leaving behind a large excess of free alcohol to react with any of the 
electrophilic silane species 61. As this forms, the more nucleophilic 1-decanol serves to 
increase the rate of formation of the charge separated species 62 relative to the less 
nucleophilic cyclohexanol. This explains the high selectivity for silylation of a primary 
alcohol in the presence of a secondary alcohol despite their drastically different rates of 
silylation in standalone experiments. This competition study inspired us to study the 
selective-silylation and glycosylation of differentially substituted diol glycosyl acceptors. 
2.3.2 Using Sugar Silanes for Selective Silylation of Diols 
We wanted to explore the selective silylation of a dihydroxysugar compound with 
the B(C6F5)3 catalyst. Sugars with the 2- and 3-hydroxy positions protected and free 4- 
and 6-hydroxyl groups were targeted due to their ease of synthesis
31
 and the fact that they 
contain differentially substituted alcohols (Scheme 2.16). This would allow rapid access 
to substrates to test the selective silylation with sugar silanes and B(C6F5)3. 
Scheme 2.16 Generic Synthesis of 4,6-Dihydroxy Sugars 
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This general synthesis was used to make the 2,3-diacetoxy-4,6-dihydroxy sugar 
90. It was found that 90 was not soluble in toluene, however a mixture of 2:1-4:1 toluene: 
methylene chloride worked well at dissolving 90. Solubility is crucial to selectivity 
experiments because if the diol is only partially dissolved and is silylated, it will become 
more soluble than the diol prompting unselective bis-silylation to occur. It was found that 
mixing 90 and thiophenyl glucose sugar silane in a 1:1 ratio with 4 mol% B(C6F5)3 in a 
0.04M solution of 2:1 toluene: methylene chloride gave a 67% yield of silyl-linked 
compound 91, with approximately 15:1 selectivity for the primary 6-hydroxyl group 
(Scheme 2.17). Optimization showed that increasing the equivalents of sugar silane from 
1.0 to 1.3 further increased the yield of 91 to an excellent 87%. Treatment of 91 with 
NIS/TMSOTf yielded the desired disaccharide 92 in 75% isolated yield with complete 
control of anomeric stereochemistry and no need to protect the 4-hydroxyl group of the 
glycosyl acceptor. 
Scheme 2.17 First B(C6F5)3 Catalyzed Selective Glycosylation of a Diol 
 
These selective diol glycosylation conditions were next applied to the synthesis of 
a disaccharide with a mannose glycosyl acceptor. When treating mannose diol 93 under 
the same conditions as previously described, the silyl-linked compound 94 was obtained 
as a single regioisomer in 65% yield (Scheme 2.18). This was also converted to the 6-
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hydroxy-linked disaccharide 95 in 70% yield without requiring protection of the 4-
hydroxyl group of the mannose diol in any step. 
Scheme 2.18 Additional B(C6F5)3 Catalyzed Synthesis of a Disaccharide 
 
These two examples represent the utility of catalyst-derived selectivity in the 
dehydrogenative silylation of diols, and how they can be applied to streamlining the 
synthesis of disaccharides. However, while these represent intriguing new uses of sugar 
silanes, it would truly be an advance in the field if selective silylation of a secondary 
alcohol in the presence of a more nucleophilic primary alcohol was achieved. This could 
provide a very practical, efficient method for the synthesis of various disaccaharides by 
eliminating laborious protecting group manipulations. 
It has been demonstrated in Piers’ work, as well as our studies with sugar silanes, 
that the more nucleophilic of two alcohols will be preferentially silylated in a B(C6F5)3 
catalyzed dehydrogenative silylation. We set out to use this to our advantage when 
exploring site-selective glycosylation of a secondary alcohol. Rather than try to discover 
a catalyst that operates inversely to the nucleophilicity of an alcohol, it was hoped that a 
sacrificial silane could be used to react with the more reactive primary alcohol. This 
would then be followed in the same pot by the addition of a sugar silane to form the silyl-
linked compound at the less reactive hydroxyl group. Although the use of a sacrificial 
silane does constitute the use of a protecting group, it is added in the same pot as the 
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sugar silane and will be removed in the same pot as the glycosylation. This represents a 
sequence with no additional protection-deprotection steps.  
With this strategy for site-selective glycosylation of the less reactive alcohol of a 
diol in mind, experiments were designed to look at installation of the sugar silane at the 
4-hydroxy position of diol 90. Initially, Et3SiH was chosen as the sacrificial silane, and a 
series of experiments showed this strategy was indeed viable. Treatment of 90 with an 
equivalent of Et3SiH and 4 mol% B(C6F5)3 followed by thiophenyl glucose sugar silane, 
produced 4-hydroxy silyl-linked compound 96 in one pot and a 50% yield (Scheme 2.19). 
Scheme 2.19 First Attempt at Site-Selective Silylation of a Secondary Alcohol 
 
While this achieved the desired goal of tethering at the less-nucleophilic alcohol 
in a diol, it was not an ideal solution to this challenging problem. The 50% yield was 
lower than desired, and the selectivity for the primary 6-hydroxyl silylation by Et3SiH 
varied. Additionally, the glycosylation of 96 posed some unique problems that will be 
discussed in greater detail in the following subsection. 
Switching the sacrificial silane from Et3SiH to Ph3SiH produced very low yields 
of the desired 6-hydroxy silylated product at room temperature. However, it was found 
that increasing the catalyst loading slightly, as well as the temperature of the reaction, led 
to excellent yields of desired monosilylated sugar. This allowed for the development of a 
one pot silylation procedure with sacrificial triphenylsilane followed by the sugar silane. 
Reaction of an equivalent of diol 90 with 1.05 equivalents of Ph3SiH and 8 mol% 
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B(C6F5)3 at 75 °C followed by cooling to room temperature and addition of 1.3 
equivalents of thiophenyl glucose sugar silane as a solution in toluene produced the 
desired silyl-linked compound 97 in 70% yield (Scheme 2.20).  
Scheme 2.20 Utilizing Triphenylsilane as the Sacrificial Silane in the Synthesis of 97 
 
This result again demonstrates the ability to selectively tether glycosides to 
polyfunctional molecules for intramolecular aglycone delivery, based on catalyst 
selection. We also applied these conditions to the selective silylation of mannose diol 93 
and observed a nearly identical 71% yield of the desired silyl-linked compound 98 
(Scheme 2.21). 
Scheme 2.21 Utilizing Triphenylsilane as the Sacrificial Silane in the Synthesis of 98 
 
With the ability to tether the sugar silane to either of the alcohols in sugar diols 
such as 97 and 98 we set out to test the intramolecular aglycone delivery of the 4-hydroxy 
tethered compounds. It has been demonstrated in this subsection that the primary 6-
hydroxyl tethered compounds performed well in the glycosylation, however the same was 
not observed for 4-hydroxy tethered compounds. Further exploration into the 
glycosylation of these compounds was necessary to complete the sequence of 
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glycosylating either alcohol of a differentially substituted diol based on choice of 
reagents. 
2.3.3 Glycosylation of 4-Hydroxy Tethered Compounds 
An efficient one pot synthesis was developed for the synthesis of 4-hydroxy 
tethered silyl-linked compounds from sugar silanes and a 4,6-dihydroxy sugar compound. 
While this worked with excellent efficiency in the synthesis of compounds such as 97 and 
98, early attempts at their activation for glycosylation did not fare as well. Studies on this 
glycosylation sequence began with an attempt at glycosylating the 6-triethylsilyl-
protected compound 99. Upon activation with NIS/TMSOTf and subsequent treatment 
with nBu4NF, a complex mixture was obtained in which it appeared that the triethylsilyl 
protected 6-hydroxy group of the glycosyl acceptor had been glycosylated as the major 
product (Scheme 2.22). 
Scheme 2.22 Unexpected Glycosylation Outcome with Triethylsilyl Protecting Group 
 
This result was problematic because the mechanism by which the undesired 
glycoside 99 was produced was not well understood. Compound 96 could have 
undergone a silyl-transfer resulting in the sugar silane being tethered to the 6-hydroxy 
position. Triethylsilyl cleavage could have led to competitive intramolecular aglycone 
delivery from the untethered 6-hydroxy position. Additionally, both silyl groups could 
have been cleaved and an intermolecular glycosylation could have occurred at the more 
reactive primary 6-hydroxyl group. Aside from these pathways it is conceivable that the 
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triethylsilyl protected 6-hydroxyl was glycosylated followed by desilylation leading to 
99. In order to better understand what might be occurring under the NIS/TMSOTf 
conditions, a control experiment was designed where the 6-hydroxyl group of the 
glycosyl acceptor had a 6-O-benzyl protecting group instead of a triethylsilyl group. This 
should serve to rule out any silyl-transfer mechanisms, and given the more robust nature 
of a benzyl protecting group compared to the triethylsilyl group, also rule out undesired 
deprotection pathways. To test this, compound 100 was synthesized and treated to the 
NIS/TMSOTf catalyzed glycosylation conditions. This resulted in an 80% yield of 
glycoside 101 derived from addition of the 6-O-benzyl protected primary alcohol, 
primarily as the β-anomer, with no detection of the desired 4-hydroxyl glycosylation 
product (Scheme 2.23).  
Scheme 2.23 Control Experiment to Determine Mechanism of Undesired Glycosylation 
 
The glycosylation result suggests that the previously observed undesired 
glycosylation of the triethylsilyl protected 6-hydroxy group most likely occurred by 
addition to the electrophilic oxocarbenium ion followed by desilylation. It provided 
strong evidence ruling out a silyl-transfer mechanism, and since it is unlikely the benzyl 
group was deprotected under the reaction conditions, also ruled out the intermolecular 
glycosylation pathway. Additional evidence for the glycosylation of the 6-O-benzyl 
protected primary alcohol was observed by low resolution mass spectrometry. The 
positive ion of the sodium adduct for 101 with the dimethyl silyl-group still linking the 2-
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hydroxy and 4-hydroxy group of the glycosyl donor and acceptor, respectively, was the 
major peak prior to the addition of nBu4NF. 
This result is precedented. Looking back at Stork’s use of the dimethylsilyl linker 
for intramolecular aglycone delivery, a very similar result was observed.
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 When 
attempting to glycosylate the 4-hydroxy silyl-linked compound 102, using Tf2O 
activation of the sulfoxide resulted in only 12% of the desired product 103 (Scheme 
2.24). The major product was derived from the addition of the benzyl protected 6-
hydroxy group as well, as 104 was isolated in 82%.  
Scheme 2.24 Stork's Observation of Similar Undesired Glycosylation Products 
 
The fact that the undesired glycoside 104 was isolated with the silyl-linkage still 
intact provides further evidence that the glycosylation occurs directly from the benzyl 
ether. It is clear from both of these results that the glycosylation of 4-hydroxy-linked 
sugars were problematic and several factors must be considered when moving forward. 
First, the protecting group on the 6-hydroxyl group must be sufficiently robust and 
sterically bulky so that its natural positioning is not within proximity of the reactive 
oxocarbenium species generated upon activation of the glycosyl donor. Second, a screen 
of activation conditions must be done to provide a sufficiently reactive intermediate 
allowing for glycosylation of the weakly nucleophilic 4-hydroxyl group of glucose or 
mannose.  
By switching from triethyl- to the triphenylsilyl protecting group we proposed the 
first problem could be addressed. This protecting group possesses much greater steric 
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bulk, and stronger Si—O bond compared to the triethylsilyl protecting group. The use of 
triphenylsilane proved to be advantageous in the site-selective B(C6F5)3 catalyzed 
dehydrogenative silylation of a diol as well. As described in the previous subsection, 
Ph3SiH provided higher yields and better selectivity for selective silylation of the 4,6-
hydroxy sugars. With the 4-hydroxy linked compound 97, possessing a triphenylsilyl 
protecting group at the 6-hydroxyl position in hand, a screening of glycosylation 
conditions was possible.  
Attempting to glycosylate 97 with NIS and TMSOTf led almost exclusively to the 
addition of succinimide into the oxocarbenium ion (Scheme 2.25). Although this resulted 
in no production of the desired disaccharide, we were pleased to observe that the switch 
to a triphenylsilyl protecting group completely suppressed the undesired addition of the 
6-hydroxyl group. 
Scheme 2.25 Attempt at Glycosylation of 97 with NIS and TMSOTf 
 
The addition of succinimide, which is a byproduct of activation of the thiophenyl 
group, prompted us to explore activation conditions that do not produce nucleophilic 
byproducts that can provide competition in the glycosylation of the desired glycosyl 
acceptor. A potential solution to this problem was the use of Kahne’s method for 
sulfoxide activation
45
 which was utilized by Stork and coworkers in their reports of 
temporary silicon tethers for intramolecular aglycone delivery. Not only is this method 
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well known to glycosylate unreactive glycosyl acceptors, but it also does not produce any 
overly nucleophilic byproducts.  
Testing this method by treating 97 with m-CPBA to generate the sulfoxide in situ 
followed by treatment with Tf2O and 2,6-DTBMP led mostly to decomposition of the 
silyl-linker and further decomposition of the separate sugar components (Scheme 2.26). 
Scheme 2.26 Attempt at Glycosylation of 97 with Kahne's Method of Activation 
 
The fact that this worked poorly, in addition to Stork’s undesirable results using 
the same activation method, showed that exploration of additional methods was 
necessary. Another common method for the activation of thioglycosides is by utilizing 
dimethyl(methylthio)sulfonium triflate (DMTST), which is generated by treating methyl 
disulfide with methyl triflate. It produces no nucleophilic byproducts and is quite mild 
when buffered with a hindered pyridine base such as 2,6-DTBMP. Using Wong’s method 
of generating DMTST, silyl-linked compound 97 was then activated (Scheme 2.27).
46
 
Scheme 2.27 Attempt at Glycosylating 97 with DMTST 
 
At temperatures between -40 °C and room temperature, no desired product was 
formed. Instead, adventitious water added into the oxocarbenium at a greater rate than the 
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tethered 4-hydroxyl group to produce 106. This was most likely the result of the stability 
of the anomeric triflate, which forms after activation of the thiophenyl leaving group with 
DMTST, and is stable up to room temperature. It is apparent that oxocarbenium 
formation is readily occurring under the DMTST activation conditions; however, the 
tethered hydroxyl group is not sufficiently reactive to generate any of the desired product. 
A set of activation conditions that are known to be even more reactive must be uncovered 
in order to get the poorly nucleophilic 4-hydroxyl group to glycosylate.  
It is known that the 4-hydroxyl position of glucose is a very poor nucleophile, and 
it has proven no different in the glycosylation studies to this point. One concern was that 
by choosing the acetate protecting groups, that the inductive withdrawing effects were 
making the poor nucleophile even worse. A careful survey of the literature was conducted 
with these considerations in mind. A glycosylation method was desired that results in 
high yields, specifically for 4-hydroxy glucose glycosyl acceptors containing acetate 
protecting groups. A method developed by Fugedi and coworkers utilizing an activating 
complex similar to DMTST seemed to address all of these issues.
47
 Fugedi’s reagent is 
made by premixing methyl disulfide and triflic anhydride to make the active Tf2O∙Me2S2 
species. An additional perk of this method is that it utilizes only a slight excess of the 
glycosyl donor relative to the acceptor (1.2:1). This translates well to silyl-tethered 
intramolecular aglycone delivery as it is inherently a 1:1 ratio of acceptor to donor; 
methods requiring an excess of either the acceptor or donor to get useful yields are not 
desired. 
With these factors in mind, we hoped to apply this method to the successful 
glycosylation of 97. Following the procedure reported by Fugedi and coworkers, 97 was 
60 
 
treated with 1.5 equivalents of Tf2O∙Me2S2 at -40 °C with 2,6-DTBMP added to buffer 
any adventitious acid (Scheme 2.28). Activation of the thiophenyl leaving group occurred 
rapidly; however, no product generation was observed. Instead, over time, addition of 
methyl thiolate occurred. The nucleophilic sulfur species presumably forms as the 
methylsulfenyl triflate reacts with a nucleophile.  
Scheme 2.28 Attempt at Glycosylating 97 with Tf2O∙Me2S2 at -40 °C 
 
In addition to the formation of 107, water also underwent glycosylation to form 
compound 106, as was seen with the DMTST activation conditions. Running the reaction 
under the same conditions at room temperature led to almost instantaneous consumption 
of the starting material with no formation of the desired product. It was hoped that by 
adding the Tf2O∙Me2S2 reagent at -40 °C followed by warming to 0 °C, an effective 
balance of reactivity could be realized. Upon attempting this, two major products were 
detected by low resolution mass spectrometry corresponding to the desired glycoside 
without a proton and a benzyl group (Scheme 2.29). The reaction was not treated with 
nBu4NF, and the two major products were isolated. The products obtained were indeed 
missing a proton and benzyl protecting group, and corresponded to glucal 108, which was 
obtained in 38% yield and the 1,6-anhydro sugar 109 in 32% yield.  
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Scheme 2.29 Second Attempt at Glycosylating 97 with Tf2O-Me2S2 
 
Both of these compounds contained the silyl-linkage intact, which demonstrates 
the lack of reactivity of the tethered 4-hydroxyl group of glucose. It was evident that the 
poor nucleophilicity of the tethered alcohol required additional screening to achieve the 
desired glycosylation. We wanted to explore the glycosylation of the sugar silane tethered 
to the 4-hydroxyl group of a mannose sugar, hoping that a slight change in the acceptor’s 
stereochemistry may lead to increased reactivity. We first treated 98 under the NIS and 
TMSOTf conditions, and although succinimide addition (111) was the major product, the 
desired disaccharide 110 was also isolated, albeit in 10% yield (Scheme 2.30). 
Scheme 2.30 Attempt at Glycosylating 98 with NIS and TMSOTf 
 
This was an exciting result because it suggested the reactivity of the tethered 
aglycone was sufficient to form the desired glycoside, and switching to an activation 
method that produces nonnucleophilic byproducts should increase the yield of 110. 
Switching to DMTST as the activation method was next explored. Unfortunately the 
desired product 110 was not produced under several different variations of the DMTST 
activation conditions ( 
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Scheme 2.31). Instead the major product was the addition of adventitious water 
producing 112, both in the presence and absence of 4Å MS.  
Scheme 2.31 Attempt at Glycosylating 98 with DMTST 
 
This was disappointing as the small amount of product formed with the 
NIS/TMSOTf catalyzed conditions suggested that the appropriate reactivity may be there 
to synthesize the desired disaccharide 110 in synthetically useful yields. It was not the 
case, and at this stage of the project it was determined that future work would be invested 
into looking more carefully at the glycosylation of unreactive 4-hydroxy sugar alcohols. 
2.3.4 Gaining Additional Insight on Site-Selective Silylation/Glycosylation of Diols 
Different substitution patterns on the sugar diols were next explored. It was hoped 
that a 2,6-diol would lead to better results as the 2-hydroxyl position of glucose is known 
to be much more nucleophilic than the 4-hydroxyl position.
48
 However, it was found that 
the increased nucleophilicity of the 2-hydroxyl group severely diminished the selectivity 
for silylation of the primary alcohol (Scheme 2.32).  Conditions identical to those used 
for 4,6-sugar diols led to a mixture of approximately 1:1 mono- to bis-silylated products 
114 and 115, respectively. Reducing the temperature to 50 °C led to less bis-silylation 
than at 75 °C. Further attempts at lowering catalyst loading led to increased selectivity for 
desired product 114; however, as B(C6F5)3 was lowered from 8 to 4 to 2 mol%, an 
increasing amount of starting material 113 remained even after prolonged reaction times. 
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Scheme 2.32 Attempt at Site-Selective Silylation of a 2,6-Sugar Diol 
 
In order to better understand the interplay between B(C6F5)3-catalyzed site-
selective silylation of a diol and the reactivity of glycosylation, mono-silylated compound 
114 was isolated and silylated with a thiophenyl glucose sugar silane to produce 116 in 
65% yield (Scheme 2.33). This silyl-linked compound was then treated to the 
NIS/TMSOTf glycosylation conditions, providing the desired disaccharide solely as the 
α-anomer 117 in 79% yield.  
Scheme 2.33 Glycosylation of 2-Hydroxy Glucose Compound 114 
 
 The fact that 116 glycosylated so readily, but performed with poor selectivity in 
the B(C6F5)3-catalyzed site-selective silylation of 2,6-hydroxy sugar diol 113 is 
problematic for our desired plan. This suggested that, when using this strategy to 
selectively glycosylate the less reactive alcohol of a diol, a high yielding glycosylation 
may be preceded by a poorly selective silylation step. However, further exploration of 
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additional diols was needed in order to better understand the relation between selectivity 
of silylation and yield of glycosylation. 
Since the nucleophilicity of the 2-hydroxyl group in glucose was too similar to the 
primary 6-hydroxyl group in 113 to attain selectivity in the dehydrogenative silylation, 
we wanted to explore the comparable mannose 2,6-diol 118. It is known that axial 
alcohols are less nucleophilic than their equatorial counterparts, so the slightly increased 
difference in nucleophilicity between the primary and secondary alcohol in 118 could 
produce selectivity in the silylation step as well as useful yields in glycosylation. 
Exploring the site-selective silylation of 118 with the thiophenyl glucose sugar silane and 
4 mol% B(C6F5)3, a 50% yield of the desired primary alcohol silylation product 119 was 
obtained as well as some of the bis-silylated compound (Scheme 2.34). This compound 
was converted into disaccharide 120 in 67% yield upon treatment with NIS and TMSOTf.  
Scheme 2.34 Site-Selective Glycosylation of the Primary Alcohol of 118 
 
While the glycosylation of the 6-hydroxyl group of a sugar in the presence of 
unprotected secondary alcohols can often be done effectively in an intermolecular 
fashion, this result was noteworthy for several reasons. In addition to having complete 
control of anomeric stereochemistry of the newly formed glycosidic bond, the glycosyl 
acceptor bearing benzyl protecting groups is ―armed.‖ Fraser-Reid has reported the 
selectivity of silylation of diols such as 114 and  118 is highly dependent on the glycosyl 
donor being ―disarmed‖ by inductively withdrawing protecting groups such as acetate or 
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benzoates.
49
 The fact that the selectivity for the primary 6-hydroxyl group is based on the 
silylation catalyst and not the protecting groups could prove useful when strategically 
installing glycosides with orthogonal protecting groups.  
With the successful silylation and glycosylation of the primary alcohol of diol 
118, we next wanted to explore site-selective glycosylation of the axial 2-hydroxyl group. 
Initial treatment with conditions utilized previously using Ph3SiH as a sacrificial silane 
followed by a sugar silane resulted in low yields of the desired silyl-linked compound 
121 (Scheme 2.35). In order to make sure the silylation worked, diol 118 was treated with 
Ph3SiH to give the desired 6-hydroxy silylated alcohol 122 in 64% yield. Reacting this 
alcohol with the thiophenyl glucose sugar silane and 4 mol% of the B(C6F5)3 catalyst 
surprisingly produced very low yields of the desired product 121, thus preventing further 
study of its glycosylation.  
Scheme 2.35 Difficulties in Site-Selective Silylation of the Secondary Alcohol of 118 
 
With a better understanding of the selective silylation and glycosylation of 2,6-
diols we hoped to explore a 3,6-sugar diol in this sequence as well. Diol 123 was 
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synthesized and it was hoped that the reduced nucleophilicity of the 3-hydroxy group 
relative to the 2-hydroxy group would provide good selectivity in silylation. This 
however was not the case, as treatment of 123 with an equivalent of Ph3SiH resulted in a 
nonselective mixture of mono-silylated compound 124 and bis-silylated 125 (Scheme 
2.36). 
Scheme 2.36 Attempt at Selective Silylation of a 3,6-Sugar Diol 
 
Selectivity studies on several sugar diols have been carried out where 
differentiation between a primary and secondary alcohol was explored. We were also 
curious to see if selectivity between two secondary alcohols in a sugar could be achieved. 
A logical starting point for this would be the study between the 2- and 3-hydroxy groups 
of mannose as one is axial and the other equatorial, providing a difference in 
nucleophilicity (Scheme 2.37). Attempts at selective silylation of diol 126 again produced 
a mixture of mono- and bis-silylated compounds 127, 128, and 129.  
Scheme 2.37 Attempt at Selective Silylation between Two Secondary Alcohols 
 
2.4 Future Directions and Summary of Dehydrogenative Silylation 
2.4.1 Building Upon Selective Silylation/Glycosylation of Diols Studies 
The utilization of B(C6F5)3-catalyzed dehydrogenative silylation has been 
introduced in conjunction with sugar silanes for the site-selective glycosylation of diols 
based on reactivity patterns and reagent choice. This has been shown to be an effective 
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strategy for the site-selective glycosylation of primary alcohols in the presence of 
unprotected secondary alcohols. However, in the case of glycosylating the less reactive 
alcohol in the presence of a primary alcohol, challenges were observed in either the 
glycosylation step (with 4,6-sugar diols) or in the selective silylation step (with 2,6- and 
3,6- sugar diols). While it has been disappointing that our goal of site-selectively 
glycosylating both positions of a sugar diol has not come to fruition, a foundation for 
understanding the reactivity patterns in this strategy has been developed.  
The continuation of this project will build from the silylation and glycosylation 
studies described in the previous section. Additional studies on the use of silyl tethering 
for the intramolecular aglycone delivery of unreactive nucleophiles such as 4-hydroxy 
sugars should be conducted in order to uncover which of the numerous methods for 
thioether activation can lead to the desired product (Scheme 2.38). Additionally, the use 
of B(C6F5)3 for the silylation of diols has in some cases proven highly selective, while in 
other cases only moderate selectivity was observed. A more thorough screening of 
dehydrogenative silylation catalysts and conditions with sugar silanes as well as 
sacrificial silanes would be beneficial. This would produce an understanding of what 
choice of catalyst should be used based upon predicted reactivity patterns.  
Scheme 2.38 Screening Activation Conditions for Glycosylating Unreactive Aglycones 
 
2.4.2 Selective Silylation of Complex Substrates 
As discussed in the previous chapter, the ultimate goal in the development of 
sugar silanes is to be able to have a toolbox of catalysts that enable the selective 
68 
 
silylation/glycosylation of a desired functional group in a complex setting.  An attractive 
compound for exploring the borane-catalyzed dehydrogenative silylation is 
hydrocortisone. In addition to the ketone and enone functional groups, it possesses a 
primary, secondary, and tertiary alcohol. It would be a marked advancement in the field 
of glycosylation to be able to selectively glycosylate each of hydrocortisone’s alcohols 
individually based on choice of catalyst and sacrificial silane. Initial attempts at selective 
silylation of hydrocortisone with the borane and triphenylsilane were plagued by 
solubility issues. Toluene and methylene chloride, which are solvents that have been 
compatible with borane reactivity, would not dissolve hydrocortisone, leading to very 
little observed reactivity (Scheme 2.39). 
Scheme 2.39 Study on Selective Silylation of  Hydrocortisone 
 
Solvent screening with (-)-menthol and triphenylsilane showed that the addition 
of polar solvents such as THF, even as a minor component, completely shut down 
reactivity due to competing borane coordination.  This appears to be a major hurdle in the 
development of site-selective glycosylation of polar molecules with B(C6F5)3, and other 
catalysts, such as those developed by Ito and coworkers,
32,33
 should be thoroughly 
screened.  
2.4.3 Summary of Dehydrogenative Silylation with Sugar Silanes 
A method utilizing user-friendly dehydrogenative silylation conditions with sugar 
silanes and B(C6F5)3 has been developed. This method has been demonstrated to work 
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well with secondary and tertiary alcohols and can site-selectively glycosylate 
hydroxyketones as well as certain diols (Scheme 2.40).  
Scheme 2.40 Demonstrating the Utility of Dehydrogenative Silylation with Sugar Silanes 
 
It has been shown that a Cu(I)-IMes catalyst can be utilized on substrates such as 
primary alcohols that are not high yielding with the B(C6F5)3 catalyst. Additionally, by 
studying the silylation of a variety of sugar diols, reactivity patterns and limitations of the 
B(C6F5)3 catalyst and sugar silanes have been uncovered. These studies should provide 
future efforts in this area with an understanding of reactivity patterns and hopefully direct 
research towards a solution to the challenges encountered. 
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Chapter 3  
 
Merging Aglycone Synthesis and Glycosylation by Reductive Coupling 
with Sugar Silanes 
 
3.1 Reductive Coupling Background 
3.1.1 Introduction to Reductive Coupling Strategy 
Nickel-catalyzed reductive and alkylative coupling of two π-components has seen 
a great deal of development over the past two decades.
50,51
 These methods utilize the 
Ni(0)-catalyzed hetero-coupling of differentiated polar and non-polar π-components 
(Scheme 3.1). In the first example from our lab, ynal 131 was cyclized using a Ni(cod)2 
catalyst and dimethylzinc to form the cyclized allylic alcohol 132 in 73% yield with 
complete stereocontrol of the newly formed tetrasubstituted olefin.
52
 A wide variety of π-
systems have been utilized in this strategy, such as: aldehydes, enones, enals, ketones, 
imines, and epoxides as polar components; and alkynes, allenes, and dienes as nonpolar 
components. These simple and readily accessible starting materials have been used to 
synthesize a variety of useful organic frameworks.  
Scheme 3.1 First Nickel-Catalyzed Aldehyde-Alkyne Coupling 
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An advantage of this approach is that it eliminates the need to generate pre-
formed organometallic species, instead using a Ni(0)-catalyst in a substoichiometric 
amount. In order to utilize nickel as a catalytic species, a reducing agent must be used to 
alter oxidation states in the catalytic cycle. A variety of reducing agents have been 
employed in these sequences such as dialkyl zinc reagents, trialkylboranes, silanes, and 
even alcohols.
53
 We were particularly interested in processes utilizing silane reducing 
agents, as they could provide a new application for sugar silanes in site-selective 
glycosylations. 
3.1.2 Use of Silanes as Reducing Agents in Nickel-Catalyzed Reductive Coupling 
As nickel-catalyzed reductive couplings have been developed over the past two 
decades, the reducing agents have become increasingly mild and tolerant of a wide 
variety of functional groups. Initial efforts in the reductive coupling of π-systems with 
nickel(0)-phosphine catalysts used dialkyl zinc reducing agents, and later triethylborane, 
to afford the reductive or alkylative product. Although effective as reducing agents, both 
of these compounds are pyrophoric and have limited functional group compatibility. 
When attempting the nickel(0)-catalyzed cyclization of ynal 133 in the key step of the 
synthesis of (+)-allopumiliotoxin 267A, it was found that no desired allylic alcohol 
product was formed when using diethylzinc as the reducing agent.
54
 Instead, addition of 
an ethyl group from the zinc species into the aldehyde was the only product observed. 
However, it was found that when switching to the mild reducing agent triethylsilane, the 
desired cyclized product 134 was produced in a 95% isolated yield (Scheme 3.2). 
Scheme 3.2 Use of Silane as the Reducing Agent in Ni-Catalyzed Reductive Coupling 
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The synthetic utility of the nickel-catalyzed reductive coupling of two π-systems 
is readily apparent, as demonstrated in the synthesis of compound 134. The nickel-
catalyst enables 134 to be formed from two readily available organic components, an 
alkyne and aldehyde. The reaction forms a new C—C bond and a new stereocenter as 
well as a stereodefined olefin. These characteristics enable the rapid development of 
molecular complexity from simple starting materials. Although silane reducing agents 
were found to be highly useful in this intramolecular cyclization, it was not until several 
years later that silanes were demonstrated to be effective reducing agents in the 
intermolecular coupling of alkynes and aldehydes (Scheme 3.3).
55
 It was found that by 
switching from monodentate phosphine ligands to the more σ-donating N-heterocyclic 
carbene (NHC) IMes, that intermolecular reductive coupling of benzaldehyde and 1-
phenyl-1-propyne produced the desired allylic alcohol 135 in 84% yield. 
Scheme 3.3 Intermolecular Reductive Coupling of an Aldehyde and Alkyne  
 
Since this important advance in the field of the nickel-catalyzed reductive 
coupling of aldehydes and alkynes, many additional methodologies have been developed. 
In 2005 our group reported the application of ynal reductive coupling in the synthesis of 
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macrocycles.
56
 Rings sized between 11- and 22-membered were synthesized, and a 
ligand-dependent regiochemical outcome between endo- and exo-olefins was discovered. 
A representative example of this methodology is shown with the cyclization of ynal 136 
to give macrocycle 137 in 62% yield (Scheme 3.4). 
Scheme 3.4 Ni(0)-IMes Catalyzed Macrocyclization of Ynals 
 
Shortly after the macrocyclization methodology was developed, our group 
reported the reductive coupling of α-silyloxy aldehydes and alkynes to produce 1,2-anti 
diols in a highly diastereoselective fashion.
57
 It was found necessary to protect the α-
hydroxyl group with a tert-butyldimethyl silyl (TBS) group as well as the terminal alkyne 
with a trimethyl silyl (TMS) group to achieve the highest levels of diastereoselectivity. 
When α-silyloxy aldehyde 138 and alkyne 139 were treated with 10 mol% of Ni(0)-IMes 
the desired 1,2-anti diol 140 was formed in 80% yield with >98:2 dr (Scheme 3.5). This 
methodology was paired with the macrocyclization protocol in the total synthesis of the 
natural product aigialomycin D.
58
 
Scheme 3.5 Synthesis of 1,2-Anti Diols by Ni(0)-IMes Catalyzed Reductive Coupling 
 
The utility of nickel-catalyzed reductive coupling of aldehydes and alkynes with 
silane reducing agents has been demonstrated through the development and application of 
several methods highlighted thus far in this chapter. However, all of the allylic alcohols 
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have either been formed unselectively or rely on substrate control to achieve enhanced 
diastereoselectivity. In order to overcome this limitation, our lab reported the 
development of several new NHC’s in 2007 for the asymmetric reductive coupling of 
aldehydes and alkynes.
30
 Optimization studies found that NHC 54 was effective at 
achieving moderate to high levels of enantioselectivity, with a broad substrate scope, in 
nickel-catalyzed formation of allylic alcohols. Using 10 mol% of a Ni(0)-54 catalyst with 
cyclohexylcarboxaldehyde and 3-hexyne, triethylsilyl protected allylic alcohol 141 was 
obtained in 84% yield and 85% ee (Scheme 3.6). 
Scheme 3.6 Asymmetric Reductive Coupling of Aldehydes and Alkynes with NHC 54 
 
The development of NHC 54 was a key advancement in the field of nickel-
catalyzed reductive coupling. However, there remained one more element of this reaction 
that still needed to be addressed, which is the regiocontrolled addition of unbiased 
alkynes to aldehydes. High levels of regiocontrol can be achieved with alkynes 
possessing a steric or electronic bias, such as terminal alkynes, ynoates, 1,2- and 1,6-
enynes, alkyl-aryl and internal alkynes bearing two substituents with contrasting steric 
environments. Our group developed a set of ligand-based conditions for achieving high 
levels of regiocontrol with biased and unbiased substrates based solely upon ligand 
structure, not the inherent reactivity of the alkyne.
59
 Several ligands were identified that 
served to control the regiochemical addition of the alkyne to the aldehyde based upon the 
steric environment of the ligand on the alkyne in the formation of the nickellacycle 
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(Scheme 3.7). When a large ligand is used, the steric repulsion between the large group of 
the alkyne and the ligand led to addition of the alkyne carbon bearing the bulkier 
substituent to the aldehyde. Conversely, when a small ligand was used, the steric 
repulsion between the aldehydic substituent and the larger group on the alkyne led to 
addition of the less hindered end of the alkyne to the aldehyde. 
Scheme 3.7 Ligand Steric Control Model 
 
When attempting the regioselective reductive coupling of an alkyne with no 
inherent substrate bias, such as 2-hexyne, steric control must be derived from the ligand. 
When utilizing this method, it was found that coupling 2-hexyne and heptanal with 
carbene ligand 143, the desired small ligand product 142 was isolated in 78% yield and 
88:12 regioselectivity (Scheme 3.8, equation A). Switching to the large ligand 145 with 
2-hexyne and heptanal completely reversed the regioselectivity to give product 144 in 
85% yield and with 93:7 regioselectivity (Scheme 3.8, equation B).   
Scheme 3.8 Ligand Derived Regiochemical Control in Reductive Coupling 
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 This unprecedented ligand controlled reversal of regiochemistry with an unbiased 
alkyne represented a great improvement in overcoming the regiochemical challenge that 
plagued many alkyne addition methodologies. The use of nickel-catalyzed reductive 
coupling with silane reducing agents has been demonstrated throughout this subsection to 
be a highly useful method for the synthesis of allylic alcohols. With the expertise 
developed in this area over the past two decades in our lab, we hoped to employ sugar 
silanes as the reducing agent to merge aglycone synthesis with site-selective carbohydrate 
incorporation. 
3.2 Nickel-Catalyzed Reductive Coupling with Sugar Silane Reducing Agents  
3.2.1 Development of Conditions with Sugar Silanes and Terminal Alkynes 
Traditionally, glycosylation is viewed as an operation where a pre-synthesized 
aglycone and glycosyl donor are coupled to form the desired glycosidic linkage. In this 
reaction, the synthesis of the aglycone and the glycosylation event are viewed as two 
distinct operations. With the development of sugar silanes as reducing agents, and the 
large body of work on nickel-catalyzed reductive coupling of aldehydes and alkynes with 
silanes, we hoped to merge aglycone synthesis and glycoside incorporation into one 
highly efficient step (Scheme 3.9). We were optimistic that transitioning from the more 
conventional triethyl-, triisopropyl-, and di-tert-butyl silanes, to a sugar silane would be 
feasible. Detailed mechanistic studies in our group have shown a zero-order dependence 
on silane concentration in the nickel-catalyzed reductive coupling of aldehydes and 
alkynes.
60
 Each silane has a distinct reactivity profile, so gaining an understanding of the 
reactivity of a sugar silane would be the next task. 
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Scheme 3.9 Merging Aglycone Synthesis with Glycoside Incorporation  
 
Previous work in the group suggested that Ni(0)-IMes would be the most logical 
catalyst for the desired intermolecular reductive coupling with terminal alkynes, due to its 
reactivity profile and minimization of alkyne trimerization compared to phosphine 
ligand-based procedures. Initial attempts at following the previously developed protocol 
developed with 1.1 equivalents of sugar silane, 1.2 equivalents of alkyne and 1.0 
equivalent of aldehyde with 10 mol% Ni(0)-IMes produced the desired allylic alcohols, 
albeit in low yields (Scheme 3.10). 
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Scheme 3.10 Initial Attempts at Reductive Coupling with Sugar Silanes 
 
When adding a solution of thioethyl glucose sugar silane, heptanal and 
phenylacetylene to a pre-formed Ni(0)-IMes catalyst, the desired allylic alcohol 146 was 
formed in 36% yield. Using the same strategy of adding sugar silane, the corresponding 
aldehyde and phenylacetylene all at once to the nickel catalyst produced allylic alcohols 
147 and 148 in 29% and 34% yield respectively. In each case, it appeared the low yields 
were a function of competing alkyne trimerization pathways. It was proposed that instead 
of adding the mixture of sugar silane, aldehyde, and alkyne to the catalyst solution all at 
once, dropwise addition may slow the trimerization pathway, thus leading to higher 
yields of the desired allylic alcohol. When testing this hypothesis, a manual dropwise 
addition of a solution containing sugar silane, heptanal and phenylacetylene over several 
minutes to the Ni(0)-IMes catalyst increased the yield of 146 from 36% to 68%. While 
this experiment verified our hypothesis about the slow addition of reagents, it was found 
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that the yield varied greatly due to the sensitivity of the rate of addition of substrates. An 
optimization study was needed to develop conditions that were high yielding and highly 
reproducible in the reductive coupling of terminal alkynes and sugar silanes. 
It was found in these early studies that the nickel-catalyzed reductive coupling of 
aldehydes and terminal alkynes with sugar silanes produced three main products. In 
addition to the desired silyl-linked allylic alcohol product, alkyne trimerization and 
aldehyde hydrosilylation byproducts were also observed (Scheme 3.11).  
Scheme 3.11 Byproducts Observed in Reductive Coupling of Terminal Alkynes 
 
If the addition of the alkyne were too rapid, as was observed when all substrates 
were added at once, alkyne trimerization product 151 would dominate the reaction. This 
would lead to consumption of the terminal alkyne with little production of desired allylic 
alcohol 149, while the sugar silane and aldehyde remained, eventually producing the 
hydrosilylation product 150. Conversely, if the sugar silane and aldehyde are in the 
presence of Ni(0)-IMes without a sufficient concentration of the alkyne, production of 
hydrosilylation product 150 dominates followed by generation of trimerization product 
151 from the remaining terminal alkyne.  
These observations were taken into careful consideration when designing a series 
of experiments aimed at finding a balance between alkyne trimerization and aldehyde 
hydrosilylation. An optimization screen was conducted for the reductive coupling of 
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heptanal, 1-octyne and thioethyl glucose sugar silane with 10 mol% Ni(0)-IMes catalyst 
(Table 3.1). 
Table 3.1 Optimization Studies with Sugar Silanes and Terminal Alkynes 
 
It was proposed that by increasing the amount of alkyne from the reported 1.2 
equivalents to 1.5, that more alkyne would be available for the productive formation of 
152, even in the event that some is lost to trimerization. Addition of all substrates to the 
catalyst mixture with 1.5 equivalents of 1-octyne led to a very low yield as the 
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trimerization pathway was accelerated by the increased concentration of 1-octyne (entry 
1). Syringe drive addition of the substrates over a ten minute period increased the yield of 
152 to 39% (entry 2). Further increasing the equivalents of 1-octyne from 1.5 to 2.0 with 
a ten minute syringe-drive addition only resulted in a small yield increase to 43%, which 
suggests that using 1.5 equivalents of alkyne is preferential (entry 3). Reducing the rate of 
syringe-drive addition of all substrates from ten to thirty minutes increased the yield 
appreciably to 69% (entry 4). Further reducing the syringe-drive addition rate of a 
solution of all substrates to the nickel catalyst to 100 or 200 minutes showed no 
appreciable effect on the yield of 152 (entries 5 and 6). Thirty minute syringe-drive 
addition of all reagents as a solution to a catalyst mixture heated to 35 °C reduced the 
yield of 152 to 50% as the rate of trimerization was accelerated by gentle heating (entry 
7). Exploring the effect of Ti(OiPr)4 as an additive to the thirty minute syringe-drive 
addition of a solution of the substrates had no effect on the reaction, leading to a 68% 
yield (entry 8). It was hypothesized that syringe-drive addition of 1-octyne to a mixture 
of sugar silane, heptanal and Ni(0)-IMes at the appropriate rate could further increase the 
yield of 152. Testing this hypothesis by syringe drive addition of 1-octyne to the silane, 
aldehyde and nickel-catalyst resulted in a low yield of 152 due to the increased presence 
of aldehyde hydrosilylation (entry 9). The hydrosilylation suggested that the alkyne was 
not present in a sufficient concentration, leading to oxidative addition of the Ni(0)-IMes 
catalyst into the Si—H bond, ultimately resulting in the observed hydrosilylation of 
heptanal. Increasing the rate of syringe-drive addition of 1-octyne to 45 minutes still 
resulted in low yields of 152, however the amount of hydrosilylation was reduced (entry 
10). In an effort to find balance in the rate of addition of a solution of 1-octyne, syringe-
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drive addition was carried out over 25 minutes, resulting in a 74% yield of 152 (entry 11). 
Accelerating the syringe-drive addition of the alkyne to eight minutes led to large 
amounts of the trimerization product (entry 12), demonstrating the balance that must be 
found in the rate of addition of the alkyne to the aldehyde, silane and catalyst system. 
That balance was found in the optimized procedure of entry 11, which is as follows: to 10 
mol% of a Ni(0)-IMes catalyst in THF, 1.5 equivalents of alkyne is added as a solution in 
THF by syringe-drive addition. As the first drop of alkyne solution adds to the catalyst 
mixture, a solution of 1.0 equivalents of aldehyde and 1.1 equivalents of sugar silane are 
added simultaneously. The syringe drive addition of alkyne is carried out with a 0.6M 
solution of alkyne in THF at a rate of 1 mL per 50 minutes. 
With an optimized procedure developed for the Ni(0)-IMes-catalyzed reductive 
coupling of aldehydes and terminal alkynes using sugar silane reducing agents, we hoped 
to apply the conditions to other aldehyde and alkyne combinations (Scheme 3.12). 
Scheme 3.12 Reductive Coupling of Terminal Alkynes with Optimized Procedure 
 
As demonstrated in the optimization studies, the production of 152 proceeded in 
74% yield from heptanal and 1-octyne. When using the branched aldehyde 
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cyclohexylcarboxaldehyde and 1-octyne, 153 was produced in 86% yield. Heptanal 
underwent reductive coupling with cyclohexylacetylene to produce 154 in 80% yield. 
These results not only demonstrate the high yielding optimized procedure, but equally as 
important, they demonstrate the reproducibility as additional trials of these reactions 
produced the product in nearly identical yields. Further expansion of the scope was not 
pursued due to issues encountered in the glycosylation of these substrates, which will be 
highlighted later in this chapter. 
3.2.2 Reductive Coupling with Internal Alkynes and Sugar Silanes 
The nickel-catalyzed reductive coupling of aldehydes and internal alkynes 
generally proceed in higher yields than the corresponding coupling with terminal alkynes. 
This is due to the decreased tendency of internal alkynes to undergo nickel-catalyzed 
trimerization reactions. The trimerization side reaction, which required careful 
optimization to overcome in the previous subsection, is therefore no longer a problem 
with internal alkynes in reductive coupling. An optimized protocol was developed similar 
to that of our group’s 2004 report, with the exception that adding 1.1 equivalents of 
Ti(OiPr)4 to the reaction led to more efficient couplings. In this case, a solution of sugar 
silane, aldehyde and alkyne are added to the pre-formed Ni(0)-IMes catalyst and 
Ti(OiPr)4, with no syringe drive addition necessary, generally leading to high yields of 
the trisubstituted allylic alcohol (Scheme 3.13). 
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Scheme 3.13 Scope of Reductive Coupling with Internal Alkynes and Sugar Silanes 
 
The reductive coupling of the straight-chained aliphatic aldehyde heptanal with 4-
octyne and 3-hexyne proceeded to give 155 and 156 in 83% and 87% yield, respectively. 
The branched aliphatic aldehyde isobutyraldehyde also performed well, coupling with 3-
hexyne to produce allylic alcohol 157 in 75% yield. Switching from aliphatic aldehydes 
to an aromatic aldehyde did not decrease the efficiency of the reaction. Benzaldehyde 
was coupled with 3-hexyne and 4-octyne and the sugar silane to give 158 and 159 in 92% 
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and 75% yield, respectively. The reductive coupling of benzaldehyde with 1-phenyl-1-
propyne proceeded to give 160 in 64% yield with an excellent 95:5 regioisomeric ratio. 
Similarly, coupling heptanal with 1-phenyl-1-propyne resulted in a near quantitative yield 
of 161 with 93:7 regiocontrol. The high levels of regiocontrol observed in the reductive 
coupling products 160 and 161 are the result of an electronic bias in the aryl-alkyl 
substituted internal alkyne. We desired to explore the regiocontrolled addition with an 
internal alkyne bearing a propargylic alcohol. When attempting to couple 1-hydroxy-2-
propyne with heptanal, 162 was not detected. Further exploration of free alcohols is 
needed to understand if this will be a limitation of the methodology. In conclusion, it has 
been demonstrated that the Ni(0)-IMes catalyzed reductive coupling of both aliphatic and 
aromatic aldehydes with internal alkynes proceeds in good to excellent yield to produce 
the desired silyl-linked trisubstituted allylic alcohols. 
3.2.3 Reductive Macrocyclizations with Sugar Silanes 
As described previously in this chapter, nickel-catalyzed reductive coupling has 
been utilized for the synthesis of a variety of different-sized macrocyclic rings from the 
respective ynal precursor. We hoped to explore this approach with sugar silanes because 
1,2-cis glycosides appended to allylic alcohols of macrocycles are found in natural 
products such as amphotericin B.
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 Initial studies on macrocyclizations with sugar silane 
reducing agents produced respectable yields for the 14-carbon ynal 136 giving the desired 
macrocycle 163 in 50% yield (Scheme 3.14). However, attempts at cyclizing ynal 164, 
containing a pendant ketone, produced a complex mixture in which only 8% of 165 was 
isolated. Additional work must be done in this area as carbohydrate-bearing macrocycles 
are important biologically relevant molecules.  
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Scheme 3.14 Attempts at Macrocyclization with Sugar Silanes and Ni(0)-IMes 
 
3.2.4 Reductive Coupling with Sugar Silanes Using Chiral NHCs 
All reductive coupling products with sugar silanes thus far have been produced 
non-selectively as a 1:1 mixture of diastereomers at the newly formed stereocenter. It 
would be useful to apply the chiral NHC ligands developed by our group to produce the 
allylic alcohol with high levels of diastereocontrol. This process was explored using 
chiral NHC 54 and conditions for coupling an aldehyde with an internal alkyne using a 
sugar silane reducing agent (Scheme 3.15). 
 
 
 
 
 
 
87 
 
Scheme 3.15 Diastereoselective Reductive Coupling with Sugar Silanes 
 
 Using 10 mol% Ni(0)-54, heptanal and 3-hexyne were coupled to produce allylic 
alcohol 166 in 93% yield with a modest 3:1 dr. In order to have a direct comparison of 
selectivity, we wished to use an aldehyde-alkyne combination reported in the previous 
communication on asymmetric reductive coupling, where triethylsilane was used as the 
reducing agent. This was done by coupling cyclohexylcarboxaldehyde with 3-hexyne to 
give 167 in 76% yield with a 5.3:1 dr. The reductive coupling product for this aldehyde 
and alkyne combination in the original communication proceeded in 84% yield and 85% 
ee. While the yield was comparable when using the sugar silane protocol, the selectivity 
observed in the newly formed stereocenter was diminished. The 5.3:1 dr observed in the 
production of 167 corresponds to 68% ee at the carbinol stereocenter. The diminished 
selectivity is most likely a function of the Ti(OiPr)4, which is not present in the 
triethylsilane reaction, lowering the energy between diastereomeric transition states. It is 
unlikely the change in silanes resulted in the diminished selectivity due to the fact that 
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silanes have been shown to be zero-order in the nickel-catalyzed reductive coupling of 
aldehydes and alkynes. When attempting the reductive coupling with terminal alkynes 
and Ni(0)-54, low yields were observed due to competing trimerization pathways, 
necessitating a re-optimization to find a balance in reactivity. 
3.3 Glycosylation of Allylic Alcohols 
3.3.1 Initial Attempts at Glycosylating Allylic Alcohols 
The nickel-catalyzed reductive coupling of aldehydes and alkynes with sugar silane 
reducing agents has now been demonstrated.  The sugar silanes were used to couple both 
internal and terminal alkynes, to make macrocycles, and to make diastereomerically 
enriched allylic alcohols with a chiral catalyst system. These advances mark the first step 
in merging aglycone synthesis with glycoside incorporation; the second is the 
glycosylation of the newly synthesized allylic alcohol.   
Initial attempts at glycosylating the silyl-linked allylic alcohols were carried out 
with NIS-based activation methods. Reagent combinations such as NIS and TMSOTf had 
proven to be very successful in the glycosylation of silyl-linked compounds produced in 
the ketone hydrosilylation and alcohol dehydrogenative silylation projects. Unfortunately, 
when attempting to glycosylate tethered allylic alcohols with NIS-based methods, very 
complex reaction mixtures were observed as numerous undesired byproducts were 
produced, providing low yields of the desired glycoside (~15-30%). Careful 
consideration of the difference between glycosylating allylic alcohols and those discussed 
in previous chapters revealed that the presence of the olefin alone was not responsible for 
the vastly different reactivity with these substrates. This can be observed in the 
glycosylation of 80 with NIS and TMSOTf. The steroid aglycone contains a homoallylic 
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alcohol, yet it is glycosylated in an excellent 96% yield producing 81 (Scheme 3.16). 
This suggests that the undesired side reactions in intramolecular aglycone delivery are a 
consequence of the unique reactivity of allylic alcohols. 
Scheme 3.16 Glycosylation of an Aglycone Containing an Olefin with NIS and TMSOTf 
 
While evaluating the unique features of glycosylating an allylic alcohol, we 
realized that upon activation and delivery of the aglycone, a highly activated leaving 
group is formed at the allylic position. This intermediate 168 is prone to a variety of side 
reactions (Scheme 3.17). If a sufficiently basic species is present in the reaction mixture, 
elimination can occur if R
1
 or R
3
 contain a proton, leading to an aglycone derived diene 
byproduct. Additionally, if a sufficiently nucleophilic species is present in the reaction 
mixture, displacement can occur in an SN2-like fashion or through an allylic displacement 
pathway. These unique features presented by the intramolecular aglycone delivery of an 
allylic alcohol required a careful selection of reagents for the activation of the anomeric 
leaving group. 
Scheme 3.17 Generation of a Sensitive Intermediate with Allylic Alcohol Glycosylation 
 
Considering the factors discussed regarding the sensitivity of intermediate 168, a 
careful review of the literature was conducted to choose a suitable reagent for activation 
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that would preferentially react under mild conditions without producing any basic or 
nucleophilic byproducts.  Sinay and coworkers developed a method that appeared to fit 
these parameters, in which the bench stable nitrogen-centered radical cation 171 is used 
to activate a sulfur leaving group by single electron oxidation, facilitating oxocarbenium 
formation.
62
 It is a notably mild procedure, as the byproducts consist of the corresponding 
triarylamine and a sulfur-centered radical. A representative example is seen in the 
glycosylation of primary alcohol 170 with the glycosyl donor 169, which, upon activation 
with 1.5 equivalents of radical cation 171, gave disaccharide 172 in 80% yield and a 25:1 
β:α selectivity (Scheme 3.18). 
Scheme 3.18 Sinay's Radical Cation 171 Activation Method 
 
3.3.2 Development of Radical Cation Glycosylation Conditions 
The mild features of the radical cation procedure were first tested on the 
glycosylation of tethered trisubstituted allylic alcohols. Initial screening of conditions did 
not result in an increase in the yield, and the desired glycosides were produced in a 
maximum of 35% yield (Scheme 3.19). However, it was noted that the reaction 
proceeded with a noticeable decrease in undesired side reactions. While using radical 
cation 171 for activation, the main side reaction appeared to be cleavage of the silyl-
linkage prior to glycosylation. This was encouraging, and further screening of conditions 
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was undertaken to discover conditions to prevent decomposition of the silyl-linker and 
promote conversion to the desired glycoside. 
Scheme 3.19 Initial Screening of Conditions with Radical Cation 171 
 
 It was proposed that switching from the silyl-linked trisubstituted allylic alcohols 
to 1,2-trans allylic alcohols would be a better starting point for screening conditions. We 
hypothesized that glycosylation would be more facile with less electron rich disubstituted 
allylic alcohols. This is due to the decreased electron density of the olefin relative to a 
trisubstituted allylic alcohol, and the diminished steric environment on the aglycone. At 
the time this screen was to be conducted, the investigation of nickel-catalyzed reductive 
coupling of aldehydes and terminal alkynes was not yet complete.  
Scheme 3.20 Independent Synthesis of Silyl-Linked Disubstituted Allylic Alcohol 
 
Therefore in order to produce an appreciable quantity of a silyl-linked 1,2-trans 
allylic alcohol, the alcohol was independently synthesized and then tethered to the sugar 
silane by a Cu(I)-IMes-catalyzed dehydrogenative silylation (Scheme 3.20). The 
synthesis of 174 from the sugar silane and allylic alcohol 173 generally proceeded in a 
75-85% yield and easily produced a gram of 174, which was ideal for screening 
glycosylation conditions. 
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To gain a better understanding of the activation of 174 with radical cation 171, a 
series of exploratory reactions were conducted (Scheme 3.21). We wanted to know if 
using a superstoichiometric amount of radical cation 171, as Sinay and coworkers did, 
was necessary. Treatment of 174 with 20 mol% of the radical cation led to very low 
conversion to the desired glycoside 175. Instead, 174 remained as the major component 
of the reaction, suggesting that once the radical cation is reduced under the reaction 
conditions, it is not re-oxidized to the active radical cation form by any other species. 
This suggested that it was indeed necessary to use the radical cation in a 
superstoichiometric fashion.  
Scheme 3.21 Initial Exploratory Screening in the Glycosylation of 174 
 
It was proposed that nucleophilic additives could form a pentavalent silicate 
species, facilitating the delivery of the allylic alcohol aglycone to the oxocarbenium ion. 
Additionally, this should aid cleavage of the Si—O bond present in the problematic 
intermediate 168, prior to any undesired side reactions taking place. The nucleophilic 
additive must be chosen judiciously, so as to avoid competitive addition to the 
oxocarbenium ion. In order to overcome this, neutral nucleophiles were chosen so if they 
did glycosylate, the cation of the nucleophile would be a good leaving group, allowing 
reversible formation of the oxocarbenium ion.  
When activating 174 with 1.5 equivalents each of the radical cation and 2,6-
DTBMP, and DABCO as the nucleophilic additive, very little conversion was observed. 
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This was potentially due to competitive oxidation of DABCO, or the formation of an 
inactive complex between the two species.
63
 When the same reaction was carried out in 
the absence of 2,6-DTBMP, low conversion was observed. However, when the reaction 
was allowed to stir for two days, the desired glycoside 175 was isolated in 43% yield. It 
is unlikely that single electron oxidation of the sulfur leaving group accounted for the 
observed result. Rather, the prolonged reaction time and mixture of reagents likely 
resulted in activation of the leaving group by an alternative mechanism. Additional 
studies with DABCO and radical cation 171 showed that if the equivalents of DABCO 
were greater than 171, no reaction was observed, presumably due to the rapid 
deactivation of the radical cation by DABCO. Activating silyl-linked compound 174 with 
1.5 equivalents of the radical cation, 2.0 equivalents 2,6-DTBMP and 5.0 equivalents of 
THF resulted in a 25% yield of glycoside 175. These conditions, in the absence of 2,6-
DTBMP, led to rapid decomposition of the silyl-linked material producing no desired 
product. Using 2.0 equivalents of triphenylphosphine as the nucleophilic additive with 
1.5 equivalents of radical cation and 2.0 equivalents of 2,6-DTBMP resulted in no 
activation of the thioethyl leaving group. Instead, cleavage of the silyl-linker was 
observed, producing the 2-hydroxy sugar and the allylic alcohol. Addition of 3.0 
equivalents of pyridine with 1.5 equivalents of radical cation led to no observed reaction, 
again likely due to the competitive single electron oxidation or formation of an inactive 
complex with 171, resulting in large amounts of remaining starting material. Our screen 
suggested that nucleophilic additives either served to competitively deactivate the radical 
cation, facilitate decomposition of the silyl-linked starting material, or both.  
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When treating silyl-linked compound 174 with 1.5 equivalents of radical cation 
171 in the absence of added base, no production of the desired glycoside was detected. 
Instead, rapid decomposition of the starting material was observed. It is possible that 
upon activation, the hexafluoroantimonate counter ion forms an acidic or nucleophilic 
species, resulting in the observed decomposition. This suggests the necessity for a base to 
buffer the reaction, preventing the decomposition of the silyl-linker prior to 
intramolecular aglycone delivery. Based on previous results, 2,6-DTBMP has been the 
most compatible organic base, as other bases such as triethylamine, DABCO, and 
pyridine rapidly deactivate the radical cation reagent. It should be noted that alkoxide 
bases were not screened due to their potential for competing O-glycoside formation. A 
comprehensive set of experiments was devised to determine the optimal ratio of radical 
cation to 2,6-DTBMP in the glycosylation of 174 (Scheme 3.22).  
Scheme 3.22 Screening Reagent Ratios to Optimize Glycosylation of 174 
 
In a series of sixteen experiments with 1.0 equivalent of silyl-linked compound 
174, the amount of radical cation was varied in increments between 1.0 and 2.0 
equivalents. The equivalents of 2,6-DTBMP were also varied in increments between 1.0 
and 1.8. These experiments revealed that as the ratio of radical cation to 2,6-DTBMP 
became greater than one, the consumption of starting material increased.  However, as 
this ratio increased, decomposition was a major problem, resulting in low yields of the 
desired product. As the ratio of radical cation to 2,6-DTBMP decreased to one or less, 
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reactivity was shut down, and large amounts of starting material remained. This is 
presumably due to the unproductive oxidation of 2,6-DTBMP, as this hindered pyridine 
base is unlikely to form a complex by nucleophilic addition to 171. This study of reagent 
stoichiometry revealed that the ideal ratio of radical cation 171 to 2,6-DTBMP was 1.5 to 
1.1 relative to 1.0 equivalent of 174. At this optimized level of reactivity with 2,6-
DTBMP as the base, the desired 1,2-cis glycoside was only produced in 43% yield. It was 
concluded that 2,6-DTBMP was not a suitable base for the productive intramolecular 
aglycone delivery utilizing radical cation 171 as the activating agent.  
Results with the radical cation suggested that finding a suitable base to buffer the 
reaction conditions should elevate the yields. However, little success had been realized 
with organic bases, so we sought to gain an understanding of the compatibility of 
inorganic bases under the radical cation activation conditions (Table 3.2). When using 
basic alumina, potassium carbonate, and sodium thiosulfate pentahydrate, small amounts 
of the desired glycoside 175 were detected, but the major pathway was decomposition of 
the starting material (entries 1-3). Utilizing magnesium sulfate as the inorganic base 
produced no detectable amount of 175, and decomposition of the starting material was 
rapidly observed (entry 4). Approximately 20% of glycoside 175 was formed when a 
carboxylate salt was used; however, it appeared to shut down reactivity leading to large 
amounts of recovered 174 (entry 5). A breakthrough was discovered when employing 
sodium bicarbonate, producing 175 in 55% yield (entry 6). It was found that sodium 
sulfate was also a suitable base, as 175 was formed in approximately 35% yield, although 
decomposition was still an issue (entry 7). 
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Table 3.2 Screening Inorganic Bases in Radical Cation Glycosylations 
 
Sodium bicarbonate was identified as the best base to explore further optimization 
studies in the glycosylation of 174 (Table 3.3). A control experiment with the silyl-linked 
compound and NaHCO3 was conducted in the absence of the radical cation (entry 1). 
This led exclusively to recovery of starting material, which was important not only to 
determine that NaHCO3 does not aid in glycosylation, but it also does not cleave the silyl-
linker in 174. The starting point for optimization studies comes from the initial reaction 
conditions discovered in the inorganic base screen, producing 175 in 55% yield (entry 2). 
When decreasing the equivalents of radical cation to 1.2 with a slight increase of 
NaHCO3 to 7.0 equivalents, the yield of 175 decreased to 38% (entry 3). It was 
determined the incorporation of 4Å MS was necessary as attempting the glycosylation in 
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their absence led to increased glycosylation of adventitious water, resulting in a low yield 
of 175 (entry 4). Heating the reaction to 50 °C accelerated the decomposition pathway as 
well as increased the addition of water to the oxocarbenium ion, producing a low yield of 
175 (entry 5). Diluting the reaction from 0.05 to 0.02M resulted in a slight increase of the 
yield of 175 to 59% (entry 6). An additional increase in yield was observed when the 
silyl-linked 174 was added dropwise to a mixture of radical cation and NaHCO3 as a 
solution in acetonitrile, resulting in a 64% yield (entry 7). Using the same procedure as 
entry 7 with KHCO3 resulted in a similar 61% yield of 175, suggesting negligible 
counterion effects (entry 8). Increasing the equivalents of NaHCO3 to 20 with the 
dropwise addition of 174 produced the desired glycoside 175 in an optimized yield of 
70% (entry 9). Although it is not ideal to use 20 equivalents of a reagent in a procedure, 
the reagent is very inexpensive (5 kg NaHCO3 for $137.50, Sigma Aldrich) and has a low 
molecular weight, resulting in minimal mass addition even at high equivalency. 
Additionally, using only 5 equivalents of NaHCO3 produced similar yields and can be 
used as an optimized protocol. It should be noted that nBu4NF is added to all 
glycosylation experiments following activation to remove the silyl-linkage. The best 
workup procedure was obtained by filtering off the molecular sieves from the reaction 
mixture, followed by concentration with silica gel and dry loading for column 
chromatography.  
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Table 3.3 Radical Cation Glycosylation with NaHCO3 Optimization Study 
 
With a procedure now developed for the glycosylation of 1,2-trans allylic 
alcohols by intramolecular aglycone delivery, we sought to explore the scope and 
generality of this radical cation based procedure (Scheme 3.23). Applying the radical 
cation based method to other silyl-tethered disubstituted allylic alcohols resulted in lower 
yields than those seen with compound 174. The reductive coupling product of 
cylcohexylcarboxaldehyde and 1-octyne gave 176 in 50% yield. The reductive coupling 
product of heptanal and cyclohexylacetylene was activated to give the glycoside 177 in 
only 46% yield. Similar to the previous two examples, the glycosylated macrocycle 178 
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was produced in 50% yield. While these yields were somewhat synthetically useful, they 
were routinely 10-20% less than yields observed in the glycosylation of 174. We 
proposed that switching from a dimethylsilyl to a diisopropylsilyl linker may prevent 
undesired decomposition pathways. However, when applying the optimized radical 
cation procedure to the corresponding diisopropylsilyl linked compound of 179, the 
desired glycoside was produced in 31% yield. It should be noted that the silyl-linked 
compound corresponding to 179 was made by dehydrogenative silylation. The sugar 
silane containing a diisopropylsilane also performed very poorly as a reducing agent in 
the nickel-catalyzed reductive coupling of aldehydes and alkynes. When attempting to 
glycosylate trisubstituted allylic alcohols with the radical cation procedure, glycosides 
180 and 181 were produced in 29% and 35% yield respectively, which illustrated the 
additional challenges of glycosylating allylic alcohols containing trisubstituted olefins. 
Scheme 3.23 Scope of Radical Cation Glycosylation Method 
 
100 
 
The moderate to poor yields observed while exploring the generality of the 
optimized radical cation procedure were disappointing. The novelty of merging aglycone 
synthesis with glycoside incorporation has been limited by the problems glycosylating 
allylic alcohols presented. We hoped that the advantages of using sugar silanes as 
reducing agents in the nickel-catalyzed reductive coupling of aldehydes and alkynes 
would not be lost in these challenges. 
3.3.3 Hydrogenation Studies on Silyl-Linked Allylic Alcohols 
Studies on the glycosylation of allylic alcohols have shown the inherent 
challenges that lie within harnessing highly sensitive intermediates. The intramolecular 
aglycone delivery of allylic alcohols produced by nickel-catalyzed reductive coupling led 
to poor yields of the desired glycoside. However, intramolecular aglycone delivery of 
non-allylic alcohol aglycones proceeded in good to excellent yields. We hoped to 
combine these two strategies by using sugar silanes as reducing agents to produce allylic 
alcohols, followed by hydrogenation of the olefin, to increase the yields of glycosylation. 
A screen of hydrogenation conditions was carried out with silyl-linked compounds 154 
and 156 (Table 3.4). We searched for a catalyst system that would selectively 
hydrogenate the olefin in the presence of benzyl protecting groups and be mild enough to 
prevent decomposition of the silyl linker.  
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Table 3.4 Screen of Hydrogenation Catalysts for Reducing Allylic Alcohols 
 
The reduction of trisubstituted allylic alcohol 156 was first explored, and it was 
found that using PtO2 in EtOH led to decomposition of the starting material (entry 1). 
When utilizing 10 mol% Pd/C in EtOAc, no decomposition was observed, and a small 
amount of the reduced olefin product was detected by low resolution mass spectrometry 
(entry 2). Increasing catalyst loading to 20 mol% Pd/C in EtOAc improved the 
conversion to the reduced product (entry 3). However, after 24 hours at room 
temperature, only 50% of 156 had been converted to the desired product. Using 20 mol% 
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Pd(OH)2 in EtOH resulted in decomposition of the silyl-linker, debenzylation, and 
recovery of starting material (entry 4). Trying 20 mol% Pd/C in EtOH led only to 
cleavage of the silyl-linker in 156 (entry 5).  
When attempting the reduction of disubstituted allylic alcohol 154 with 10% Pd/C 
in MeOH, and ammonium formate as a H2 surrogate, no reaction was observed (entry 6). 
A one pot reductive coupling-hydrogenation protocol was explored by incorporating a 
hydrogen atmosphere upon completion of the Ni(0)-IMes catalyzed reductive coupling. 
This approach only resulted in decomposition of the silyl-linkage (entry 7). Successful 
reduction of 154 was completed by treatment with 20 mol% Pd/C in EtOAc at room 
temperature to give complete conversion to the aliphatic product (entry 8). This catalyst 
system was selected as the ideal choice for the hydrogenation of allylic alcohols tethered 
to sugar silanes. 
We envisioned applying this reductive coupling-hydrogenation protocol to a 
diastereomerically enriched trisubstituted allylic alcohol. Upon hydrogenation of the 
olefin, a new stereocenter is formed, and the silyl-linked carbohydrate could potentially 
shield one face of the olefin, leading to a highly diastereoselective reduction. This 
sequence was tested in the hydrogenation of trisubstituted allylic alcohol 166 (Scheme 
3.24). Gentle heating at 40 °C in EtOAc with 15 mol% Pd/C gave approximately 85% 
conversion to reduced product 182, which was inseparable from the starting material. The 
mixture of products complicated accurate determination of the dr of the reduced product, 
but it was estimated near 10:1. Activation of 182, still containing ~15% allylic alcohol 
166, with NIS and TMSOTf resulted in only 38% of the desired glycoside 183. 
Determination of the relative stereochemistry was again complicated by the inseparable 
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diastereomers of 183. Further exploration is needed to understand the reasons for the low 
yielding glycosylation of 182. It is conceivable that even in small quantities, allylic 
alcohols generate highly reactive species under NIS/TMSOTf activation conditions 
which impacted the glycosylation of 182. Additionally, the thioethyl leaving group may 
not be reactive enough for the high yielding glycosylation of 182 due to steric hindrance 
on the aglycone. Using a thiophenyl leaving group and ensuring complete conversion to 
the reduced product would be important for future studies with the hydrogenation 
protocol.  
Scheme 3.24 Attempt at Hydrogenation/Glycosylation of Trisubstituted Allylic Alcohol 
 
 A limitation of the hydrogenation conditions was realized when attempting the 
reduction of 167 with Pd/C in EtOAc where no reaction resulted (Scheme 3.25). The only 
difference between 166 and 167 are the n-hexyl and cyclohexyl allylic substituents, 
respectively. A barrier of reactivity was discovered with the small increase in steric bulk. 
This is a limitation requiring further experimentation, as increased temperatures, reaction 
times and additional aliquots of catalyst did not produce the desired reduction product. 
Scheme 3.25 Limitation in the Hydrogenation of Olefins with Increased Steric Bulk 
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3.4 Summary and Future Directions 
The goal of this research project was to merge aglycone synthesis with glycoside 
incorporation. The first step was accomplished by developing conditions for the Ni(0)-
catalyzed reductive coupling of aldehydes and alkynes (Scheme 3.26). This was applied 
to the intermolecular synthesis of di- and tri-substituted allylic alcohols from terminal and 
internal alkynes respectively. The intramolecular cyclization of a 14-carbon ynal was 
carried out to produce a macrocycle in modest yield. Additionally, the utility of chiral 
NHCs was demonstrated by producing diastereomerically enriched allylic alcohols.  
Scheme 3.26 Highlights of Reductive Coupling with Sugar Silanes 
 
The glycosylation of the silyl-tethered allylic alcohols by intramolecular aglycone 
delivery presented a unique challenge due to the proposed generation of sensitive 
intermediate 168 (Scheme 3.27). Initial studies revealed that NIS-based activation 
methods were not suitable for the glycosylation of allylic alcohols. A mild radical cation 
based method was explored, and it was found that buffering the reaction with a base was 
necessary. Screening revealed sodium bicarbonate was the ideal base paired with radical 
cation 171 for glycosylation of allylic alcohols. However, optimization studies only 
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resulted in modest yields of the 1,2-cis glycosides when using disubstituted allylic 
alcohols. The optimized procedure was ineffective at glycosylating trisubstituted allylic 
alcohols, resulting in yields of approximately 30%. Studies were conducted on the 
hydrogenation of silyl-tethered allylic alcohols, and conditions using Pd/C in EtOAc were 
found to be selective for the hydrogenation of unhindered allylic alcohols without 
debenzylation or silyl-cleavage.  
Scheme 3.27 Highlights of Intramolecular Aglycone Delivery with Allylic Alcohols 
 
Glycosyl fluoride-based sugar silanes are currently being explored to determine 
their effectiveness as reducing agents in the reductive coupling of alkynes and aldehydes, 
producing silyl-linked allylic alcohols. Mild methods for the activation of fluoride 
leaving groups are hypothesized to increase the efficiency of intramolecular aglycone 
delivery with allylic alcohols. The body of work reported in this chapter has improved 
our understanding of reactive intermediates such as 168. It is hoped that the shortcomings 
of our efforts to merge aglycone synthesis with glycoside incorporation provide lessons 
for the eventual success of this method. Additionally, further exploration into the 
hydrogenation-glycosylation sequence could provide a useful protocol for generating 
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glycosides containing two new stereocenters on the aglycone from simple starting 
materials in rapid fashion. This protocol would be well suited in conjunction with the 
latest developments in ligand-controlled regioselective addition of unbiased alkynes to 
aldehydes. These developments would further highlight the applications of sugar silanes 
and the synthetic utility brought about by merging transition-metal catalysis and 
carbohydrate chemistry to synthesize glycosides selectively using novel pathways. 
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Chapter 4  
 
Experimental Procedures and Spectral Data 
 
4.1 Chapter 1 Experimental Procedures and Spectral Data 
4.1.1 Chapter 1 Experimental Procedures 
All reagents were used as received unless otherwise noted. Solvents were purified 
under nitrogen using a solvent purification system (Innovative Technology, inc., Model # 
SPS-400-3 and PS-400-3). Ni(COD)2 (Strem Chemicals, Inc., used as received), CuCl 
(Sigma-Aldrich, used as received), 1,3-dimesitylimidazolium chloride (IMes·HCl) were 
stored and weighed in an inert atmosphere glovebox. Ti(O-i-Pr)4 and Me2Si(H)Cl were 
distilled and stored under inert atmosphere in Schlenk flasks. All nickel reactions were 
conducted in flame-dried glassware under a nitrogen atmosphere. 
1
H and 
13
C spectra 
were obtained in CDCl3 at rt, unless otherwise noted, on a Varian Mercury 400 or Varian 
Unity 500 MHz instrument. Chemical shifts of 
1
H NMR spectra were recorded in parts 
per million (ppm) on the δ scale from an internal standard of residual chloroform (7.27 
ppm). Chemical shifts of 
13
C NMR spectra were recorded in ppm from the central peak of 
CDCl3 (77.0 ppm) on the δ scale. High resolution mass spectra (HRMS) were obtained on 
a VG-70-250-s spectrometer manufactured by Micromass Corp. (Manchester UK) at the 
University of Michigan Mass Spectrometry Laboratory. 
General Procedure for the Preparation of Sugar Silanes (General Procedure 4.1) 
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The respective 2-OH sugar (1.0 equiv) was dissolved in dry CH2Cl2 (0.2M) and 
cooled to 0 °C in an ice bath.  Freshly distilled NEt3 (2.0 equiv) was added and stirred for 
3 minutes, Me2Si(H)Cl (1.5 equiv) was then added.  This was allowed to stir for 4 hours 
then volatiles were removed by rotary evaporation, the resulting oil was extracted from 
NaHCO3 (aq.) (diluted over ice) 3 times with CH2Cl2.  The combined organic extracts 
were dried quickly over MgSO4, filtered, concentrated, and the resulting oil was either 
used directly or stored frozen in C6H6.  Note – the sugar silanes are stable for months 
when stored frozen in benzene, or under high vacuum. Alternatively, the corresponding 
2-OH sugars are very stable to be stored for long periods of time on the bench top.   
General Procedure for the Ni(0)-IMes Promoted Hydrosilylation of Ketones 
(General Procedure 4.2) 
A solid mixture of Ni(COD)2 (10%), IMes·HCl (10%), and KO-t-Bu (10%) was 
dissolved in dry THF (0.02M) at rt under an inert atmosphere (N2), and stirred for 10-15 
minutes until the catalyst mixture was a dark blue color.  Ti(Oi-Pr)4 (1.1-2.2 equiv) was 
then added to the catalyst mixture followed by the addition of the sugar silane (1.1 
equiv), and ketone (1.0 equiv) as a solution in dry  THF (0.2M).  Upon completion of the 
reaction, as monitored by TLC, the reaction mixture was filtered through a short plug of 
silica gel with a mixture of EtOAc/hexanes and concentrated by rotary evaporation.  The 
resulting residue was purified via flash chromatography (SiO2) to afford the desired 
product.  Note – For the site-selective hydrosilylation of a ketone in the presence of a free 
hydroxyl group, using 2.2 equiv of Ti(O-i-Pr)4, and a 0.05 M solution in THF results in 
higher yields of the desired product. 
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General Procedure for the CuCl/IMes Promoted Hydrosilylation of Ketones 
(General Procedure 4.3) 
A solid mixture of CuCl (5%), IMes·HCl (5%) and KO-t-Bu (10%) was dissolved 
in dry toluene (0.015M) at rt under an inert atmosphere (N2), and stirred for 20 minutes.  
A mixture of ketone (1.0 equiv) and silane (1.1 equiv) was dissolved in dry toluene 
(0.2M), the catalyst was then added to this mixture as a solution in a minimum of dry 
toluene.  Upon completion of the reaction, as monitored by TLC, the reaction mixture 
was filtered through a short plug of silica gel with a mixture of EtOAc/Hexanes and 
concentrated by rotary evaporation.  The resulting residue was purified via flash 
chromatography (SiO2) to afford the desired product. 
General Procedure for NIS/TMSOTf Mediated Glycosylation of Silyl-Linked 
Compounds (General Procedure 4.4) 
The respective silyl-linked compound (1.0 equiv) was dissolved in dry CH2Cl2 
(0.02M) and cooled to -40 °C.  N-iodosuccinimide (NIS) (1.3-1.4 equiv) and 2,6-di-tert-
butyl-4-methyl pyridine (2,6-DTBMP) (2.0-4.0 equiv) were added and stirred for 3 
minutes.  To this solution, trimethylsilyl trifluoromethanesulfonate (TMSOTf) (1.2-2.4 
equiv) was added, this is stirred for 10-15 minutes and then warmed to 0 °C.  Upon 
disappearance of the silyl-linked compound, as monitored by TLC (generally 30 to 90 
min), n-Bu4NF (5-10 equiv, 1M THF) was added, and the reaction was warmed to rt and 
stirred overnight.  The reaction mixture was then quenched with sat. Na2S2O3 (aq.) and 
extracted three times from sat. NH4Cl (aq.) with EtOAc.  The combined organic extracts 
were dried over MgSO4, filtered, concentrated, and purified by flash chromatography on 
SiO2 to afford the desired product. 
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Thioethyl Glucose Dimethyl Sugar Silane 
 
Following the general procedure 4.1, ethyl 3,4,6-tri-O-benzyl-1-thio-β-D-
glucopyranoside (1.237 g, 2.50 mmol), NEt3 (0.697 mL, 5.00 mmol), and Me2Si(H)Cl 
(0.416 mL, 3.75 mmol) were stirred for 4 hours at 0 °C.  The product (1.38 g, 2.50 mmol, 
100%) was obtained as a red oil after aqueous work up.  
1
H NMR (500MHz, CDCl3) δ 
7.25-7.28 (m, 13H), 7.12-7.16 (m, 2H), 4.91 (d, J = 11.5 Hz, 1H), 4.85 (d, J = 11.0 Hz, 
1H), 4.82 (sept, J = 3.0 Hz, 1H), 4.78 (d, J = 10.5 Hz, 1H), 4.61 (d, J = 12.5 Hz, 1H), 
4.553 (d, J = 12.5 Hz, 1H), 4.546 (d, J = 11.0 Hz, 1H), 4.37 (d, J = 9.0 Hz, 1H anomeric), 
3.75 (dd, J = 10.5, 1.5 Hz, 1H), 3.69 (dd, J = 11.0, 4.5 Hz, 1H), 3.53-3.62 (m, 3H), 3.49 
(ddd, J = 9.5, 5.0, 2.0 Hz, 1H), 2.77 (dq, J = 12.5, 7.5 Hz, 1H), 2.71 (dq, J = 12.0, 8.0 Hz, 
1H), 1.32 (t, J = 7.5 Hz, 3H), 0.31 (d, J = 3.0 Hz, 3H), 0.25 (d, J = 2.5 Hz, 3H); 
13
C NMR 
(100 MHz, CDCl3) δ 138.5, 138.2, 138.0, 128.34, 128.30, 128.27, 127.9, 127.71, 127.69, 
127.52, 127.48, 127.45, 87.2, 86.1, 79.2, 77.9, 75.9, 75.6, 75.0, 73.4, 69.1, 24.7, 15.0, -
0.6, -0.8; IR (film, cm
-1
) 2956, 2926, 2864, 2129, 1651, 1385, 1083; HRMS (ES) m/z 
calcd for C31H40O5SSi [M+Na]
+
 575.2263, found 575.2269.  
Thiophenyl Glucose Dimethyl Sugar Silane 
 
Following the general procedure 4.1, phenyl 3,4,6-tri-O-benzyl-1-thio-β-D-
glucopyranoside (1.00 g, 1.8 mmol), NEt3 (0.513 μL, 3.7 mmol), and Me2Si(H)Cl (307 
μL, 2.8 mmol) were stirred for 4 hours at 0 °C.  The product (1.10 g, 1.8 mmol, 99%) was 
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obtained as a red oil after aqueous work up.  
1
H NMR (500 MHz, CDCl3) δ 7.56-7.59 (m, 
2H), 7.24-7.38 (m, 16H), 7.15-7.20 (m, 2H), 4.91 (d, J = 11.0 Hz, 1H), 4.87 (d, J = 11.5 
Hz, 1H), 4.85 (sept, J = 3.0 Hz, 1H), 4.79 (d, J = 10.5 Hz, 1H), 4.62 (d, J = 12.0 Hz, 1H), 
4.61 (d, J = 9.5 Hz, 1H anomeric) 4.59 (d, J = 12.0 Hz, 1H), 4.55 (d, J = 12.5 Hz, 1H), 
3.80 (dd, J = 10.5, 1.5 Hz, 1H), 3.73 (dd, J = 11.0, 5.0 Hz, 1H), 3.67 (t, J = 9.0 Hz, 1H), 
3.65 (t, J = 9.0 Hz, 1H), 3.58 (t, J = 8.25 Hz, 1H), 3.54 (ddd, J = 9.5, 4.5, 1.5 Hz, 1H), 
0.29 (d, J = 2.5 Hz, 3H), 0.24 (d, J = 3.0 Hz, 3H); 
13
C NMR (100 MHz, CDCl3) δ 138.4, 
138.2, 138.0, 134.1, 131.5, 128.8, 128.4, 128.3, 127.9, 127.8, 127.7, 127.53, 127.49, 
127.48, 127.2, 88.8, 87.2, 79.2, 77.8, 75.6, 75.1, 75.0, 73.4, 69.0, -0.6, -0.9; IR (film, cm
-
1
) 3060, 3028, 2864, 2129, 1452, 1362, 1066; HRMS (ES) m/z calcd for C35H40O5SSi 
[M+Na]
+
 623.2263, found 623.2274. 
Thioethyl Mannose Dimethyl Sugar Silane 
 
Following the general procedure 4.1, ethyl 3,4,6-tri-O-benzyl-1-thio-α-D-
mannopyranoside (1.74 g, 3.5 mmol),
 
 NEt3 (0.98 mL, 7.0 mmol), and Me2Si(H)Cl (587 
μL, 5.3 mmol) were stirred for 4 hours at 0 °C.  The product (1.93 g, 3.5 mmol, 100%) 
was obtained as a red oil after aqueous work up.  
1
H NMR (500MHz, CDCl3) δ 7.25-7.39 
(m, 13H), 7.15-7.18 (m, 2H), 5.27 (d, J = 2.0 Hz, 1H anomeric), 4.84 (d, J = 11.0 Hz, 
1H), 4.76 (sept, J = 2.5 Hz, 1H), 4.73 (d, J = 11.5 Hz, 1H), 4.68 (d, J = 12.0 Hz, 1H), 
4.62 (d, J = 11.5 Hz, 1H), 4.50 (d, J = 11.5 Hz, 1H), 4.49 (d, J = 11.0 Hz, 1H), 4.18 (t, J 
= 2.25 Hz, 1H), 4.13 (ddd, J = 10.0, 5.0, 2.0 Hz, 1H), 3.95 (t, J = 9.5 Hz, 1H), 3.76-3.83 
(m, 2H), 3.70 (dd, J = 11.0, 2.0 Hz, 1H), 2.67 (dq, J = 13.0, 7.0 Hz, 1H), 2.59 (dq, J = 
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13.0, 7.5 Hz, 1H), 1.29 (t, J = 7.5 Hz, 3H), 0.26 (d, J = 2.5 Hz, 3H), 0.24 (d, J = 2.5 Hz, 
1H); 
13
C NMR (100 MHz, CDCl3) δ 138.43, 138.40, 138.1, 128.28, 128.25, 128.20, 
127.89, 127.65, 127.59, 127.50, 127.4, 85.0, 80.7, 74.9, 74.6, 73.2, 72.5, 72.2, 72.1, 69.1, 
25.2, 15.0, -0.6, -0.7; IR (film, cm
-1
) 3030, 2870, 2122, 1453, 1384, 1250, 1097; HRMS 
(ES) m/z calcd for C31H40O5SSi [M+Na]
+
 575.2263, found 575.2273. 
Thiophenyl Mannose Dimethyl Sugar Silane 
 
Following the general procedure 4.1, phenyl 3,4,6-tri-O-benzyl-1-thio-α-D-
mannopyranoside (0.765 g, 1.4 mmol), NEt3 (0.390 mL, 2.8 mmol), and Me2Si(H)Cl 
(0.233 mL, 2.1 mmol) were stirred for 4 hours at 0 °C.  The product (0.828 g, 1.4 mmol, 
98%), was obtained as a red oil after aqueous work up.  
1
H NMR (500 MHz, CDCl3) δ 
7.48-7.51 (m, 2H), 7.39-7.42 (m, 2H), 7.23-7.37 (m, 14H), 7.18-7.21 (m, 2H), 5.50 (d, J 
= 1.5 Hz, 1H anomeric), 4.87 (d, J = 11.0 Hz, 1H), 4.78 (d, J = 11.5 Hz, 1H), 4.76 (sept, 
J = 3.0 Hz, 1H), 4.68 (d, J = 11.5 Hz, 1H), 4.67 (d, J = 12.0 Hz, 1H), 4.52 (d, J = 11.0 
Hz, 1H),. 4.48 (d, J = 12.0 Hz, 1H), 4.34 (t, J = 2.0 Hz, 1H), 4.29 (ddd, J = 9.5, 4.5, 1.5 
Hz, 1H), 4.00 (t, J = 9.5 Hz, 1H), 3.79-3.86 (m, 2H), 3.74 (dd, J = 11.0, 2.0 Hz, 1H), 0.26 
(d, J = 3.0 Hz, 3H), 0.22 (d, J = 3.0 Hz, 3H); 
13
C NMR (100 MHz, CDCl3) δ 138.36, 
138.31, 134.4, 131.3, 128.9, 128.32, 128.28, 128.18, 127.9, 127.65, 127.57, 127.4, 127.2, 
88.7, 80.5, 75.0, 74.5, 73.2, 72.8, 72.5, 72.3, 69.1, -0.6, -0.7; IR (film, cm
-1
) 3061, 3030, 
2869, 2123, 1453, 1368, 1251, 1101; HRMS (ES) m/z calcd for C35H40O5SSi [M+Na]
+
 
623.2263, found 623.2248. 
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Ethyl 2-O-dimethyl[(4-phenylbutan-2-yloxy)silane]-3,4,6-tri-O-benzyl-1-thio-β-D-
glucopyranoside (Scheme 1.14, compound 16) 
 
Following the general procedure 4.2, silane (182 mg, 0.33 mmol), freshly distilled 
(bulb-to-bulb) benzylacetone (45 μL, 0.30 mmol), Ni(COD)2 (8 mg, 0.03 mmol), 
IMes·HCl (10 mg, 0.03 mmol), KO-t-Bu (3 mg, 0.03 mmol) and Ti(O-i-Pr)4 (98 μL, 0.33 
mmol) were stirred at rt for 13 hours.  The desired product was obtained as an inseparable 
mixture of diastereomers (54:46) (204 mg, 0.29 mmol, 97%, 54:46) as a clear oil, upon 
purification by flash chromatography on SiO2 (10% EtOAc/Hex).  
1
H NMR (500 MHz, 
CDCl3) δ 7.24-7.40 (m, 16H), 7.14-7.19 (m, 2H), 7.09-7.13 (m, 2H), 4.98 (d, J = 11.5 Hz, 
1H), 4.89 (d, J = 11.5 Hz, 0.5H), 4.88 (d, J = 11.0 Hz, 0.5H), 4.75 (d, J = 10.5 Hz, 0.5H), 
4.74 (d, J = 11.0 Hz, 0.5H), 4.52-4.63 (m, 3H), 4.40 (d, J = 9.5 Hz, 0.5H anomeric), 4.39 
(d, J = 9.5 Hz, 0.5H anomeric), 4.00-4.08 (m, 1H), 3.67-3.78 (m, 3H), 3.54-3.64 (m, 2H), 
3.48-3.52 (m, 1H), 2.66-2.80 (m, 3H), 2.55-2.62 (m, 1H), 1.74-1.84 (m, 1H), 1.65-1.73 
(m, 1H), 1.31 (t, J = 7.5 Hz, 3H), 1.21 (d, J = 6.0 Hz, 1.5H), 1.19 (d, J = 6.0 Hz, 1.5H), 
0.23 (s, 1.5H), 0.22 (s, 1.5H), 0.19 (s, 1.5H), 0.18 (s, 1.5H), Note – diastereomers are 
reported as a 1:1 ratio of the total amount of protons; 
13
C NMR (100 MHz, CDCl3) major 
and minor diastereomer signals reported δ 142.53, 142.50, 138.8, 138.2, 137.9, 128.3,4, 
128.32, 128.24, 128.19, 127.9, 127.7, 127.5, 127.26, 127.24, 127.21, 127.1, 125.58, 
125.56, 87.1, 86.2, 79.1, 78.2, 75.18, 75.15, 74.9, 74.48, 74.43, 73.4, 69.1, 68.3, 68.1, 
41.0, 32.04, 32.02, 24.7, 23.7, 23.6, 15.1, -0.8, -0.9, -1.2, -1.3; IR (film, cm
-1
) 3029, 2965, 
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2923, 2865, 1496, 1453, 1366, 1256, 1134, 1086; HRMS (ES) m/z calcd for C41H5206SSi 
[M+Na]
+
 723.3152, found 723.3162. 
[4-phenylbutan-2]-3,4,6-tri-O-benzyl-α-D-glucopyranoside (Scheme 1.14, compound 
17) 
 
Following the general procedure 4.4, compound 16 (112 mg, 0.16 mmol), NIS (47 
mg, 0.21 mmol), TMSOTf (35 μL, 0.19 mmol), 2,6-DTBMP (66 mg, 0.32 mmol) were 
stirred for 10 min at -40 °C, and 30 min at 0 °C, then excess n-Bu4NF (0.96 mmol, 0.96 
mL) was added as a 1M solution in THF and stirred overnight to afford the desired 
products as a 46:54 mixture of diastereomers as clear oils, which were separated and 
characterized independently (combined 90 mg, 0.15 mmol, 97%, 54:46) upon purification 
by flash chromatography on SiO2 (20% EtOAc/Hex). Major diastereomer 
1
H NMR 
(500 MHz, CDCl3) δ 7.39-7.42 (m, 2H), 7.25-7.36 (m, 13H), 7.13-7.21 (m, 5H), 5.02 (d, 
J = 3.0 Hz, 1H anomeric), 4.97 (d, J = 11.0 Hz, 1H), 4.85 (d, J = 10.0 Hz, 1H), 4.83 (d, J 
= 10.5 Hz, 1H), 4.62 (d, J = 12.5 Hz, 1H), 4.49 (d, J = 10.5 Hz, 1H), 4.47 (d, J = 12.0 Hz, 
1H), 3.83-3.92 (m, 2H), 3.58-3.76 (m, 5H), 2.70-2.78 (m, 1H), 2.60-2.68 (m, 1H), 1.92-
2.07 (m, 2H), 1.77-1.85 (m, 1H), 1.23 (d, J = 6.5 Hz, 3H); 
13
C NMR (100 MHz, CDCl3) δ 
141.8, 138.8, 138.2, 137.9, 128.35, 128.34, 128.32, 128.27, 127.9, 127.8, 127.66, 127.63, 
127.56, 125.8, 96.0, 83.6, 77.3, 75.3, 75.0, 73.5, 72.8, 72.7, 70.8, 68.4, 38.6, 32.0, 19.1; 
IR (film, cm
-1
) 3461, 3061, 3029, 2924, 1495, 1453, 1381, 1129, 1065, 1034 ; HRMS 
(ES) m/z calcd for C37H42O6 [M+Na]
+
 605.2879, found 605.2877.  Minor diastereomer 
1
H NMR (500 MHz, CDCl3) δ 7.39-7.42 (m, 2H), 7.26-7.36 (m, 13H), 7.18-7.22 (m, 3H), 
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7.14-7.17 (m, 2H), 4.99 (d, J = 3.5 Hz, 1H anomeric), 4.96 (d, J = 11.5 Hz, 1H), 4.84 (d, 
J = 10.5 Hz, 1H), 4.83 (d, J = 10.5 Hz, 1H), 4.65 (d, J = 12.5 Hz, 1H), 4.50 (d, J = 12 Hz, 
1H), 4.49 (d, J = 10.5 Hz, 1H), 3.89 (d, J = 9.0 Hz, 1H), 3.62-3.83 (m, 6H), 2.64-2.75 (m, 
2H), 1.90-1.98 (m, 2H), 1.74-1.82 (m, 1H), 1.28 (d, J = 6.5 Hz, 3H); 
13
C NMR (100 
MHz, CDCl3) δ 141.7, 138.8, 138.1, 137.9, 128.42, 128.35, 128.32, 128.27, 127.93, 
127.87, 127.83, 127.70, 127.63, 127.59, 125.9, 98.5, 83.5, 77.4, 75.28, 75.26, 75.0, 73.5, 
73.2, 70.6, 68.5, 38.0, 31.5, 21.3; IR (film, cm
-1
) 3559, 3471, 3029, 2922, 2864, 1454, 
1363, 1129, 1066, 1036; HRMS (ES) m/z calcd for C37H42O6 [M+Na]
+
 605.2879, found 
605.2876. 
Ethyl 2-O-[(1,4-dioxaspiro[4.5]decan-8-yloxy)dimethylsilane]-3,4,6-tri-O-benzyl-1-
thio-β-D-glucopyranoside (Scheme 1.15, compound 18) 
 
Following the general procedure 4.2, silane (182 mg, 0.33 mmol), 1,4-
cyclohexanedione monoethylene acetal (47 mg, 0.30 mmol), Ni(COD)2 (8 mg, 0.03 
mmol), IMes·HCl (10 mg, 0.03 mmol), KO-t-Bu (3.4 mg, 0.03 mmol), and Ti(O-i-Pr)4 
(98 μL, 0.33 mmol) were stirred for 3 hr at rt.  The product (197 mg, 0.28 mmol, 93%) 
was obtained as a viscous yellow oil after purification by flash chromatography on SiO2 
(10 to 20% EtOAc/Hex).  
1
H NMR (500 MHz, CDCl3) δ 7.24-7.38 (m, 13H), 7.08-7.12 
(m, 2H), 4.93 (d, J =  11.5 Hz, 1H), 4.89 (d, J = 11.5 Hz, 1H), 4.73 (d, J = 11.0 Hz, 1H), 
4.61 (d, J = 12.0 Hz, 1H), 4.56 (d, J = 12.0 Hz, 1H) 4.53 (d, J = 11.0 Hz, 1H) 4.40 (d, J = 
9.5 Hz, 1H anomeric), 4.01 (tt, J = 7.5, 3.5 Hz, 1H), 3.90-3.96 (m, 4H), 3.75 (dd, J = 
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11.0, 2.0 Hz, 1H), 3.66-3.73 (m, 2H), 3.60 (t, J = 9.25, 1H), 3.55 (t, J = 8.75 Hz, 1H), 
3.49 (ddd, J = 9.5, 5.0, 2.0 Hz, 1H), 2.77 (dq, J = 12.75, 7.5 Hz, 1H), 2.71 (dq, J = 13.5, 
7.5 Hz, 1H), 1.64-1.85 (m, 6H), 1.46-1.54 (m, 2H), 1.31 (t, J = 7.5 Hz, 3H), 0.21 (s, 3H), 
0.16 (s, 3H); 
13
C NMR (100 MHz, CDCl3) δ 138.7, 138.2, 138.0, 128.32, 128.30, 128.2, 
127.9, 127.72, 127.69, 127.5, 127.2, 127.0, 108.4, 87.0, 86.2, 79.1, 78.3, 75.1, 74.9, 74.4. 
73.4, 69.1, 68.3, 64.17, 64.15, 32.03, 32.00, 31.34, 31.32, 24.6, 15.0, -0.9, -1.3; IR (film, 
cm
-1
) 3030, 2929, 1497, 1453, 1363, 1255, 1094; HRMS (ES) m/z calcd for C39H52O8SSi 
[M+Na]
+
 731.3050, found 731.3062. 
8-(1,4-dioxaspiro[4.5]decane)-3,4,6-tri-O-benzyl-α-D-glucopyranoside (Scheme 1.15, 
compound 19) 
 
Following the general procedure 4.4, compound 18 (425 mg, 0.60 mmol), NIS 
(175 mg, 0.78 mmol), 2,6-DTBMP (185 mg, 0.90 mmol), TMSOTf (142 μL, 0.78 mmol) 
were stirred for 10 min at -40 °C, then warmed to 0 °C and allowed to stir for 1 hour. n-
Bu4NF (3.0 mL, 3.0 mmol) was added as a 1M solution in THF, warmed to rt and stirred 
overnight. The product (289 mg, 0.49 mmol, 82%) was obtained as a colorless oil after 
flash chromatography on SiO2 (33% EtOAc/Hex w/ 5% NEt3).  
1
H NMR (400 MHz, 
CDCl3) δ 7.22-7.38 (m, 13 H), 7.10-7.14 (m, 2H), 4.98 (d, J = 3.2 Hz, 1H anomeric), 
4.94 (d, J = 11.2 Hz, 1H), 4.80 (d, J = 10.8 Hz, 2H), 4.61 (d, J = 12.0 Hz, 1H) 4.47 (d, J = 
12.0 Hz, 1H) 4.45 (d, J = 10.8 Hz, 1H), 3.89-3.93 (m, 4H), 3.84 (ddd, J = 10.0, 3.2, 2.0 
Hz, 1H), 3.57-3.66 (m, 6H), 1.96 (d, J = 10.0 Hz, 1H) 1.66-1.91 (m, 6H), 1.50-1.59 (m, 
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2H); 
13
C NMR (100 MHz, CDCl3) δ 138.7, 138.1, 137.9, 128.33, 128.31, 127.9, 127.84, 
127.80, 127.7, 127.63, 127.56, 108.0, 97.0, 83.6, 75.3, 75.0, 73.5, 73.4, 72.9, 70.6, 68.4, 
64.3, 64.2, 31.6, 31.3, 29.9, 28.1; IR (film, cm
-1
) 3476, 3029, 2937, 1496, 1453, 1365, 
1134, 1068, 1028; HRMS (ES) m/z calcd for C35H42O8 [M+Na]
+
 613.2777, found 
613.2786. 
Ethyl 2-O-[4-(dimethylsilyloxy)-1-methylpiperidine]-3,4,6-tri-O-benzyl-1-thio-β-D-
glucopyranoside (Scheme 1.15, compound 20) 
 
Following the general procedure 4.2, silane (182 mg, 0.33 mmol), N-methyl-4-
piperidone (37 μL, 0.30 mmol), Ti(O-i-Pr)4 (98 μL, 0.33 mmol), Ni(COD)2 (8 mg, 0.03 
mmol), IMes·HCl (10 mg, 0.03 mmol), and KO-t-Bu (3 mg, 0.03 mmol) were stirred for 
6 hours at rt.  The product (200 mg, 0.30 mmol, 100%) was obtained after flash 
chromatography on SiO2 (15% MeOH/EtOAc w/ ~1% NEt3) as a viscous light orange oil.  
1
H NMR (500 MHz, CDCl3) δ 7.24-7.38 (m, 13H), 7.08-7.12 (m, 2H), 4.95 (d, J = 11.0 
Hz, 1H), 4.89 (d, J = 11.5 Hz, 1H), 4.73 (d, J = 10.5 Hz, 1H), 4.61 (d, J = 12.0 Hz, 1H), 
4.56 (d, J = 12.0 Hz, 1H), 4.53 (d, J = 10.5 Hz, 1H), 4.39 (d, J = 9.5 Hz, 1H anomeric), 
3.88 (br s, 1H), 3.75 (dd, J = 11.0, 1.5 Hz, 1H), 3.67-3.72 (m, 2H), 3.60 (t, J = 9.25 Hz, 
1H), 3.55 (t, J = 8.75 Hz, 1H), 3.49 (ddd, J = 10.0, 5.0, 1.5 Hz, 1H), 2.77 (dq, J = 12.5, 
7.5 Hz, 1H), 2.72 (dq, J = 12.5, 7.5 Hz, 1H), 2.65 (br s, 2H),  2.23 (s, 3H), 1.98-2.10 (m, 
2H), 1.74-1.86 (m, 2H), 1.58 (m, 2H), 1.32 (t, J = 7.25 Hz, 3H), 0.22 (s, 3H), 0.17 (s, 
3H); 
13
C NMR (100 MHz, CDCl3) δ 138.7, 138.1, 137.9, 128.33, 128.31, 128.2, 127.9, 
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127.7, 127.5, 127.3, 127.1, 87.0, 86.1, 79.1, 78.2, 75.1, 74.9, 74.5, 73.4, 69.1, 52.9, 45.9, 
34.2, 24.6, 15.1, -0.9, -1.3; IR (film, cm
-1
) 3030, 2927, 2864, 2780, 1452, 1362, 1255, 
1148, 1087; HRMS (ES) m/z calcd for C37H51NO6SSi [M+H]
+
 666.3285, found 
666.3284. 
4-(methylpiperidin-1)-3,4,6-tri-O-benzyl-α-D-glucopyranoside (Scheme 1.15, 
compound 21) 
 
Following the general procedure 4.4, compound 20 (125 mg, 0.19 mmol), NIS (55 
mg, 0.24 mmol), 2,6-DTBMP (77 mg, 0.38 mmol), TMSOTf (41 μL, 0.23 mmol) were 
stirred at -40 °C for 10 min, then warmed to 0 °C and stirred for 1 hour, then excess n-
Bu4NF was added  (1.14 mL, 1.14 mmol) as a 1M solution in THF, warmed to rt and 
allowed to stir overnight.  The product (73 mg, 0.13 mmol, 70%) was obtained after 
purification by flash chromatography on SiO2 (7:1:2 to 3:1:1 EtOAc:MeOH:MeCN w/ ~ 
1% NEt3).  
1
H NMR (500 MHz, CDCl3) δ 7.39-7.42 (m, 2H), 7.26-7.37 (m, 11H), 7.13-
7.16 (m, 2H), 5.03 (d, J = 3.5 Hz, 1H anomeric), 4.99 (d, J = 11.0 Hz, 1H), 4.85 (d, J = 
11.0 Hz, 1H), 4.84 (d, J = 10.5 Hz, 1H), 4.64 (d, J = 12.0 Hz, 1H), 4.51 (d, J = 11.5 Hz, 
1H), 4.49 (d, J = 10.5 Hz, 1H), 3.87 (ddd, J = 10.0, 3.75, 1.75 Hz, 1H), 3.61-3.79 (m, 
6H), 2.68 (br s, 2H), 2.28 (s, 3H), 2.20 (br s, OH), 2.16 (br s, 2H), 1.92 (br s, 1H), 1.62-
1.77 (m, 2H); 
13
C NMR (100 MHz, CDCl3) δ 138.7, 138.0, 137.9, 128.40, 128.37, 
128.36, 128.0, 127.9, 127.84, 127.77, 127.69, 127.6, 97.1, 83.6, 77.3, 75.3, 75.1, 73.5, 
72.9, 70.7, 68.5, 53.1, 46.1, 32.5, 30.8; IR (film, cm
-1
) 3453, 3030, 2920, 2850, 2784, 
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1452, 1384, 1155, 1068, 1043; HRMS (ES) m/z calcd for C33H41NO6 [M+H]
+
 548.3012, 
found 548.3019. 
Ethyl 2-O-[((1R,2S,5R)-2-isopropyl-5-methylcyclohexyloxy)dimethylsilane]-3,4,6-tri-
O-benzyl-1-thio-β-D-glucopyranoside (Scheme 1.16, compound 22) 
 
Following the general procedure 4.3, silane (243 mg, 0.44 mmol), (-)-menthone 
(62 mg, 0.40 mmol), CuCl (2 mg, 0.02 mmol), IMes·HCl (7 mg, 0.02 mmol) and NaO-t-
Bu (3 mg, 0.04 mmol) were stirred for 8 hours at rt to give the product as an inseparable 
2:1 mixture of diastereomers.  The product (192 mg, 0.27 mmol, 68%, 2:1) was obtained 
as a clear oil upon purification by flash chromatography on SiO2 (10% EtOAc/Hex).  
1
H 
NMR (500 MHz, CDCl3) δ 7.23-7.41 (m, 13 H), 7.07-7.14 (m, 2H), 5.01 (d, J = 11.0 Hz, 
0.67H), 4.97 (d, J = 11.5 Hz, 0.33H) 4.88 (d, J = 12.0 Hz, 0.33H), 4.86 (d, J = 11.0 Hz, 
0.67H), 4.75 (d, J = 11.0 Hz, 0.67H), 4.72 (d, J = 11.0 Hz, 0.33H), 4.50-4.63 (m, 3 H), 
4.39 (d, J = 9.5 Hz, 0.67H anomeric), 4.38 (d, J = 9.5 Hz, 0.33H anomeric), 4.26 (br s, 
0.33H), 3.66-3.78 (m, 3H), 3.53-3.62 (m, 2.67H), 3.48-3.53 (m, 1H), 2.68-2.81 (m, 2H), 
2.20 (septd, J = 7.0, 2.5 Hz, 0.67H), 1.99-2.04 (m, 0.67H), 1.78-1.88 (m, 0.67H), 1.48-
1.65 (m, 2.33H), 1.26-1.40 (m, 1H), 1.32 (t, J = 7.5 Hz, 3Hmajor), 1.31 (t, J = 7.5 Hz, 
3Hminor), 0.74-1.15 (m, 10.67H), 0.73 (d, J = 7.0 Hz, 3Hmajor), 0.23 (s, 3Hmajor), 0.19 (s, 
3Hminor), 0.15 (s, 3Hmajor + minor), Note – diastereomers are reported as a 2:1 ratio of the 
total amount of protons, the stereochemistry of the major diastereomer and the dr of the 
reduction  was determined on a crude reaction mixture of the silyl-linked compound after 
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complete desilylation by n-Bu4NF and comparison to known compounds;
4,5
 
13
C NMR 
(100 MHz, CDCl3) major and minor diastereomer signals reported δ 138.9, 138.8, 
138.24, 138.22, 138.0, 128.34, 128.31, 128.16, 128.13, 127.94, 127.89, 127.7, 127.5, 
127.3, 127.2, 127.11, 127.96, 87.2, 87.0, 86.4, 86.3, 79.1, 78.3, 78.2, 75.2, 75.1, 74.9, 
74.5, 74.3, 73.4, 72.6, 69.3, 69.2, 68.8, 49.7, 48.8, 45.4, 43.1, 42.6, 35.3, 34.5, 31.6, 28.7, 
25.5, 25.2, 24.8, 24.6, 24.0, 22.8, 22.4, 22.2, 21.2, 21.1, 20.9, 15.9, 15.0, -0.4, -1.0, -1.5; 
IR (film, cm
-1
) 3029, 2953, 2921, 2866, 1453, 1365, 1254, 1067;  HRMS (ES) m/z calcd 
for C41H58O6SSi [M+Na]
+
 729.3621, found 729.3639. 
Phenyl 2-O-[((1R,2S,5R)-2-isopropyl-5-methylcyclohexyloxy)dimethylsilane]-3,4,6-
tri-O-benzyl-1-thio-β-D-glucopyranoside (Scheme 1.16, compound 24) 
 
Following the general procedure 4.3, silane (198 mg, 0.33 mmol), (-)-menthone 
(46 mg, 0.30 mmol), CuCl (2 mg, 0.015 mmol), IMes·HCl (5 mg, 0.015 mmol), and 
NaO-t-Bu (3 mg, 0.03 mmol) were stirred for 5 hours at rt to give the desired product as 
an inseparable 2:1 mixture of diastereomers.  The product (144 mg, 0.19 mmol, 64%, 
2:1) was obtained as a clear viscous oil upon purification by flash chromatography on 
SiO2 (5% EtOAc/Hex). 
1
H NMR (500 MHz, CDCl3) δ 7.52-7.57 (m, 2H), 7.21-7.41 (m, 
16H), 7.10-7.17 (m, 2H), 5.02 (d, J = 11.0 Hz, 0.67H), 4.98 (d, J = 11.5 Hz, 0.33H), 4.89 
(d, J = 11.5 Hz, 0.33H), 4.86 (d, J = 10.5 Hz, 0.67H) , 4.78 (d, J = 11.0 Hz, 0.67H) 4.73 
(d, J = 10.5 Hz, 0.33H), 4.52-4.66 (m, 4H), 4.27 (br s, 0.33H), 3.76-3.86 (m, 2H), 3.69-
3.74 (m, 1H), 3.51-3.66 (m, 3.67H), 2.21 (septd, J = 6.75, 2.25 Hz, 0.67H), 2.01 (d, J = 
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12.0 Hz, 0.67H), 1.80-1.89 (m, 0.67H), 1.48-1.64 (m, 2.33H), 1.26-1.41 (m, 1.33H), 
1.09-1.18 (m, 0.67H), 0.75-1.07 (m, 5.67H), 0.87 (d, J = 7.0 Hz, 3Hminor), 0.85 (d, J = 
7.0Hz, 3Hmajor), 0.84 (d, J = 6.5 Hz, 3Hminor), 0.74 (d, J = 7.0 Hz, 3Hmajor), 0.25 (s, 
3Hmajor), 0.20 (s, 3Hminor), 0.16 (s, 3Hminor), 0.13 (s, 3Hmajor), Note – diastereomers are 
reported as a 2:1 ratio of the total amount of protons, the stereochemistry of the major 
diastereomer and the dr of the reduction  was determined on a crude reaction mixture of 
the silyl-linked compound after complete desilylation by n-Bu4NF and comparison to 
known compounds; 
13
C NMR (100 MHz, CDCl3) δ major and minor diastereomer signals 
reported 138.8, 138.7, 138.26, 138.24, 138.0, 137.0, 134.5, 131.1, 131.0, 128.8, 128.37, 
128.33, 128.30, 128.18, 128.15, 127.90, 127.8, 127.73, 127.69, 127.67, 127.52, 127.51, 
127.3, 127.2, 126.97, 126.96, 126.91, 89.1, 88.8, 87.2, 87.0, 79.03, 78.98, 78.16, 78.12, 
75.2, 75.1, 74.9, 73.9, 73.8, 73.4, 72.7, 69.14, 69.07, 68.9, 49.7, 48.8, 45.4, 43.2, 35.2, 
34.5, 31.6, 28.7, 25.6, 25.2, 24.0, 22.8, 22.3, 22.2, 21.2, 21.1, 20.9, 15.9, -0.4, -1.1, -1.2, -
1.4; IR (film, cm
-1
) 3030, 2953, 2919, 2867, 1454, 1383, 1256, 1067; HRMS (ES) m/z 
calcd for C45H58O6SSi [M+Na]
+
 777.3621, found 777.3635. 
(1R,2S,4S)-2-isopropyl-4-methylcyclohexan-3,4,6-tri-O-benzyl-α-D-glucopyranoside 
(Scheme 1.16, compound 23) 
 
Following the general procedure 4.4, compound 24 (87 mg, 0.12 mmol), NIS (34 
mg, 0.15 mmol), 2,6-DTBMP (47 mg, 0.24 mmol) and TMSOTf (25 μL, 0.14 mmol) 
were stirred for 10 min at -40 °C, warmed to 0 °C and stirred for 45 min, then excess n-
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Bu4NF was added (0.72 mL, 0.72 mmol) as a 1M solution in THF, warmed to rt, and 
stirred overnight.  The product (49 mg, 0.08 mmol, 72%, 5:1) was obtained as an 
inseparable 5:1 mixture of diastereomers as a colorless oil after purification by flash 
chromatography on SiO2 (10 to 20% EtOAc/Hex).  
1
H NMR (500 MHz, CDCl3) Major 
diastereomer δ 7.26-7.43 (m, 13H), 7.14-7.18 (m, 2H), 4.99 (d, J = 4.0 Hz, 1H 
anomeric), 4.98 (d, J = 12.0 Hz, 1H), 4.85 (d, J = 11.5 Hz, 1H), 4.84 (d, J =10.5 Hz, 1H), 
4.66 (d, J = 12.0 Hz, 1H), 4.51 (d, J = 11.0 Hz, 1H), 4.48 (d, J = 10.5 Hz, 1H), 3.95 (d, J 
= 10.0 Hz, 1H), 3.60-3.84 (m, 5H), 3.41 (td, J = 10.5, 4.0 Hz, 1H), 2.21 (d, J =12.5 Hz, 
1H), 2.15 (septd, J =7.0, 2.0 Hz, 1H), 1.97 (d, J = 9.0 Hz, 1H), 1.56-1.80 (m, 2H), 1.24-
1.46 (m, 2H), 0.78-1.05 (m, 3H), 0.93 (d, J = 7.0 Hz, 3H), 0.87 (d, J = 7.0 Hz, 3H), 0.78 
(d, J = 7.0 Hz, 3H), diagnostic peaks of the minor diastereomer at 5.03 (d, J = 3.5 Hz, 
0.2H anomeric), and 4.11 (br s, 0.2H) (aglycone carbinol); 
13
C NMR (100 MHz, CDCl3) 
major and minor diastereomer signals reported δ 138.8, 138.2, 138.0, 128.36, 128.33, 
128.11, 127.96, 127.92, 127.85, 127.7, 127.64, 127.60, 100.1, 95.4, 83.5, 81.1, 77.5, 75.2, 
75.0, 73.6, 73.5, 73.0, 72.6, 70.6, 68.6, 48.7, 48.2, 42.9, 37.3, 34.9, 34.2, 31.6, 28.4, 26.4, 
25.5, 22.8, 22.2, 21.2, 21.1, 20.9, 15.7; IR (film, cm
-1
) 3564, 3030, 2922, 2867, 1453, 
1384, 1132, 1067, 1027; HRMS (ES) m/z calcd for C37H48O6 [M+Na]
+
 611.3349, found 
611.3355. 
Ethyl 2-O-[(1,4-dioxaspiro[4.5]decan-8-yloxy)dimethylsilane]-3,4,6-tri-O-benzyl-1-
thio-α-D-mannopyranoside (Scheme 1.17, compound 25) 
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Following the general procedure 4.2, silane (182 mg, 0.33 mmol), 1,4-
cyclohexanedione monoethylene acetal (47 mg, 0.30 mmol), Ti(O-i-Pr)4 (98 μL, 0.33 
mmol), Ni(COD)2 (8 mg, 0.03 mmol), IMes·HCl (10 mg, 0.03 mmol), and KO-t-Bu (3 
mg, 0.03 mmol) were stirred at room temperature for 4 hours.  The product (183 mg, 0.26 
mmol, 86%) was obtained as a colorless oil after purification by flash chromatography on 
SiO2 (10 to 20% EtOAc/Hex).  
1
H NMR (500 MHz, CDCl3) δ 7.24-7.37 (m, 13H), 7.15-
7.18 (m, 2H), 5.28 (d, J = 1.5 Hz, 1H anomeric), 4.83 (d, J = 10.5 Hz, 1H), 4.71 (d, J = 
11.5 Hz, 1H), 4.68 (d, J = 12.0 Hz, 1H), 4.64 (d, J = 11.5 Hz, 1H), 4.52 (d, J = 12.0 Hz, 
1H), 4.50 (d, J = 10.5 Hz, 1H), 4.28 (t, J = 2.25 Hz, 1H), 4.13 (ddd, J = 10.0, 5.0, 1.5 Hz, 
1H), 3.90-4.00 (m, 5H), 3.82 (dd, J = 11.0, 5.0 Hz, 1H), 3.77 (dd, J = 9.0, 2.5 Hz, 1H), 
3.71 (dd, J = 10.5, 1.5 Hz, 1H), 2.66 (dq, J = 13.0, 7.5 Hz, 1H), 2.58 (dq, J = 13.0, 7.5 
Hz, 1H), 1.64-1.86 (m, 6H), 1.46-1.55 (m, 2H), 0.17 (s, 3H), 0.15 (s, 3H); 
13
C NMR (100 
MHz, CDCl3) δ 138.49, 138.47, 138.3, 128.27, 128.25, 128.21, 127.9, 127.8, 127.6, 
127.52, 127.49, 127.36, 108.4, 85.4, 80.3, 74.9, 74.8, 73.2, 72.2, 71.0, 69.2, 68.1, 64.20, 
64.17, 32.05, 32.00, 31.2, 25.2, 15.0, -1.5, -1.7; IR (film, cm
-1
) 3030, 2938, 2874, 1452, 
1378, 1256, 1099, 1036; HRMS (ES) m/z calcd for C39H52O8SSi [M+Na]
+
 731.3050, 
found 731.3055. 
8-(1,4-dioxaspiro[4.5]decane)-3,4,6-tri-O-benzyl-β-D-mannopyranoside (Scheme 
1.17, compound 26) 
 
Following the general procedure 4.4, compound 25 (144 mg, 0.20 mmol) NIS (59 
mg, 0.26 mmol), 2,6-DTBMP (83 mg, 0.41 mmol) and TMSOTf (44 μL, 0.24 mmol) 
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were stirred at -40 °C for 15 minutes, warmed to 0 °C and stirred for 45 min, then n-
Bu4NF (1.2 mL, 1.2 mmol) was added as a 1M solution in THF and the reaction was 
warmed to rt and stirred overnight.  The product (67 mg, 0.11 mmol, 57%) was obtained 
as a colorless oil upon purification by flash chromatography on SiO2 (40 to 50% 
EtOAc/Hex).  
1
H NMR (500 MHz, CDCl3) δ 7.38-7.41 (m, 2H), 7.26-7.36 (m, 11H), 
7.21-7.24 (m, 2H), 4.91 (d, J = 11.0 Hz, 1H), 4.79 (d, J = 12.0 Hz, 1H), 4.68 (d, J = 12.0 
Hz, 1H), 4.56 (d, J = 12.0 Hz, 1H), 4.55 (d, J = 11.0 Hz, 1H), 4.52 (s, 1H anomeric), 4.07 
(br s, 1H), 3.89-3.98 (m, 5H), 3.86 (t, J = 9.5 Hz, 1H), 3.78 (dd, J = 10.5, 1.5 Hz, 1H), 
3.69 (dd, J = 10.5, 5.5 Hz, 1H), 3.58 (dd, J = 9.0, 3.0 Hz, 1H), 3.43 (ddd, J = 9.5, 5.5, 1.5 
Hz, 1H), 2.45 (d, J = 1.5 Hz, 1H), 1.70-1.98 (m, 6H), 1.52-1.61 (m, 2H); 
13
C NMR (100 
MHz, CDCl3) δ 138.3, 138.2, 137.9, 128.5, 128.35, 128.31, 128.1, 127.9, 127.8, 127.7, 
127.5, 108.2, 97.4, 81.6, 75.23, 75.16, 74.3, 73.7, 73.4, 71.3, 69.3, 68.8, 64.3, 31.4, 31.3, 
29.9, 27.9; IR (film, cm
-1
) 3476, 3029, 2940, 2872, 1452, 1372, 1100; HRMS (ES) m/z 
calcd for C35H42O8 [M+Na]
+
 613.2777, found 613.2781. 
Phenyl 2-O-[((1R,2S,5R)-2-isopropyl-5-methylcyclohexyloxy)dimethylsilane]-3,4,6-
tri-O-benzyl-1-thio-α-D-mannopyranoside (Scheme 1.17, compound 27) 
 
Following the general procedure 4.3, silane (198 mg, 0.33 mmol), (-)-menthone 
(46 mg, 0.30 mmol), CuCl (1.5 mg, 0.015 mmol), IMes·HCl (5 mg, 0.015 mmol), and 
NaO-t-Bu (3 mg, 0.03 mmol) were stirred for 4 hours at rt to give the desired product as 
an inseparable 2:1 mixture of diastereomers.  The product (171 mg, 0.23 mmol, 75%, 
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2:1) was isolated as a colorless oil upon purification by flash chromatography on SiO2 
(5% EtOAc/Hex).  
1
H NMR (500 MHz, CDCl3) δ 7.47-7.51 (m, 2H), 7.38-7.41 (m, 2H), 
7.20-7.36 (m, 16H), 5.54 (d, J = 2.0 Hz, 0.33H anomeric), 5.53 (d, J = 2.0 Hz, 0.67H 
anomeric), 4.88 (d, J = 11.0 Hz, 0.33H), 4.87 (d, J = 10.5 Hz, 0.67H), 4.77 (d, J = 11.5 
Hz, 1H), 4.65-4.70 (m, 2H), 4.46-4.56 (m, 3H), 4.28-4.34 (m, 1H), 4.19 (br s, 0.33H), 
3.97-4.02 (m, 1H), 3.74-3.88 (m, 3H), 3.53 (td, J = 10.5, 4.5 Hz, 0.67H), 2.14 (septd, J = 
7.0, 3.0 Hz, 0.67H), 1.92-1.97 (m, 0.67H), 1.66-1.77 (m, 0.67H), 1.43-1.63 (m, 1.67H), 
1.20-1.35 (m, 1.67H), 1.11 (ddt, J = 12.25, 9.75, 2.75 Hz, 0.67H), 0.72-1.04 (m, 4H), 
0.83 (d, J = 7.0 Hz, 3Hmajor), 0.82 (d, J = 6.5 Hz, 3Hmajor), 0.80 (d, J = 7.0 Hz, 3Hminor), 
0.78 (d, J = 6.5 Hz, 3Hminor), 0.71 (d, J = 7.0 Hz, 3Hmajor), 0.17 (s, 3Hmajor), 0.16 (s, 
3Hminor), 0.15 (s, 3Hmajor + minor), Note – diastereomers are reported as a 2:1 ratio of the 
total amount of protons, the stereochemistry of the major diastereomer and the dr of the 
reduction  was determined on a crude reaction mixture of the silyl-linked compound after 
complete desilylation by n-Bu4NF and comparison to known compounds; 
13
C NMR (100 
MHz, CDCl3) major and minor diastereomer signals reported δ 138.53, 138.47, 138.43, 
138.3, 138.2, 134.74, 134.66, 131.7, 131.4, 131.3, 128.9, 128.8, 128.3, 128.2, 127.92, 
127.85, 127.77, 127.66, 127.63, 127.58, 127.35, 127.12, 127.09, 89.3, 89.0, 80.3, 75.03, 
74.85, 73.16, 73.13, 72.99, 72.86, 72.6, 72.2, 72.1, 70.7, 70.6, 69.28, 69.24, 68.8, 49.8, 
48.6, 45.3, 43.1, 35.1, 34.4, 31.6, 28.8, 25.7, 25.5, 25.3, 24.0, 22.8, 22.4, 22.2, 21.1, 21.0, 
20.8, 15.8, -1.20, -1.22, -1.36, -1.40; IR (film, cm
-1
) 3029, 2952, 2915, 2866, 1453, 1255, 
1099; HRMS (ES) m/z calcd for C45H58O8SSi [M+Na]
+
 777.3621, found 777.3640.   
(1R,2S,4S)-2-isopropyl-4-methylcyclohexan-3,4,6-tri-O-benzyl-β-D-
mannopyranoside (Scheme 1.17, compound 28) 
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Following the general procedure 4.4, compound 27 (68 mg, 0.09 mmol), NIS (26 
mg, 0.12 mmol), 2,6-DTBMP (37 mg, 0.18 mmol), and TMSOTf (20 μL, 0.11 mmol) 
were stirred at -40 °C for 10 min, then warmed to 0 °C and stirred for 1.5 hours.  n-
Bu4NF (0.63 mL, 0.63 mmol) was added as a 1M solution in THF and stirred at rt 
overnight to give the products as a 10:1 mixture of diastereomers.  The products 
(combined 39 mg, 0.07 mmol, 74%, 10:1) were isolated as a white solid and clear oil 
respectively, and characterized independently after purification by flash chromatography 
on SiO2 (10 to 20% EtOAc/Hex).  Data for the major diastereomer matches that 
previously reported. Major diastereomer 
1
H NMR (500 MHz, CDCl3) δ 7.38-7.41 (m, 
2H), 7.24-7.36 (m, 13H), 4.91 (d, J = 11.0 Hz, 1H), 4.80 (d, J = 12.0 Hz, 1H), 4.69 (d, J 
= 12.0 Hz, 1H), 4.62 (d, J = 12.5 Hz, 1H), 4.60 (d, J = 12.0 Hz, 1H), 4.55 (d, J = 12.0 Hz, 
1H), 4.54 (s, 1H anomeric), 4.04 (br s, 1H), 3.87 (t, J = 9.5 Hz, 1H), 3.75 (dd, J = 10.5, 
1.5 Hz, 1H), 3.71 (dd, J = 10.5, 5.0 Hz, 1H), 3.55-3.63 (m, 2H), 3.41 (ddd, J = 10.0, 5.0, 
2.0 Hz, 1H), 2.38 (s, 1H), 2.29 (septd, J = 7.0, 2.0 Hz, 1H), 1.99 (d, J = 12.0 Hz, 1H), 
1.62-1.70 (m, 2H), 1.24-1.41 (m, 2H), 0.80-1.05 (m, 3H), 0.92 (d, J = 6.5 Hz, 3H), 0.91 
(d, J = 7.0 Hz, 3H), 0.83 (d, J = 6.5 Hz, 3H); 
13
C NMR (100 MHz, CDCl3) δ 138.4, 
138.3, 138.0, 128.44, 128.35, 128.29, 128.16, 127.8, 127.75, 127.71, 127.68, 127.5, 96.1, 
81.9, 76.5, 75.3, 75.2, 74.4, 73.6, 71.2, 69.7, 69.2, 47.7, 40.4, 34.3, 31.3, 25.3, 23.1, 22.3, 
21.0, 15.8; IR (film, cm
-1
) 3472, 3028, 2950, 2920, 2865, 1452, 1383, 1102; HRMS (ES) 
m/z calcd for C37H48O6 [M+Na]
+
 611.3349, found 611.3337.  Minor diastereomer 
1
H 
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NMR (500 MHz, CDCl3) δ 7.38-7.42 (m, 2H), 7.23-7.36 (m, 13H), 4.91 (d, J =11 Hz, 
1H), 4.81 (d, J = 12 Hz, 1H), 4.69 (d, J = 11.5 Hz, 1H), 4.64 (d, J = 12 Hz, 1H), 4.58 (d, 
J = 11 Hz, 1H), 4.57 (d, J = 12 Hz, 1H), 4.44 (s, 1H anomeric), 4.07 (d, J = 2.5 Hz, 1H), 
4.02 (br s, 1H), 3.69 (t, J = 9.0 Hz, 1H), 3.74 (dd, J = 11, 2.0 Hz, 1H), 3.70 (dd, J = 11, 
5.5 Hz, 1H), 3.56 (dd, J = 9.5, 3.0 Hz, 1H), 3.41 (ddd, J = 9.5, 5.0, 2.0 Hz, 1H), 2.39 (br 
s, 1H), 2.16-2.22 (m, 1H), 1.81-1.91 (m, 1H), 1.69-1.86 (m, 1H), 1.60-1.68 (m, 1H), 
1.20-1.44 (m, 2H), 0.80-1.00 (m, 3H), 0.90 (d, J = 7.0 Hz, 3H),  0.89 (d, J = 7.0 Hz, 3H), 
0.85 (d, J = 7.0 Hz, 3H); 
13
C NMR (100 MHz, CDCl3) δ 138.4, 138.3, 138.0, 128.42, 
128.35, 128.31, 128.1, 127.9, 127.73, 127.69, 127.65, 127.5, 101.3, 81.8, 78.5, 75.3, 75.2, 
74.3, 73.6, 71.3, 69.5, 69.0, 48.3, 41.1, 35.0, 28.9, 26.2, 24.6, 22.4, 21.3, 20.9; IR (film, 
cm
-1
) 3444, 3027, 2917, 2848, 1452, 1383, 1103; HRMS (ES) m/z calcd for C37H48O6 
[M+Na]
+
 611.3349, found 611.3359. 
Ketoester Reduction Product (Scheme 1.18, compound 29) 
 
Following the general procedure 4.2, silane (182 mg, 0.33 mmol), ketoester (43 
μL, 0.30 mmol), Ni(COD)2 (8 mg, 0.03 mmol), IMes·HCl (10 mg, 0.03 mmol), KO-t-Bu 
(3.4 mg, 0.03 mmol), and Ti(O-i-Pr)4 (195 μL, 0.66 mmol) were stirred for 4.5 hr at rt to 
give the product as an inseparable 85:15 mixture of silyl-linked esters.  The product (125 
mg, 0.18 mmol, 60%, 85:15) was obtained as a colorless oil after flash chromatography 
on SiO2. 
1
H NMR (500 MHz, CDCl3) δ 7.23-7.40 (m, 13H), 7.14-7.22 (m, 2H), 5.27 (s, 
1H), 4.96-5.04 (m, 0.26H, indicative of minor product), 4.84 (d, J = 11.0 Hz, 1H), 4.62-
4.74 (m, 3H), 4.52 (d, J = 12.0 Hz, 1H), 4.51 (d, J = 11.0 Hz, 1H), 4.27 (br s, 1H), 4.08-
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4.18 (m, 2H), 3.94-4.02 (m, 2H), 3.82 (dd, J = 11.0, 5.0 Hz, 1H), 3.77 (dd, J = 9.5, 2.0 
Hz, 1H), 3.72 (d, J = 10.5  Hz, 1H), 2.34-2.53 (m, 2H), 2.22-2.48 (m, 2H), 1.66-1.80 (m, 
2H), 1.13-1.34 (m, 10H), 0.17 (s, 3H), 0.14 (s, 3H). 
Ethyl 2-O- 2-(4-(dimethylsilyloxy)cyclohexyl)ethanol -3,4,6-tri-O-benzyl-1-thio-β-D-
glucopyranoside (Scheme 1.23, compound 43) 
 
Following the general procedure 4.2, silane (182 mg, 0.33 mmol), hydroxyketone 
42 (43 mg, 0.30 mmol), Ni(COD)2 (8 mg, 0.03 mmol), IMes·HCl (10 mg, 0.03 mmol), 
KO-t-Bu (3.4 mg, 0.03 mmol), and Ti(O-i-Pr)4 (195 μL, 0.66 mmol) were stirred for 3 hr 
at rt to give the desired product as an inseparable 5:1 mixture of diastereomers.  
Compound 43 (187 mg, 0.26 mmol, 86%, 5:1) was obtained as a viscous colorless oil 
after purification by flash chromatography on SiO2 (25 to 30% EtOAc/hexanes).  
1
H 
NMR (500 MHz, CDCl3) δ 7.23-7.39 (m, 13H), 7.07-7.12 (m, 2H), 4.98 (d, J = 11.5 Hz, 
1H), 4.88 (d, J = 11.5 Hz, 1H), 4.73 (d, J = 10.5 Hz, 1H), 4.61 (d, J = 12.0 Hz, 1H), 4.56 
(d, J = 12.5 Hz, 1H), 4.52 (d, J = 10.5 Hz, 1 H), 4.40 (d, J = 9.5 Hz, 1H anomeric), 4.10-
4.12 (m, 1H), 3.53-3.78 (m, 7H), 3.49 (ddd, J = 9.0, 5.0, 1.75 Hz, 1H), 2.77 (dq, J = 12.5, 
7.5 Hz, 1H), 2.72 (dq, J = 12.5, 7.5 Hz, 1H), 1.59-1.74 (m, 2H), 1.37-1.49 (m, 8H), 1.25-
1.39 (m, 1H), 1.32 (t, J = 7.5 Hz, 3H), 1.15 (br s, 1H), 0.20 (s, 3H), 0.18 (s, 3H); 
diagnostic peaks for minor diastereomer: 4.74 (d, J = 10.5 Hz, 1H), 1.85-1.97 (m, 1H), 
0.22 (s, 3H), 0.17 (s, 3H) Note – the relative stereochemistry of the major and minor 
diastereomers was confirmed based on the Karplus correlations of the carbinol methine 
proton of the desilylated diol; 
13
C NMR (100 MHz, CDCl3) major and minor 
129 
 
diastereomer signals reported δ 138.9, 138.2, 138.0, 129.1, 128.34, 128.32, 128.2, 127.9, 
127.74, 127.70, 127.6, 127.2, 127.1, 87.1, 87.0, 86.3, 86.1, 79.1, 78.5, 78.2, 75.1, 74.9, 
74.5, 73.4, 71.5, 69.2, 67.6, 60.9, 61.1, 39.6, 38.9, 35.5, 33.2, 32.7, 31.4, 27.13, 27.09, 
24.7, 15.1, -0.89, -0.90, -1.16, -1.17; IR (film, cm
-1
) 3437, 3031, 2926, 2858, 1454, 1364, 
1255, 1057, 1028; HRMS (ES) m/z calcd for C39H54O7SSi [M+Na]
+
 717.3257, found 
717.3283. 
2-(4-cyclohexyl)ethanol-3,4,6-tri-O-benzyl-α-D-glucopyranoside (Scheme 1.23, 
compound 39) 
 
Following the general procedure 4.4, silyl-linked compound 43 (81 mg, 0.12 
mmol), NIS (37 mg, 0.16 mmol), 2,6-DTBMP (96 mg, 0.47 mmol), and TMSOTf (51 
μL, 0.28 mmol) were stirred at -40 °C for 10 min, then warmed to 0 °C and stirred for 1.5 
hr.  n-Bu4NF (1.2 mL, 1.2 mmol) was added as a 1M solution in THF, warmed to room 
temperature and stirred over night.  The products 39 (combined 67 mg, 0.11 mmol, 97%, 
5:1) were isolated as a clear oil and white crystalline solid respectively, and 
independently characterized after purification by flash chromatography on SiO2 (50 to 
65% EtOAc/hexanes). Major diastereomer 
1
H NMR (500 MHz, CDCl3) δ 7.41-7.44 (m, 
2H), 7.26-7.37 (m, 11H), 7.14-7.18 (m, 2H), 5.00 (d, J = 11.0 Hz, 1H), 4.99 (d, J = 4.0 
Hz, 1H anomeric), 4.86 (d, J = 11.0 Hz, 1H), 4.85 (d, J = 10.5 Hz, 1H), 4.65 (d, J = 12.0 
Hz, 1H), 4.52 (d, J = 12.5 Hz, 1H), 4.51 (d, J = 11.0 Hz, 1H), 3.85-3.91 (m, 2H), 3.63-
3.80 (m, 7H), 2.00 (d, J = 10.0 Hz, 1H), 1.81-1.89 (m, 2H), 1.44 -1.60 (m, 7H), 1.22-1.37 
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(m, 3H). 
13
C NMR (100 MHz, CDCl3) δ 138.8, 138.1, 137.9, 128.39, 128.35, 128.34, 
128.0, 127.9, 127.85, 127.76, 127.66, 127.58, 97.0, 83.7, 77.3, 75.25, 75.15, 73.5, 73.03, 
72.97, 70.6, 68.5, 60.7, 39.0, 32.7, 30.8, 28.7, 27.6, 27.5; IR (film, cm
-1
) 3436, 3031, 
2926, 2860, 1453, 1363, 1132, 1067, 1028; HRMS (ES) m/z calcd for C35H44O7 [M+Na]
+
 
599.2985, found 599.2974.  Minor diastereomer 
1
H NMR (500 MHz, CDCl3) δ 7.38-
7.41 (m, 2H), 7.25-7.36 (m, 11H), 7.13-7.17 (m, 2H), 5.04 (d, J = 4.0 Hz 1H anomeric), 
4.98 (d, J = 11.0 Hz, 1H), 4.84 (d, J = 11.5 Hz, 1H), 4.83 (d, J = 11.0 Hz, 1H), 4.64 (d, J 
= 12.0 Hz, 1H), 4.51 (d, J = 11.5 Hz, 1H), 4.49 (d, J = 10.5 Hz, 1H), 3.88 (ddd, J = 10.0, 
3.75, 1.75 Hz, 1H), 3.60-3.79 (m, 7H), 3.56 (tt, J = 11.0, 4.25 Hz, 1H), 1.99-2.08 (m, 
3H), 1.76-1.85 (m, 2H), 1.48 (q, J = 6.5 Hz, 2H), 1.14-1.44 (m, 4H), 0.92-1.04 (m, 2H); 
13
C NMR (100 MHz, CDCl3) δ 138.8, 138.2, 138.0, 128.38, 128.37, 128.35, 128.0, 127.8, 
127.72, 127.66, 127.57, 97.0, 83.7, 77.4, 75.3, 75.1, 73.5, 73.0, 70.5, 68.6, 60.9, 39.4, 
33.33, 33.29, 31.7, 31.3, 31.1; IR (film, cm
-1
) 3401, 3032, 2924, 2853, 1452, 1353, 1130, 
1070, 1040; HRMS (ES) m/z calcd for C35H44O7 [M+Na]
+
 599.2985, found 599.2971.  
Ethyl 2-O- 4-(2-(dimethylsilyloxy)ethyl)cyclohexanone -3,4,6-tri-O-benzyl-1-thio-β-
D-glucopyranoside (Scheme 1.24, compound 44) 
 
Following the general procedure 4.3, silane (182 mg, 0.33 mmol), hydroxyketone 
42 (43 mg, 0.30 mmol), CuCl (1.5 mg, 0.015 mmol), IMes·HCl (5 mg, 0.015 mmol), and 
NaO-t-Bu) (3 mg, 0.03 mmol) were stirred for 3 hr at rt to give the desired product.  
Compound 44 (119 mg, 0.17 mmol, 57%) was obtained as a colorless oil after 
purification by flash chromatography on SiO2 (20% EtOAc/hexanes).  
1
H NMR (500 
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MHz, CDCl3) δ 7.23-7.38 (m, 13H), 7.08-7.11 (m, 2H), 4.94 (d, J = 11.5 Hz, 1H), 4.89 
(d, J = 11.5 Hz, 1H), 4.73 (d, J = 11.0 Hz, 1H), 4.61 (d, J = 12.5 Hz, 1H), 4.56 (d, J = 
12.0 Hz, 1H), 4.53 (d, J = 10.5 Hz, 1H), 4.40 (d, J = 9.5 Hz, 1H anomeric), 3.74-3.78 (m, 
3H), 3.67-3.72 (m, 2H), 3.62 (t, J = 9.25 Hz, 1H), 3.55 (t, J = 8.75 Hz, 1H), 3.49 (ddd, J 
= 9.75, 4.75, 1.75 Hz, 1H), 2.77 (dq, J = 12.5, 7.5 Hz, 1H), 2.72 (dq, J = 12.5, 7.5 Hz, 
1H), 2.20-2.38 (m, 4H), 1.93-2.01 (m, 2H), 1.77-1.86 (m, 1H), 1.49 (q, J = 7.0 Hz, 2H), 
1.28-1.39 (m, 2H), 1.32 (t, J = 7.5 Hz, 3H), 0.22 (s, 3H), 0.20 (s, 3H); 
13
C NMR (100 
MHz, CDCl3) δ 212.3, 138.7, 138.2, 137.9, 128.4, 128.34, 128.26, 127.9, 127.78, 127.76, 
127.6, 127.3, 127.1, 87.1, 86.2, 79.2, 78.2, 75.2, 75.0, 74.6, 73.5, 69.1, 60.5, 40.8, 38.0, 
32.7, 32.6, 32.4, 24.7, 15.1, -1.95, -2.02; IR (film, cm
-1
) 3031, 2925, 2865, 1715, 1453, 
1384, 1256, 1089, 1029; HRMS (ES) m/z calcd for C39H52O7SSi [M+Na]
+
 715.3101, 
found 715.3095. 
4-(2-ethyl)cyclohexanone-3,4,6-tri-O-benzyl-α-D-glucopyranoside (Scheme 1.24, 
compound 45) 
 
Following the general procedure 4.4, silyl-linked compound 44 (80 mg, 0.12 
mmol), NIS (36 mg, 0.16 mmol), 2,6-DTBMP (95 mg, 0.46 mmol), and TMSOTf (50 
μL, 0.28 mmol) were stirred at -40 °C for 10 min, then warmed to 0 °C and stirred for 30 
min. n-Bu4NF (1.2 mL, 1.2 mmol) was added as a 1M solution in THF, warmed to rt and 
stirred over night.  Compound 45 (41 mg, 0.07 mmol, 62%) was obtained as white 
crystalline solid after purification by flash chromatography on SiO2 (50 to 60% 
EtOAc/hexanes).  
1
H NMR (500 MHz, CDCl3) δ 7.38-7.41 (m, 2H), 7.22-7.37 (m, 11H), 
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7.15-7.19 (m, 2H), 4.95 (d, J = 11.0 Hz, 1H), 4.91 (d, J = 3.0 Hz, 1H anomeric), 4.88 (d, 
J = 11.0 Hz, 1H), 4.84 (d, J = 10.5 Hz, 1H), 4.63 (d, J = 12.0 Hz, 1H), 4.54 (d, J = 12.0 
Hz, 1H), 4.52 (d, J = 10.5 Hz, 1H), 3.71-3.85 (m, 5H), 3.68 (dd, J = 10.25, 2.25 Hz, 1H), 
3.62 (dd, J = 9.5, 9.0 Hz 1H), 3.56 (dt, J = 10.0, 6.5 Hz, 1H), 2.28  (m, 4H), 2.01-2.10 
(m, 3H), 1.81-1.91 (m, 1H), 1.60-1.72 (m, 2H), 1.36-1.48 (m, 2H); 
13
C NMR (100 MHz, 
CDCl3) δ 211.7, 138.6, 138.0, 137.9, 128.42, 128.37, 128.0, 127.85, 127.82, 127.74, 
127.69, 98.5, 83.4, 77.5, 75.3, 75.1, 73.6, 72.9, 70.8, 68.6, 66.2, 40.62, 40.60, 35.1, 32.9, 
32.7, 32.4; IR (film, cm
-1
) 3450, 3031, 2926, 1713, 1453, 1357, 1135, 1068, 1028; HRMS 
(ES) m/z calcd for C35H44O7 [M+Na]
+
 597.2828, found 597.2818.  
Hydroxyaldehyde Reduction Product (Scheme 1.27, compound 48) 
 
Following the general procedure 4.2, silane (91 mg, 0.17 mmol), 
hydroxyaldehyde 47 (21 mg, 0.15 mmol), Ni(COD)2 (4.1 mg, 0.015 mmol), IMes·HCl 
(5.1 mg, 0.015 mmol), KO-t-Bu (1.7 mg, 0.015 mmol), and Ti(O-i-Pr)4 (97 μL, 0.33 
mmol) were stirred for overnight at rt to give the desired product 48.  Compound 48 (46 
mg, 0.07 mmol, 44%) was obtained as a colorless oil after purification by flash 
chromatography on SiO2 (10 to 30% EtOAc/hexanes). 
1
H NMR (500 MHz, CDCl3) δ 
7.24-7.38 (m, 13H), 7.08-7.12 (m, 2H), 4.92 (d, J = 11.0 Hz, 1H), 4.88 (d, J = 11.5 Hz, 
1H), 4.60 (d, J = 12.0 Hz, 1H), 4.56 (d, J = 12.0 Hz, 1H), 4.53 (d, J = 10.5 Hz, 1H), 4.39 
(d, J = 9.5 Hz, 1H), 3.75 (dd, J = 11.0, 1.5 Hz, 1H), 3.66-3.74 (m, 4H), 3.61 (t, J = 9.0 
Hz, 1H), 3.47-3.57 (m, 3H), 2.68-2.81 (m, 2H), 1.89-1.98 (m, 2H), 1.66-1.74 (m, 2H), 
1.39 (q, J = 6.5 Hz, 2H), 1.14-1.36 (m, 7H) 0.87-0.97 (m, 2H), 0.20 (s, 3H), 0.18 (s, 3H).  
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Hydroxyaldehyde Glycosylation Product (Scheme 1.27, compound 49) 
 
Following the general procedure 4.4, compound 48 (36 mg, 0.0.05 mmol), NIS 
(16 mg, 0.07 mmol), TMSOTf (22 μL, 0.12 mmol), 2,6-DTBMP (42 mg, 0.20 mmol) 
were stirred for 5 minutes at -40 °C, and 1 hour at 0 °C then excess n-Bu4NF (0.5 mL, 0.5 
mmol) was added as a 1M solution in THF and stirred overnight to afford the desired 
product.  The product (27 mg, 0.048 mmol, 95%) was obtained as a colorless viscous oil 
upon purification by flash chromatography on SiO2 (50 to 60% EtOAc/Hex). 
1
H NMR 
(500 MHz, CDCl3) δ 7.38-7.41 (m, 2H), 7.26-7.37 (m, 11H), 7.14-7.18 (m, 2H), 4.95 (d, 
J = 11.5 Hz, 1H), 4.89 (d, J = 3.5 Hz, 1H), 4.86 (d, J = 11.0 Hz, 1H), 4.83 (d, J = 11.0 
Hz, 1H), 4.64 (d, J = 12.0 Hz, 1H), 4.52 (d, J = 12.5 Hz, 1H), 4.50 (d, J = 10.5 Hz, 1H), 
3.60-3.80 (m, 7H), 3.55 (tt, J = 11.0, 4.5 Hz, 1H), 3.47-3.53 (m, 1H), 2.06 (d, J =7.5 Hz, 
1H), 1.94-2.00 (m, 2H), 1.73-1.81 (m, 2H), 1.53 (q, J = 7.0 Hz, 2H), 1.20-1.40 (m, 5H), 
0.93-1.04 (m, 2H). 
Ethyl 2-O-[(3R,5S,8R,9S,10S,13S,14S,17S)-3-(dimethylsilyloxy)-10,13-
dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-ol]-3,4,6-tri-O-benzyl-1-
thio-β-D-glucopyranoside (Scheme 1.28, compound 50) 
 
Following the general procedure 4.2, silane (182 mg, 0.33 mmol), 
dihydrotestosterone (87 mg, 0.30 mmol), Ni(COD)2 (8 mg, 0.03 mmol), IMes·HCl (10 
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mg, 0.03 mmol), KO-t-Bu (3.4 mg, 0.03 mmol), and Ti(O-i-Pr)4 (195 μL, 0.66 mmol) 
were stirred for 6.5 hr at rt to give the product as an inseparable 5:1 mixture of 
diastereomers.  The product (226 mg, 0.27 mmol, 89%, 5:1) was obtained as a viscous 
yellow oil after flash chromatography on SiO2 (20 to 25% EtOAc/Hex).  
1
H NMR 7.24-
7.40 (m, 13H), 7.06 (m, 2H), 5.03 (d, J = 11.5 Hz, 1H), 4.86 (d, J = 11.5 Hz, 1H), 4.71 
(d, J = 11.0 Hz, 1H), 4.61 (d, J = 12.5 Hz, 1H), 4.56 (d, J = 12.5 Hz,  1H), 4.51 (d, J = 
10.5 Hz, 1H), 4.40 (d, J = 9.5 Hz, 1H anomeric), 4.17 (t, J = 2.5 Hz, 1H) 3.47-3.81 (m, 
7Hmajor + minor), 2.68-2.81 (m, 2H), 2.00-2.10  (m, 1H), 0.56-1.82 (m, 31Hmajor + minor) 
{assignable peaks within this multiplet: 1.32 (t, J = 7.5 Hz, 3Hmajor), 0.73 (s, 3Hmajor), 
0.71 (s, 3Hmajor)}, 0.21 (s, 3H), 0.19 (s, 3H), diagnostic peaks for minor diastereomer 4.97 
(d, J = 11.5 Hz, 1Hminor), 4.90 (d, J = 11 Hz, 1Hminor) benzylic, Note – the stereochemistry 
of the major diastereomer and the dr of the reduction  was determined on a crude reaction 
mixture of the silyl-linked compound after complete desilylation by n-Bu4NF and 
comparison to known compounds; 
13
C NMR (100 MHz, CDCl3) major and minor 
diastereomer signals reported δ 138.9, 138.2, 138.0, 128.34, 128.31, 128.2, 127.95, 
127.93, 127.72, 127.69, 127.5, 127.3, 127.0, 87.2, 87.0, 86.2, 82.0, 79.1, 78.3, 78.1, 75.3, 
75.1, 74.9, 74.6, 73.4, 71.7, 69.1, 67.2, 54.5, 54.1, 51.01, 50.95, 44.9, 42.9, 38.8, 38.2, 
37.1, 36.74, 36.67, 36.4, 35.9, 35.5, 35.4, 32.3, 31.64, 31.57, 31.47, 30.5, 29.7, 29.4, 28.6, 
28.4, 24.7, 23.4, 23.3, 20.7, 20.3, 15.1, 12.3, 11.4, 11.1, -0.9, -1.0, -1.1, -1.2; IR (film, 
cm
-1
) 3429, 3028, 2925, 2867, 1496, 1452, 1362, 1253, 1133, 1067, 1027; HRMS (ES) 
m/z calcd for C50H70O7SSi [M+Na]
+
 865.4509, found 865.4501. 
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3-(3R,5S,8R,9S,10S,13S,14S,17S)-10,13-dimethylhexadecahydro-1H-
cyclopenta[a]phenanthrene-17-ol 3,4,6-tri-O-benzyl-α-D-glucopyranoside (Scheme 
1.28, compound 51) 
 
Following the general procedure 4.4, compound 50 (145 mg, 0.17 mmol), NIS (54 
mg, 0.24 mmol), TMSOTf (75 μL, 0.41 mmol), 2,6-DTBMP (141 mg, 0.69 mmol) were 
stirred for 5 minutes at -40 °C, and 1 hour at 0 °C then excess n-Bu4NF (1.7 mL, 1.7 
mmol) was added as a 1M solution in THF and stirred overnight to afford the desired 
products as a 5:1 mixture of diastereomers.  The products (combined 117 mg, 0.16 mg, 
95%, 5:1) were obtained as colorless viscous oils, separated and characterized 
independently upon purification by flash chromatography on SiO2 (30 to 40% 
EtOAc/Hex).  Major diastereomer 
1
H NMR (500 MHz, CDCl3) δ 7.41-7.44 (m, 2H), 
7.26-7.38 (m, 11H), 7.14-7.17 (m, 2H), 5.02 (d, J = 11.0 Hz, 1H), 4.97 (d, J = 3.5 Hz, 1H 
anomeric), 4.87 (d, J = 11.0 Hz, 1H), 4.84 (d, J = 10.5 Hz, 1H), 4.64 (d, J = 12.0 Hz, 1H), 
4.51 (d, J = 12.0 Hz, 1H), 4.50 (d, J = 10.5 Hz, 1H), 3.91 (m, 1H), 3.85 (ddd, J = 10.0, 
3.5, 1.5 Hz, 1H), 3.78 (dd, J = 10.5, 3.5 Hz, 1H), 3.68-3.75 (m, 2H), 3.61-3.68 (m, 3H), 
2.02-2.11 (m, 1H), 1.96 (d, J = 9.5 Hz, 1H), 1.78-1.81 (m, 2H), 1.52-1.70 (m, 4H), 1.13-
1.52 (m, 12 H), 1.07 (td, J = 13.0, 4.0 Hz, 1H), 0.85-1.02 (m, 2H), 0.80 (s, 3H), 0.74 (s, 
3H), 0.70-0.78 (m, 1H); 
13
C NMR (100 MHz, CDCl3) δ 138.9, 138.1, 138.0, 128.44, 
128.37, 128.2, 127.90, 127.87, 127.83, 127.7, 127.6, 97.3, 83.8, 82.0, 77.4, 75.2, 73.5, 
73.3, 73.1, 70.7, 68.6, 54.3, 51.0, 43.0, 40.2, 36.7, 36.0, 35.5, 33.1, 32.5, 31.4, 30.5, 28.4, 
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27.4, 23.3, 20.4, 11.4, 11.1; IR (film, cm
-1
) 3453, 3063, 3030, 2928, 1496, 1453, 1358, 
1135, 1067; HRMS (ES) m/z calcd for C46H6O7 [M+Na]
+
 747.4237, found 747.4250.  
Minor diastereomer 
1
H NMR (500 MHz, CDCl3) δ 7.37-7.41 (m , 2H), 7.26-7.36 (m, 
11H), 7.14-7.17 (m, 2H), 5.03 (d, J = 3.5 Hz, 1H anomeric), 4.98 (d, J = 11.0 Hz, 1H), 
4.84 (d, J = 11.0 Hz, 1H), 4.64 (d, J = 12.5 Hz), 4.51 (d, J = 12.0 Hz, 1H), 4.49 (d, J = 
10.5 Hz, 1H), 3.90 (ddd, J = 10.0, 4.0, 2.0 Hz, 1H), 3.55-3.78 (m, 7H), 2.05 (d, J = 9.5 
Hz, 1H), 2.02-2.10 (m, 1H), 1.84-1.90 (m, 1H), 1.80 (dt, J = 12, 3.5 Hz, 1H), 1.74 (dt, J = 
13.5, 3.5 Hz, 1H), 1.54-1.68 (m, 3H), 1.20-1.47 (m, 10H), 1.01-1.12 (m, 2H), 0.80-0.98 
(m, 3H), 0.82 (s,3H), 0.74 (s, 3H), 0.60-0.98 (m, 1H); 
13
C NMR (100 MHz, CDCl3) δ 
138.8, 138.2, 138.0, 128.35, 128.33, 127.9, 127.8, 127.7, 127.6, 127.5, 97.0, 83.8, 81.9, 
77.4, 75.3, 75.0, 73.5, 73.0, 70.5, 68.7, 54.4, 51.0, 45.0, 43.0, 36.8, 36.7, 36.0, 35.6, 35.5, 
31.6, 30.5, 29.7, 28.5, 27.8, 23.4, 20.8, 12.3, 11.1; IR (film, cm
-1
) 3439, 3029, 2928, 
1452, 1356, 1207, 1131, 1067, 1025; HRMS (ES) m/z calcd for C46H60O7 [M+Na]
+
 
747.4237, found 747.4258.   
Ethyl 2-O-[(3R,5S,8R,9S,10S,13S,14S,17S)-3-(dimethylsilyloxy)-10,13-
dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-ol]-3,4,6-tri-O-benzyl-1-
thio-α-D-mannopyranoside (Scheme 1.28, compound 52) 
 
Following the general procedure 4.2, silane (182 mg, 0.33 mmol) 
dihydrotestosterone (87 mg, 0.30 mmol), Ni(COD)2 (8 mg, 0.03 mmol), IMes·HCl (10 
mg, 0.03 mmol), KO-t-Bu (3.4 mg, 0.03 mmol), and Ti(O-i-Pr)4 (195 μL, 0.66 mmol) 
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were stirred for 6.5 hr at rt to give the desired product as an inseparable 6:1 mixture of 
diastereomers.  The product (202 mg, 0.24 mmol, 80%, 6:1) was obtained as a viscous 
off-white oil after flash chromatography on SiO2 (10 to 20% EtOAc/hexanes).  
1
H NMR 
(500 MHz, CDCl3) Major diastereomer δ 7.24-7.38 (m, 13H), 7.15-7.18 (m, 2H), 5.32 
(d, J = 1.5 Hz, 1H anomeric), 4.84 (d, J = 11.0 Hz, 1H), 4.73 (d, J = 11.5 Hz, 1H), 4.69 
(d, J = 12.0 Hz, 1H), 4.62 (d, J = 12.0 Hz, 1H), 4.52 (d, J = 11.0 Hz, 1H), 4.50 (d, J = 
10.5 Hz, 1H), 4.30 (dd, J = 2.5, 2.0 Hz, 1H), 4.12-4.16 (m, 2H), 3.98 (t, 9.5 Hz, 1H), 4.83 
(dd, J = 11.0, 5.0 Hz, 1H), 3.77 (dd, J = 9.0, 2.25 Hz, 1H), 3.72 (dd, J = 11.0, 2.0 Hz, 
1H), 3.62 (t, J = 8.25 Hz, 1H), 2.54-2.70 (m, 2H), 2.01-2.11 (m, 1H), 1.78 (dt, J = 12.5, 
3.5 Hz, 1H), 1.09-1.66 (m, 17H), 1.29 (t, J = 7.5 Hz, 3H), 1.02, (td, J = 13.0, 4.0 Hz, 1H), 
0.80-0.96 (m, 2H), 0.69-0.78 (m, 1H), 0.76 (s, 3H), 0.73 (s, 3H), 0.16 (s, 3H), 0.15 (s, 
3H); diagnostic peak for minor diastereomer at 5.28 (d, J = 1.5 Hz, 0.15H anomeric),  
Note – the stereochemistry of the major diastereomer and the dr of the reduction  was 
determined on a crude reaction mixture of the silyl-linked compound after complete 
desilylation by n-Bu4NF and comparison to known compounds; 
13
C NMR (100 MHz, 
CDCl3) major and minor diastereomer signals reported δ 138.5, 138.3, 128.3, 128.2, 
127.9, 127.7, 127.6, 127.5, 127.4, 85.5, 82.0, 80.4, 74.9, 74.8, 73.2, 72.1, 72.0, 70.6, 69.2, 
67.0, 54.3, 51.1, 44.9, 43.0, 39.0, 36.7, 36.4, 36.0, 35.5, 25.3, 23.3, 20.3, 15.1, 11.4, 11.1, 
-1.4, -1.5, -1.7; IR (film, cm
-1
) 3465, 3030, 2925, 1452, 1371, 1255, 1097, 1047; HRMS 
(ES) m/z calcd for C50H70O7SSi [M+Na]
+
 865.4509, found 865.4484. 
3-(3R,5S,8R,9S,10S,13S,14S,17S)-10,13-dimethylhexadecahydro-1H-
cyclopenta[a]phenanthrene-17-ol 3,4,6-tri-O-benzyl-β-D-mannopyranoside (Scheme 
1.28, compound 53) 
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Following the general procedure 4.4, compound 52 (131 mg, 0.16 mmol), NIS (49 
mg, 0.22 mmol), 2,6-DTBMP (128 mg, 0.62 mmol), and TMSOTf (68 μL, 0..37 mmol), 
were stirred at -40 °C for 10 min, then warmed to 0 °C and stirred for 1.5 hours. n-Bu4NF 
(1.6 mL, 1.6 mmol) was then added as a 1M solution in THF, and the reaction was taken 
to rt and stirred overnight to give the products as a 6:1 mixture of diastereomers.  The 
products (combined 103 mg, 0.14 mmol, 92%, 6:1) were isolated as viscous, colorless 
oils, which were separated and characterized independently upon purification by flash 
chromatography on SiO2 (30% EtOAc/Hex).  Major diastereomer 
1
H NMR (500 MHz, 
CDCl3) δ 7.38-7.41 (m, 2H), 7.24-7.36 (m, 13H), 7.20-7.23 (m, 2H), 4.91 (d, J = 11.0 Hz, 
1H), 4.81 (d, J = 12.0 Hz, 1H), 4.68 (d, J = 11.5 Hz, 1H), 4.61 (d, J = 12.5 Hz, 1H), 4.56 
(d, J = 12.5 Hz, 1H), 4.55 (d, J = 10.5 Hz, 1H), 4.49 (s, 1H anomeric), 4.09 (br s, 1H), 
4.04-4.07 (m, 1H), 3.87 (t, J = 9.0 Hz, 1H), 3.76 (dd, J = 10.5, 2.0 Hz, 1H), 3.68 (dd, J = 
11.0, 5.5 Hz, 1H), 3.64 (t, J = 8.5 Hz, 1H), 3.59 (dd, J = 9.0, 2.5 Hz, 1H), 3.41 (ddd, J = 
9.5, 5.0, 2.0 Hz, 1H), 2.52 (s, 1H), 2.02-2.11 (m, 1H), 1.79 (dt, J = 12.0, 3.0 Hz, 1H), 
1.72 (d, J = 14.5 Hz, 1H), 1.10-1.68 (m, 18H), 1.05 (td, J = 13.0, 4.0 Hz, 1H), 0.85-1.00 
(m, 1H), 0.72-0.82 (m, 1H), 0.80 (s, 3H), 0.74 (s, 3H); 
13
C NMR (100 MHz, CDCl3) δ 
138.3, 138.2, 137.9, 128.4, 128.33, 128.28, 128.1, 127.8, 127.74, 127.69, 127.5, 97.2, 
81.9, 81.8, 75.2, 75.1, 74.3, 73.5, 72.8, 71.2, 69.3, 68.9, 54.2, 51.0, 42.9, 39.4, 36.7, 35.9, 
35.5, 34.2, 32.5, 31.4, 30.5, 28.2, 25.0, 23.3, 20.3, 11.4, 11.1; IR (film, cm
-1
) 3452, 3028, 
2926, 2866, 1452, 1363, 1105, 1056; HRMS (ES) m/z calcd for C46H60O7 [M+Na]
+
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747.4237, found 747.4250. Minor diastereomer 
1
H NMR (500 MHz, CDCl3) δ 7.37-
7.40 (m, 2H), 7.27-7.36 (m, 11H), 7.21-7.24 (m, 2H), 4.90 (d, J = 11.0 Hz, 1H), 4.78 (d, 
J = 12.0 Hz, 1H), 4.68 (d, J = 11.5 Hz, 1H), 4.62 (d, J = 12.0 Hz, 1H), 4.57 (d, J = 12.0 
Hz, 1H), 4.56 (s, 1H anomeric), 4.55 (d, J = 11.5 Hz, 1H), 4.06 (s, 1H), 3.83 (t, J = 9.75 
Hz, 1H), 3.79 (dd, J = 10.75, 1.75 Hz, 1H), 3.60-3.75 (m, 2H), 3.68 (dd, J = 10.5, 6.0 Hz, 
1H), 3.57 (dd, J = 9.0, 3.0 Hz, 1H), 3.43 (ddd, J = 9.5, 5.75, 1.75 Hz, 1H), 2.46 (d, J = 
2.0 Hz, 1H), 2.01-2.10 (m, 1H), 1.92-1.98 (m, 1H), 1.80 (dt, J = 12.0, 3.25 Hz, 1H), 1.73 
(dt, J = 13.25, 2.5 Hz, 1H), 1.67 (dq, J = 12.75, 3.25 Hz. 1H), 1.20-1.62 (m, 11H), 0.75-
1.10 (m, 6H), 0.82 (s, 3H), 0.74 (s, 3H), 0.58-0.65 (m, 1H); 
13
C NMR (100  MHz, CDCl3) 
δ 138.4, 138.2, 137.9, 128.5, 128.4, 128.3, 128.1, 127.9, 127.8, 127.7, 127.5, 97.2, 82.0, 
81.7, 77.4, 75.3, 75.2, 74.4, 73.4, 71.3, 69.4, 68.8, 54.5, 51.0, 44.7, 43.0, 37.0, 36.7, 35.7, 
35.5, 34.2, 31.6, 30.5, 29.2, 28.7, 23.4, 20.8, 12.3, 11.1; IR (film, cm
-1
) 3462, 3028, 2926, 
2848, 1452, 1383, 1101, 1071, 1026; HRMS (ES) m/z calcd for C46H60O7 [M+Na]
+
 
747.4237, found 747.4247. 
4.2 Chapter 2 Experimental Procedures and Spectral Data 
4.2.1 Chapter 2 Experimental Procedures 
All reagents were used as received unless otherwise noted. Solvents were purified 
under nitrogen using a solvent purification system (Innovative Technology, inc., Model # 
SPS-400-3 and PS-400-3). B(C6F5)3 (Sigma-Aldrich, used as received) when stored for 
long periods of time, an inert atmosphere was used.  However, it was found to perform 
equally well when stored in a vial kept in a dessicator and weighed on the benchtop. 
CuCl (Sigma-Aldrich, used as received and, 1,3-dimesitylimidazolium chloride 
(IMes·HCl) were stored and weighed in an inert atmosphere glovebox. All B(C6F5)3 and 
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Cu/IMes reactions were conducted in flame-dried glassware under a nitrogen atmosphere. 
1
H and 
13
C spectra were obtained in CDCl3 at rt, unless otherwise noted, on a Varian 
Mercury 400 or Varian Unity 500 MHz instrument. Chemical shifts of 
1
H NMR spectra 
were recorded in parts per million (ppm) on the δ scale from an internal standard of 
residual chloroform (7.27 ppm). Chemical shifts of 
13
C NMR spectra were recorded in 
ppm from the central peak of CDCl3 (77.0 ppm) on the δ scale. High resolution mass 
spectra (HRMS) were obtained on a VG-70-250-s spectrometer manufactured by 
Micromass Corp. (Manchester UK) at the University of Michigan Mass Spectrometry 
Laboratory. 
General Procedure for the B(C6F5)3 Promoted Dehydrogenative Silylation of 
Alcohols (General Procedure 4.5) 
A mixture of sugar silane (1.0 equiv.) and alcohol (1.0 equiv.) was dissolved in 
dry toluene (0.10M) at rt under an inert atmosphere (N2) and stirred until both substrates 
were completely dissolved.  B(C6F5)3 (4 mol%) was added as a solid under a gentle 
stream of nitrogen followed by re-attachment of the septum and nitrogen line. Upon 
completion of the reaction as monitored by TLC, the reaction mixture was either loaded 
directly onto a column, or the volatiles were removed by rotary evaporation, and then 
loaded onto a column for purification by flash chromatography (SiO2) to afford the 
desired product.  Note – dry dichloromethane was found to be the optimal co-solvent if a 
substrate is marginally soluble in toluene. 
General Procedure for the CuCl-IMes Promoted Dehydrogenative Silylation of 
Alcohols (General Procedure 4.6) 
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A solid mixture of CuCl (5%), IMes·HCl (5%) and KO-t-Bu (10%) was dissolved 
in dry toluene (0.015M) at rt under an inert atmosphere (N2), and stirred for 20 minutes.  
A mixture of alcohol (1.0 equiv) and silane (1.1 equiv) was dissolved in dry toluene 
(0.2M), the catalyst was then added to this mixture as a solution in dry toluene.  Upon 
completion of the reaction, as monitored by TLC, the reaction mixture was filtered 
through a short plug of silica gel with a mixture of EtOAc/Hexanes and concentrated by 
rotary evaporation.  The resulting residue was purified via flash chromatography (SiO2) 
to afford the desired product. 
Thiophenyl Sugar Silane and (-)-Menthol Silyl-Linked (Scheme 2.7, compound 69) 
 
Following the general procedure 4.5, silane (60 mg, 0.10 mmol), (-)-menthol (16 
mg, 0.10 mmol), and B(C6F5)3 (2 mg, 0.004 mmol) were stirred for 85 minutes at rt.  The 
product (73 mg, 0.097 mmol, 97%) was obtained as a colorless oil upon purification by 
flash chromatography on SiO2 (5 to 8% EtOAc/hex). 
1
H NMR (500 MHz, CDCl3) δ 7.53-
7.56 (m, 2H), 7.38-7.41 (m, 2H), 7.21-7.35 (m, 14H), 7.14-7.17 (m, 2H), 5.02 (d, J = 
11.0 Hz, 1H), 4.86 (d, J = 11.0 Hz, 1H), 4.78 (d, J = 10.5 Hz, 1H), 4.65 (d, J = 9.5 Hz, 
1H), 4.60 (d, J = 12.0 Hz, 1H), 4.57 (d, J = 10.5 Hz, 1H), 4.54 (d, J = 12.0 Hz, 1H), 3.76-
3.81 (m, 2H), 3.71 (dd, J = 11.0, 5.0 Hz, 1H), 3.53-3.66 (m, 4H), 2.21 (septd, J = 7.0, 2.5 
Hz, 1H), 2.01 (d, J = 12.0 Hz, 1H), 1.53-1.63 (m, 2H), 1.28-1.37 (m, 1H), 1.12 (dt, J = 
12.5, 3.0 Hz, 1H), 1.05 (q, J = 12.5 Hz, 1H), 0.86-0.97 (m, 1H), 0.86 (d, J = 7.0 Hz, 3H), 
0.85 (d, J = 7.0 Hz, 3H), 0.72-0.82 (m, 1H), 0.74 (d, J = 7.0 Hz, 3H), 0.25 (s, 3H), 0.13 
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(s, 3H); 
13
C NMR (100 MHz, CDCl3) δ 138.7, 138.23, 137.99, 134.5, 131.1, 128.9, 
128.4, 128.3, 128.2, 127.8, 127.73, 127.66, 127.52, 127.50, 127.3, 127.0, 88.8, 87.0, 79.0, 
78.2, 75.2, 74.9, 73.9, 73.4, 72.7, 69.0, 49.7, 45.4, 34.5, 31.6, 25.2, 22.8, 22.2, 21.2, 15.9, 
-1.2,-1.4; IR (film, cm
-1
) 3030, 2953, 2919, 2868, 1453, 1365, 1254, 1067; HRMS (ES) 
m/z calcd for C45H58O6SSi [M+Na]
+
 777.3621, found 777.3622. 
Glucose and (-)-Menthol Glycoside (Scheme 2.7, compound 70) 
 
 Following the general procedure 4.4, compound 69 (148 mg, 0.20 mmol), NIS (57 
mg, 0.25 mmol), TMSOTf (43 μL, 0.24 mmol), and 2,6-DTBMP (80 mg, 0.39 mmol) 
were stirred at -40 °C for 10 min,  then warmed to 0 °C and stirred for 30 min, then 
excess n-Bu4NF (1.2 mL, 1.2 mmol) was added as a 1M solution in THF, warmed to rt 
and allowed to stir overnight.  The product (113 mg, 0.19 mmol, 98%) was obtained as a 
colorless oil upon purification by flash chromatography on SiO2 (10% EtOAc/hex). 
1
H 
NMR (500 MHz, CDCl3) δ 7.39-7.42 (m, 2H), 7.25-7.37 (m, 11H), 7.14-7.17 (m, 2H), 
4.99 (d, J = 4.5 Hz, 1H), 4.97 (d, J = 11.5 Hz, 1H), 4.85 (d, J = 11.5 Hz, 1H), 4.84 (d, J = 
10.5 Hz, 1H), 4.66 (d, J = 12.0 Hz, 1H), 4.50 (d, J = 11.0 Hz, 1H), 4.48 (d, J = 10.0 Hz, 
1H), 3.94 (ddd, J = 10.0, 3.5, 2.0 Hz, 1H), 3.77 (dd, J = 10.75, 4.25 Hz, 1H) 3.60-3.74 
(m, 4H), 3.40 (td, J = 10.5, 4.0 Hz, 1H), 2.19 (d, J = 12.5 Hz, 1H), 2.14 (septd, J = 6.5, 
2.5 Hz, 1H), 1.96 (d, J = 9.0 Hz, 1H) 1.61-1.68 (m, 2H), 1.34-1.45 (m, 1H), 1.25-1.33 (m, 
1H), 0.94 – 1.06 (m, 2H), 0.92 (d, J = 7.0 Hz, 3H), 0.87 (d, J = 6.5 Hz, 3H), 0.78-0.86 
(m, 1H), 0.78 (d, J = 7.0 Hz, 3H); 
13
C NMR (100 MHz, CDCl3) δ 138.8, 138.2, 138.0, 
128.4, 128.3, 128.0, 127.92, 127.86, 127.7, 127.64, 127.60, 100.0, 83.5, 81.1, 77.4, 75.2, 
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75.0, 73.6, 73.5, 70.6, 68.6, 48.7, 42.9, 34.1, 31.6, 25.5, 22.8, 22.2, 21.2, 15.7; IR (film, 
cm
-1
) 3566, 3062, 3030, 2922, 2868, 1454, 1362, 1133, 1067, 1028; HRMS (ES) m/z 
calcd for C37H48O6 [M+Na]
+
 611.3349, found 611.3354. 
Thiophenyl Mannose Sugar Silane and (-)-Menthol Silyl-Linked (Scheme 2.7, 
compound 71) 
 
Following the general procedure 4.5, silane (60 mg, 0.10 mmol), (-)-menthol (16 
mg, 0.10 mmol) and B(C6F5)3 (2 mg, 0.004 mmol) were stirred at rt for 1.5 h. The 
product (62 mg, 0.082 mmol, 92%) was obtained as a colorless oil upon purification by 
flash chromatography on SiO2 (5 to 8% EtOAc/hex). 
1
H NMR (500 MHz, CDCl3) δ 7.48-
7.51 (m, 2H), 7.38-7.42 (m, 2H), 7.20-7.36 (m, 16H), 5.53 (s, 1H), 4.88 (d, J = 10.5 Hz, 
1H), 4.78 (d, J = 11.5 Hz, 1H), 4.67 (d, J = 12.0 Hz, 2H), 4.55 (d, J = 11.0 Hz, 1H), 4.50 
(d, J = 12.0 Hz, 1H), 4.47 (s, 1H), 4.30 (dd, J = 9.5, 5.0 Hz, 1H), 4.00 (t, J = 9.5 Hz, 1H), 
3.85 (dd, J = 11.0, 5.0 Hz, 1H), 3.80 (dd, J = 9.0, 2.5 Hz, 1H), 3.76 (d, J = 11.0 Hz, 1H), 
3.54 (td, J = 10.0, 4.5 Hz, 1H), 2.09-2.19 (m, 1H), 1.95 (d, J = 12.0 Hz, 1H), 1.52-1.63 
(m, 2H), 1.25-1.35 (m, 1H), 1.08-1.16 (m, 1H), 1.01 (q, J = 12.0 Hz, 1H), 0.75-0.87 (m, 
7H), 0.72 (d, J = 7.0 Hz, 3H), 0.17 (s, 3H), 0.15 (s, 3H); 
13
C NMR (100 MHz, CDCl3) δ 
138.5, 138.4, 138.3, 134.7, 131.4, 128.9, 128.3, 128.2, 127.92, 127.86, 127.63, 127.57, 
127.3, 127.1, 89.0, 80.3, 75.0, 74.9, 73.2, 73.0, 72.6, 72.2, 70.8, 69.3, 49.8, 45.3, 34.5, 
31.6, 25.3, 22.8, 22.2, 21.1, 15.9, -1.35, -1.40; IR and HRMS match previously reported 
data for a mixture of diastereomers at the (-)-menthol carbinol. 
Mannose and (-)-Menthol glycoside (Scheme 2.7, compound 72) 
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 Following the general procedure 4.4, compound 71 (130 mg, 0.17 mmol), NIS (50 
mg, 0.22 mmol), TMSOTf (37 μL, 0.21 mmol), and 2,6-DTBMP (70 mg, 0.34 mmol) 
were stirred at -40 °C for 10 min, then warmed to 0 °C and stirred for 90 min, then an 
excess of n-Bu4NF (1.36 mL, 1.36 mmol) was added as a 1M solution in THF and 
allowed to stir at room temperature overnight.  The product (100 mg, near quantitative) 
was isolated as a white crystalline solid upon purification by flash chromatography on 
SiO2 (10 to 20% EtOAc/hex). All spectral data matches those previously reported in 
section 4.1.1. 
Thioethyl Sugar Silane and Compound 72 Silyl-Linked (Scheme 2.8, compound 73) 
 
Following the general procedure 4.5, silane (27 mg, 0.049 mmol), compound 72 
(29 mg, 0.049 mmol) and B(C6F5)3 (2 mg, 0.004 mmol) were stirred at rt overnight.  The 
product (38 mg, 0.033 mmol, 68%) was obtained as an oil upon purification by flash 
chromatography on SiO2 (10% EtOAc/hex). 
1
H NMR (500 MHz, CDCl3) δ 7.39-7.42 (m, 
2H), 7.35-7.38 (m, 2H), 7.18-7.34 (m, 22H), 7.12-7.15 (m, 2H), 7.06-7.10 (m, 2H), 5.22 
(d, J = 11.0 Hz, 1H), 4.80 (d, J = 12.0 Hz, 1H), 4.73 (d, J = 11.0 Hz, 1H), 4.70 (d, J = 
11.0 Hz, 1H), 4.69 (d, J = 11.0 Hz, 1H), 4.60 (d, J = 12.0 Hz, 1H), 4.55 (d, J = 11.0 Hz, 
1H), 4.53 (d, J = 12.0 Hz, 1H), 4.46 (d, J = 12.0 Hz, 1H), 4.423 (d, J = 12.0 Hz, 1H), 
4.421 (d, J = 10.0 Hz, 1H), 4.39 (s, 1H), 4.36 (d, J = 9.5 Hz, 1H), 4.23 (d, J = 11.0 Hz, 
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1H), 4.17 (d, J = 2.5 Hz, 1H), 3.96 (dd, J = 9.5, 8.5 Hz, 1H), 3.73 (dd, J = 10.5, 1.5 Hz, 
1H), 3.44-3.66 (m, 8H), 3.32-3.38 (m, 1H), 3.28 (dd, J = 10.5, 7.0 Hz, 1H), 2.73 (dq, J = 
13.0, 7.5 Hz, 1H), 2.68 (dq, J = 12.5, 7.5 Hz, 1H), 2.57 (septd, J = 6.5, 2.0 Hz, 1H), 1.96 
(d, J = 12.5 Hz, 1H), 1.60-1.68 (m, 2H), 1.27-1.40 (m, 1H), 1.28 (t, J = 7.5 Hz, 3H), 1.16-
1.24 (m, 1H), 0.77-1.03 (m, 3H), 0.904 (d, J = 7.0 Hz, 3H), 0.900 (d, J = 6.5 Hz, 3H), 
0.84 (d, J  = 7.0 Hz, 3H), 0.31 (s, 3H), 0.28 (s, 3H); 
13
C NMR (100 MHz, CDCl3) δ 
139.3, 138.60, 138.56, 138.5, 138.32, 138.31, 128.3, 128.2, 128.1, 128.0, 127.8, 127.7, 
127.6, 127.53, 127.46, 127.42, 127.36, 127.2, 96.7, 87.4, 86.2, 82.4, 79.1, 18.0, 76.3, 
75.6, 75.4, 75.1, 75.0, 74.8, 74.6, 73.3, 71.2, 70.7, 70.1, 69.3, 47.9, 40.9, 34.4, 31.3, 24.7, 
24.5, 22.8, 22.3, 21.6, 15.8, 15.2, -0.7, -1.1. 
Glucose and Compound 72 Disaccharide (Scheme 2.8, compound 74) 
 
Following the general procedure 4.4, compound 73 (37 mg, 0.032 mmol), NIS 
(9.5 mg, 0.042 mmol), TMSOTf (7.0 μL, 0.039 mmol), and 2,6-DTBMP (13 mg, 0.065 
mmol) were stirred at -40 °C for 10 min, then warmed to 0 °C and stirred for 1.5 hours, 
then an excess of n-Bu4NF (192 μL, 0.192 mmol) was added as a 1M solution in THF, 
warmed to rt and allowed to stir overnight.  The product (29 mg, 0.028 mmol, 89%) was 
obtained as a colorless oil upon purification by flash chromatography on SiO2 (20% 
EtOAc/hex). 
1
H NMR (500 MHz, CDCl3) δ 7.23-7.39 (m, 27H), 7.16-7.21 (m, 3H), 5.12 
(d, J = 3.0 Hz, 1H), 4.90 (d, J = 11.0 Hz, 1H), 4.85 (d, J = 10.5 Hz, 1H), 4.83 (d, J = 10.5 
Hz, 1H), 4.76 (d, J = 11.5 Hz, 1H), 4.72 (d, J = 11.5 Hz, 1H),. 4.61-4.70 (m, 4H), 4.56 (d, 
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J = 12.0 Hz, 1H), 4.54 (d, J = 11.0 Hz, 1H), 4.49 (d, J = 12.0 Hz, 1H), 4.41 (s, 1H), 4.27 
(d, J  = 9.5  Hz, 1H), 3.92 (d, J = 2.5 Hz, 1H), 3.83 (t, J = 9.75 Hz, 1H), 3.70-3.81 (m, 
6H), 3.58-3.64 (m, 2H), 3.44 (td, J = 11.0, 4.0 Hz, 1H), 3.38 (dd, J = 9.5, 4.5 Hz, 1H), 
3.15 (d, J = 7.5 Hz, 1H), 2.30 (sept, J = 6.5 Hz, 1H), 1.91 (d, J = 12.5 Hz, 1H), 1.58-1.70 
(m, 2H), 1.28-1.40 (m, 1H), 1.05-1.12 (m, 1H) 0.73-1.00 (m, 3H), 0.91 (d, J = 6.5 Hz, 
3H), 0.82 (d, J = 7.5 Hz, 3H), 0.77 (d, J = 6.5 Hz, 3H); 
13
C NMR (100 MHz, CDCl3) δ 
139.3, 138.9, 138.5, 138.1, 138.0, 137.3, 128.6, 128.4, 128.32, 128.28, 128.25, 128.17, 
128.1, 128.0, 127.90, 127.88, 127.87, 127.8, 127.60, 127.56, 127.4, 127.34, 127.26, 
100.9, 96.9, 83.9, 82.3, 76.9, 75.6, 75.2, 75.1, 74.9, 74.7, 74.1, 73.6, 73.5, 72.8, 70.5, 
69.7, 68.5, 48.0, 41.0, 34.3, 31.4, 24.8, 22.7, 22.2, 21.1, 15.7; IR (film, cm
-1
) 3428, 3031, 
2923, 2867, 1727, 1453, 1273, 1095, 1054; HRMS (ES) m/z calcd for C64H76O11 
[M+Na]
+
 1043.5285, found 1043.5297. 
Thioethyl Sugar Silane and Galactose 75 Silyl-Linked (Scheme 2.9, compound 76) 
 
Following the general procedure 4.6, silane (61 mg, 0.11 mmol), alcohol 75 (26 
mg, 0.10 mmol), CuCl (0.5 mg, 0.0050 mmol), IMes·HCl (1.7 mg, 0.0050 mmol), and 
NaO-t-Bu (1 mg, 0.010 mmol) were stirred at rt for 15 min.  The product (68 mg, 0.084 
mmol, 84%) was obtained as an oil upon purification by flash chromatography on SiO2 
(10 to 15% EtOAc/hex).  
1
H NMR (500 MHz, CDCl3) δ 7.23-7.38 (m, 13H), 7.08-7.12 
(m, 2H), 5.50 (d, J = 5.0 Hz, 1H), 4.96 (d, J = 11.5 Hz, 1H), 4.85 (d, J = 11.0 Hz, 1H), 
4.74 (d, J = 10.5 Hz, 1H), 4.60 (d, J = 12.0 Hz, 1H), 4.50-4.58 (m, 3H), 4.38 (d, J = 9.5 
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Hz, 1H), 4.27 (dd, J = 4.5, 2.0 Hz, 1H), 4.19 (d, J = 8.0 Hz, 1H), 3.83-3.92 (m, 3H), 3.66-
3.77 (m, 3H), 3.60 (t, J = 9.5 Hz, 1H), 3.54 (t, J  = 8.75 Hz, 1H), 3.49 (ddd, J = 9.5, 5.0, 
1.5 Hz, 1H), 2.77 (dq, J = 13.0, 7.5 Hz, 1H), 2.71 (dq, J = 12.5, 7.5 Hz, 1H), 1.49 (s, 3H), 
1.42 (s, 3H), 1.29-1.34 (m, 6H), 1.29 (s, 3H), 0.24 (s, 3H), 0.20 (s, 3H); 
13
C NMR (100 
MHz, CDCl3) δ 138.76, 138.20, 138.00, 128.33, 128.31, 128.23, 127.92, 127.72, 127.54, 
127.25, 108.94, 108.38, 96.25, 87.10, 86.20, 79.14, 78.09, 74.94, 74.48, 73.41, 70.77, 
70.54, 70.48, 69.12, 68.03, 61.52, 26.11, 25.96, 24.94, 24.67, 24.34, 15.08, -1.90, -2.02; 
IR (film, cm
-1
) 3063, 3030, 2978, 2930, 1454, 1382, 1256, 1211, 1070, 1001; HRMS 
(ES) m/z calcd for C43H58O11SSi [M+Na]+ 833.3367, found 833.3408. 
Glucose and Galactose 75 Disaccharide (Scheme 2.9, compound 77) 
 
 Following the general procedure 4.4, compound 76 (58 mg, 0.072 mmol), NIS (21 
mg, 0.093 mmol), TMSOTf (16 μL, 0.086 mmol), and 2,6-DTBMP (29 mg, 0.143 mmol) 
were stirred at -40 °C for 5 min, then warmed to 0 °C and stirred for 1 hour, then and 
excess of n-Bu4NF (0.43 mL, 0.43 mmol) was added as a 1M solution in THF and 
allowed to stir at room temperature overnight.  The product (42 mg, 0.061 mmol, 84%) 
was obtained as a colorless amorphous solid upon purification by flash chromatography 
on SiO2 (30 to 45% EtOAc/hex). 
1
H NMR (500 MHz, CDCl3) δ 7.25-7.42 (m, 13H), 
7.13-7.17 (m, 2H), 5.53 (d, J = 5.0 Hz, 1H), 4.99 (d, J = 11.0 Hz, 1H), 4.94 (d, J = 3.5 
Hz, 1H), 4.83 (d, J = 11.0 Hz, 1H), 4.82 (d, J = 11.0 Hz, 1H), 4.62-4.67 (m, 2H), 4.50 (d, 
J = 12.0 Hz, 1H), 4.49 (d, J = 10.5 Hz, 1H), 4.34 (dd, J = 5.0, 2.5 Hz, 1H), 4.25 (dd, J = 
8.0, 1.5 Hz, 1H), 4.00 (td, J = 6.5, 1.5 Hz, 1H), 3.92 (dd, J = 10.0, 6.5 Hz, 1H), 3.86 (dt, J 
148 
 
= 10.0, 2.0 Hz, 1H), 3.63-3.79 (m, 6H), 2.46 (d, J = 9.0 Hz, 1H), 1.54 (s, 3H), 1.46 (s, 
3H), 1.36 (s, 3H), 1.34 (s, 3H); 
13
C NMR (100 MHz, CDCl3) δ 138.84, 138.30, 137.96, 
128.35, 128.32, 127.93, 127.90, 127.86, 127.65, 127.62, 127.54, 109.48, 108.69, 99.15, 
96.23, 83.41, 77.14, 75.21, 74.95, 73.49, 73.25, 71.04, 70.83, 70.66, 70.50, 68.43, 67.06, 
65.71, 26.09, 25.94, 24.88, 24.52; IR (film, cm
-1
) 3458, 3064, 3031, 2987, 2932, 1383, 
1256, 1211, 1070; HRMS (ES) m/z calcd for C39H48O11 [M+Na]
+
 715.3094, found 
715.3124. 
Thioethyl Glucose Sugar Silane and Ketosteroid Silyl-Linked (Scheme 2.11, 
compound 80) 
 
 Following the general procedure 4.5, silane (28 mg, 0.050 mmol), steroid (14 mg, 
0.050 mmol), and B(C6F5)3 (0.5 mg, 0.001 mmol) were stirred at room temperature 
overnight. The product (39mg, 0.046 mmol, 93%) was obtained as a colorless amorphous 
solid after purification by flash chromatography on SiO2 (20% EtOAc/hex). 
1
H NMR 
(500 MHz, CDCl3) δ 7.24-7.40 (m, 13H), 7.08-7.12 (m, 2H), 5.32 (d, J = 4.5 Hz, 1H), 
4.97 (d, J = 11.0 Hz, 1H), 4.89 (d, J = 11.0 Hz, 1H), 4.73 (d, J = 11.0 Hz, 1H), 4.61 (d, J 
= 12.0 Hz, 1H), 4.56 (d, J = 12.5 Hz, 1H), 4.53 (d, J = 10.5 Hz, 1H), 4.40 (d, J = 9.5 Hz, 
1H), 3.66-3.78 (m, 4H), 3.61 (t, J = 9.0 Hz, 1H), 3.56 (t, J = 8.5 Hz, 1H), 3.50 (ddd, J = 
9.5, 5.0, 2.0 Hz, 1H), 2.77 (dq, J = 13.0, 7.5 Hz, 1H), 2.72 (dq, J = 12.5, 7.5 Hz, 1H), 
2.47 (dd, J = 19.5, 8.5 Hz, 1H), 2.29 (d, J = 7.5 Hz, 2H), 2.04-2.15 (m, 2H), 1.91-1.99 
(m, 1H), 1.82-1.88 (m, 1H), 1.72-1.81 (m, 2H), 1.42-1.70 (m, 6H), 1.32 (t, J = 7.5 Hz, 
3H), 1.22-1.35 (m, 3H), 0.92-1.05 (m, 1H), 0.99 (s, 3H), 0.89 (s, 3H), 0.22 (s, 3H), 0.19 
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(s, 3H); 
13
C NMR (100 MHz, CDCl3) δ 221.2, 141.6, 138.8, 138.2, 137.9, 128.4, 128.3, 
128.2, 128.0, 127.7, 127.6, 127.2, 127.1, 120.5, 87.0, 86.2, 79.1, 78.2, 75.1, 74.9, 74.5, 
73.4, 72.0, 69.1, 51.8, 50.2, 47.5, 42.4, 37.2, 36.6, 35.8, 31.7, 31.5, 31.4, 30.8, 24.7, 21.9, 
20.3, 19.4, 15.1, 13.5, -0.9, -1.2; IR (film, cm
-1
) 3064, 3031, 2933, 2863, 1739, 1454, 
1372, 1256, 1086, 1030; HRMS (ES) m/z calcd for C50H66O7SSi [M+Na]
+
 861.4191, 
found 861.4193. 
Glucose and Ketosteroid Glycoside (Scheme 2.11, compound 81) 
 
 Following the general procedure 4.4, compound 80 (38 mg, 0.045 mmol), NIS (14 
mg, 0.063 mmol), TMSOTf (20 μL, 0.108 mmol), and 2,6-DTBMP (37 mg, 0.18 mmol) 
were stirred at -40 °C for 10 min, then warmed to 0 °C and stirred for 1 hour, then excess 
n-Bu4NF (0.45 mL, 0.45 mmol) was added as a 1M solution in THF, warmed to rt and 
allowed to stir overnight. The product (31 mg, 0.043 mmol, 96%) was obtained as a 
foamy solid upon purification by flash chromatography on SiO2 (30% EtOAc/hex). 
1
H 
NMR (500 MHz, CDCl3) δ 7.38-7.42 (m, 2H), 7.26-7.37 (m, 11H), 7.15-7.18 (m, 2H), 
5.34 (d, J = 5.0 Hz, 1H), 5.05 (d, J = 3.5 Hz, 1H), 4.98 (d, J = 11.0 Hz, 1H), 4.86 (d, J = 
11.0 Hz, 1H) 4.84 (d, J = 10.5 Hz, 1H), 4.65 (d, J = 12.0 Hz, 1H), 4.51 (d, J = 12.0 Hz, 
1H), 4.50 (d, J = 10.5 Hz, 1H), 3.91 (ddd, J = 11.5, 3.5, 2.0 Hz, 1H), 3.67-3.81 (m, 4H), 
3.64 (t, J = 9.0 Hz, 1H), 3.54 (tt, J = 11.5, 5.0 Hz, 1H), 2.32- 2.52 (m, 3H), 2.04-2.18 (m, 
3H), 1.83-2.00 (m, 4H), 1.44-1.72 (m, 6H), 1.22-1.34 (m, 3H), 0.97-1.11 (m, 1H), 1.04 
(s, 3H), 0.90 (s, 3H).  
13
C NMR (100 MHz, CDCl3) δ 221.0, 140.7, 138.8, 138.2, 138.0, 
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128.4, 128.3, 127.93, 127.86, 127.83, 127.7, 127.64, 127.58, 121.3, 96.9, 83.7, 77.6, 77.5, 
75.3, 75.0, 73.5, 72.9, 70.6, 68.6, 51.8, 50.2, 47.5, 40.0, 36.9, 36.8, 35.8, 31.5, 31.4, 30.8, 
27.9, 21.9, 20.3, 19.4, 13.5; IR (film, cm
-1
) 3390, 3031, 2933, 2865, 1737, 1454, 1384, 
1274, 1135, 1068, 1029; HRMS (ES) m/z calcd for C46H56O7 [M+Na]
+  
743.3924, found 
743.3928. 
Thiophenyl Glucose Sugar Silane and Diterpene 82 Silyl-Linked (Scheme 2.12, 
compound 83) 
 
 Following the general procedure 4.5, silane (60 mg, 0.10 mmol), hydroxyl ketone 
82 (17 mg, 0.10 mmol) and B(C6F5)3 (1 mg, 0.002 mmol) were stirred for 80 min. at rt.  
The product (70 mg, 0.091 mmol, 91%) was obtained as a colorless oil upon purification 
by flash chromatography on SiO2 (8% EtOAc/hex). 
1
H NMR (500 MHz, CDCl3) δ 7.53-
7.56 (m, 2H), 7.21-7.36 (m, 16H), 7.08-7.13 (m, 2H), 4.95 (d, J = 11.5 Hz, 1H), 4.86 (d, 
J = 11.5 Hz, 1H), 4.73 (d, J = 11.0 Hz, 1H), 4.63 (d, J = 9.5 Hz, 1H), 4.59 (d, J = 12.0 
Hz, 1H), 4.537 (d, J = 10.5 Hz, 1H), 4.536 (d, J = 11.5 Hz, 1H), 3.82 (t, J = 9.0 Hz, 1H), 
3.78 (dd, J = 11.0, 1.5 Hz, 1H), 3.61 (t, J = 9.0 Hz, 1H), 3.57 (t,  J = 8.5 Hz, 1H), 3.52 
(ddd, J = 9.0, 5.0, 1.5 Hz, 1H), 2.55 (dt, J = 19.0, 3.0 Hz, 1H), 2.48 (dd, J = 19.0, 2.0 Hz, 
1H), 2.32-2.38 (m, 1H), 2.14 (t, J = 6.5 Hz, 1H), 2.02-2.06 (m, 1H), 1.80 (d, J = 10.5 Hz, 
1H), 1.43 (s, 3H), 1.31 (s, 3H), 0.83 (s, 3H), 0.28 (s, 3H), 0.12 (s, 3H); 
13
C NMR (100 
MHz, CDCl3) δ 210.8, 138.9, 138.3, 138.0, 134.7, 131.3, 128.8, 128.33, 128.31, 128.2, 
128.0, 127.7, 127.5, 127.1, 127.0, 126.9, 89.0, 87.1, 80.2, 79.1, 78.1, 75.1, 74.9, 73.8, 
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73.4, 69.2, 51.7, 43.5, 38.9, 38.4, 29.0, 27.5, 25.1, 22.7, 1.2, 0.7; HRMS (ES) m/z calcd 
for C45H54O7SSi [M+Na]
+
 789.3252, found 789.3245. 
Glucose and Diterpene 82 Glycoside (Scheme 2.12, compound 84) 
 
 Following the general procedure 4.4, compound 83 (58 mg, 0.076 mmol), NIS (24 
mg, 0.106 mmol), TMSOTf (33 μL, 0.181 mmol), and 2,6-DTBMP (62 mg, 0.302 mmol) 
were stirred for 5 min at -40 °C, then warmed to 0 °C and stirred for 1 hour, then an 
excess of n-Bu4NF (0.76 mL, 0.76 mmol) was added as a 1M solution in THF and 
allowed to stir overnight at rt. The product (44 mg, 0.073, 96%) was obtained as a 
viscous oil upon purification by flash chromatography on SiO2 (20 to 30% EtOAc/hex). 
1
H NMR (500 MHz, CDCl3) δ 7.25-7.39 (m, 13H), 7.16-7.19 (m, 2H), 5.27 (s, 1H), 4.91 
(d, J = 11.0 Hz, 1H), 4.84 (d, J = 11.0 Hz, 1H), 4.82 (d, J = 10.5 Hz, 1H), 4.60 (d, J = 
12.5 Hz, 1H), 4.51 (d, J = 10.5 Hz, 1H), 4.49 (d, J = 12.0 Hz, 1H), 3.98-4.02 (m, 2H), 
3.63-3.72 (m, 4H), 3.52-3.57 (m, 1H), 2.69 (dd, J = 19.0, 1.5 Hz, 1H), 2.57 (dt, J = 19.0, 
3.0 Hz, 1H), 2.40-2.47 (m, 1H), 2.28 (t, J = 6.0 Hz, 1H), 2.04-2.08 (m, 1H), 1.78-1.84 
(m, 2H), 1.42 (s, 3H), 1.37 (s, 3H), 0.87 (s, 3H); 
13
C NMR (100MHz, CDCl
3) δ 209.2, 
138.7, 138.1, 138.0, 128.40, 128.39, 128.3, 127.9, 127.85, 127.84, 127.7, 127.64, 127.57, 
92.8, 83.3, 81.8, 77.7, 75.3, 75.0, 73.5, 72.5, 71.4, 68.8, 49.9, 43.9, 39.2, 38.7, 28.8, 27.5, 
22.7, 22.1; IR (film, cm
-1
) 3443, 3064, 3031, 2925, 1722, 1453, 1273, 1070, 1027; HRMS 
(ES) m/z calcd for C37H44O7 [M+Na]
+
 623.2985, found 623.2974. 
Thiophenyl Mannose Sugar Silane and Terpene 82 Silyl-Linked (Scheme 2.12, 
compound 85) 
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 Following the general procedure 4.5, silane (60 mg, 0.10 mmol), hydroxyketone 
82 (17 mg, 0.10 mmol), and B(C6F5)3 (1.0 mg, 0.002 mmol) were stirred at rt for 85 min.  
The product (62 mg, 0.081 mmol, 81%) was obtained as a colorless oil upon purification 
by flash chromatography on SiO2 (8% EtOAc/hex). 
1
H NMR (500 MHz, CDCl3) δ 7.50-
7.53 (m, 2H), 7.38-7.41 (m, 2H), 7.20-7.37 (m, 16H), 5.54 (s, 1H), 4.88 (d, J = 10.5 Hz, 
1H), 4.76 (d, J = 11.5 Hz, 1H), 4.663 (d, J = 11.5 Hz, 1H), 4.661 (d, J = 9.5 Hz, 1H), 4.56 
(d, J = 11.0 Hz, 1H), 4.50 (d, J = 12.0 Hz, 1H), 4.46 (s, 1H), 4.29 (dd, J = 10.0, 5.0 Hz, 
1H), 3.99 (t, J = 9.5 Hz, 1H), 3.85 (dd, J  = 11.0, 5.0 Hz, 1H), 3.79 (dd, J = 9.5, 3.0 Hz, 
1H), 3.76 (d, J = 11.0 Hz, 1H), 2.46-2.56 (m, 2H), 2.20-2.26 (m, 1H), 2.04 (t, J = 6.0 Hz, 
1H), 1.97-2.20 (m, 1H), 1.63 (d, J = 11.0 Hz, 1H), 1.40 (s, 3H), 1.27 (s, 3H), 0.81 (s, 3H), 
0.22 (s, 3H), 0.13 (s, 3H); 
13
C NMR (100 MHz, CDCl3) δ 210.9, 138.54, 138.47, 138.3, 
134.8, 131.6, 128.9, 128.3, 128.2, 127.9, 127.8, 127.63, 127.56, 127.3, 127.2, 89.2, 80.3, 
80.1, 75.0, 74.8, 73.1, 73.0, 72.0, 70.8, 69.3, 51.7, 43.4, 38.9, 28.9, 27.4, 25.2, 22.7, 0.29, 
0.27; HRMS (ES) m/z calcd for C45H54O7SSi [M+Na]+ 789.3257, found 789.3282. 
Mannose and Terpene 82 Glycoside (Scheme 2.12, compound 86) 
 
 Following the general procedure 4.4, compound 85 (53 mg, 0.069 mmol), NIS (22 
mg, 0.097 mmol), TMSOTf (30 μL, 0.166 mmol), and 2,6-DTBMP (57 mg, 0.276 mmol) 
were stirred for 10 min at -40 °C, then warmed to 0 °C and stirred for 65 min, then an 
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excess of n-Bu4NF (0.69 mL, 0.69 mmol) was added as a 1M solution in THF and 
allowed to stir overnight at rt. The product (29 mg, 0.048, 70%) was obtained as a 
colorless oil upon purification by flash chromatography on SiO2 (20 to 30% EtOAc/hex). 
1
H NMR (500 MHz, CDCl3) δ 7.25-7.39 (m, 13H), 7.20-7.23 (m, 2H), 4.96 (s, 1H), 4.89 
(d, J = 11.0 Hz, 1H), 4.76 (d, J = 11.5 Hz, 1H), 4.63 (d, J = 11.5 Hz, 1H), 4.61 (d, J, = 
12.5 Hz, 1H), 4.53 (d, J = 11.5 Hz, 2H), 3.93 (d, J = 2.5 Hz, 1H), 3.81 (t, J = 9.5 Hz, 1H), 
3.73 (dd, J = 11.0, 2.0 Hz, 1H), 3.68 (dd, J = 10.5, 5.0 Hz, 1H), 3.59 (dd, J = 9.0, 3.0 Hz, 
1H), 3.46 (ddd, J = 9.5, 5.0, 2.0 Hz, 1H), 2.57-2.67 (m, 2H), 2.40-2.47 (m, 1H), 2.36 (br 
s, 1H), 2.31 (t, J = 6.0 Hz, 1H), 2.10 (sept, J = 3.0 Hz, 1H), 1.85 (d, J = 11.0 Hz, 1H), 
1.48 (s, 3H), 1.37 (s, 3H), 0.88 (s, 3H); 
13
C NMR (100 MHz, CDCl3) δ 210.63, 138.39, 
138.36, 137.84, 94.09, 82.01, 81.87, 75.04, 74.99, 74.09, 73.37, 71.41, 69.42, 69.23, 
50.52, 43.60, 39.29, 38.49, 28.61, 27.32, 22.82, 20.58; IR (film, cm
-1
) 3440, 3064, 3032, 
2925, 1720, 1453, 1274, 1109, 1072, 1028; HRMS (ES) m/z calcd for C37H44O7 [M+Na]
+
 
623.2985, found 623.2979. 
One Pot Procedure to make Glucose (-)-menthol glycoside (Scheme 2.13, compound 
70) 
 
 Following the general procedure 4.5, silane (90 mg, 0.15 mmol), (-)-menthol (23 
mg, 0.15 mmol), and B(C6F5)3 (3 mg, 0.006 mmol) were stirred for 90 minutes at rt. The 
reaction was then cooled to -40 °C and diluted to 0.02M in dry CH2Cl2, NIS (44 mg, 0.20 
mmol), and 2,6-DTBMP (62 mg, 0.30 mmol were added followed by TMSOTf (33 μL, 
0.18 mmol), were stirred for 10 min at -40 °C, then warmed to 0 °C and stirred for 1 hr, 
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then an excess of n-Bu4NF (0.75 mL, 0.75 mmol) was added as a 1M solution in THF 
and allowed to stir overnight at rt. The product (71 mg, 0.12 mmol, 70%) was obtained as 
a colorless oil upon purification by flash chromatography on SiO2 (10 to 15% 
EtOAc/hex). All spectral data was identical to that reported for compound 70 when 
synthesized by the two-pot protocol. 
Sugar Silane 87 (Scheme 2.14, compound 87) 
 
 Following the general procedure 4.1, 2-hydroxy sugar (0.58 g, 1.16 mmol), NEt3 
(323 μL, 2.32 mmol), and Me2Si(H)Cl (193 μL, 1.74 mmol) were stirred for 4 hours at 0 
°C.  The product (0.62 g, 1.11 mmol, 96%) was obtained as a red oil after aqueous work 
up.  
1
H NMR (500 MHz, CDCl3) δ 7.54-7.57 (m, 2H), 7.22-7.29 (m, 3H), 4.70 (sept, J = 
2.0 Hz, 1H), 4.56 (d, J = 9.5 Hz, 1H), 3.86 (dd, J = 11.5, 2.0 Hz, 1H), 3.82 (dd, J = 11.5, 
4.0 Hz, 1H) 3.72 (t, J = 9.5 Hz, 1H), 3.67 (t, J = 9.5 Hz, 1H), 3.59 (t, J = 9.0 Hz, 1H), 
3.45 (ddd, J = 9.0, 3.5, 1.5 Hz, 1H), 3.28 (s, 3H), 3.27 (s, 3H), 1.31 (s, 3H), 1.30 (s, 3H), 
0.91 (s, 9H), 0.27 (d, J = 2.5 Hz, 3H), 0.24 (d, J = 2.5 Hz, 3H), 0.93 (s, 3H), 0.57 (s, 3H); 
13
C NMR (100 MHz, CDCl3) δ 133.94, 131.86, 128.71, 127.18, 99.69, 99.43, 89.09, 
78.63, 74.51, 72.45, 64.92, 61.36, 48.03, 47.83, 25.90, 18.36, 17.65, 17.63, -0.45, -0.76, -
5.06, -5.44; IR (film, cm
-1
) 2992, 2954, 2930, 2857, 2131, 1472, 1375, 1252, 1139, 1113, 
1075, 1042. 
Sugar Silane 87 and (-)-Menthol Silyl-Linked (Scheme 2.14, compound 88) 
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 Following the general procedure 4.6, silane 87 (61 mg, 0.11 mmol), (-)-menthol 
(16 mg, 0.10 mmol), CuCl (0.5 mg, 0.005 mmol), IMes·HCl (1.7 mg, 0.005 mmol), and 
NaO-t-Bu (1 mg, 0.010 mmol) were stirred at rt for 1 hr.  The product (72 mg, 0.010 
mmol, 100%) was obtained as a colorless oil upon purification by flash chromatography 
on SiO2 (5 to 8% EtOAc/hex).  
1
H NMR (500 MHz, CDCl3) δ 7.50-7.54 (m, 2H), 7.20-
7.29 (m, 3H), 4.63 (d, J = 8.5 Hz, 1H), 3.87 (dd, J = 11.5, 1.5 Hz, 1H), 3.81 (dd, J = 11.5, 
4.5 Hz, 1H), 3.66-3.75 (m, 3H), 3.62 (td, J = 10.5, 4.5 Hz, 1H), 3.46 (ddd, J = 9.0, 4.5, 
2.0 Hz, 1H), 3.29 (s, 3H), 3.27 (s, 3H), 2.21 (septd, J = 7.5, 2.0 Hz, 1H), 2.03-2.09 (m, 
1H), 1.54-1.64 (m, 2H), 1.24-1.36 (m, 1H), 1.31 (s, 3H), 1.30 (s, 3H), 1.15 (ddt, J = 12.0, 
9.5, 2.5 Hz, 1H), 0.76-1.02 (m, 3H), 0.89 (s, 9H), 0.87 (d, J = 7.0 Hz, 3H), 0.83 (d, J = 
6.5 Hz, 3H), 0.73 (d, J = 7.0 Hz, 3H), 0.21 (s, 3H), 0.20 (s, 3H), 0.08 (s, 3H), 0.03 (s, 
3H); 
13
C NMR (100 MHz, CDCl3) δ 134.80, 130.93, 128.68, 126.78, 99.65, 99.31, 89.23, 
78.50, 74.48, 72.48, 70.67, 65.07, 61.49, 49.88, 48.02, 47.95, 45.16, 34.53, 31.64, 25.87, 
25.08, 22.86, 22.15, 21.27, 18.32, 17.64, 17.49, 15.98, -0.32, -1.81, -5.06, -5.48; IR (film, 
cm
-1 
2955, 2929, 2870, 1462, 1371, 1255, 1139, 1072, 1042. 
Sugar Silane 87 and (-)-Menthol Glycoside (Scheme 2.14, compound 89) 
 
 Following the general procedure 4.4, compound 88 (67 mg, 0.094 mmol), NIS (27 
mg, 0.122 mmol), TMSOTf (20 μL, 0.113 mmol), and 2,6-DTBMP (39 mg, 0.188 mmol) 
156 
 
were stirred for 10 min at -40 °C, then warmed to 0 °C and stirred for 65 min, then an 
excess of n-Bu4NF (0.30 mL, 0.30 mmol) was added as a 1M solution in THF and 
allowed to stir overnight gradually warming to rt. The product (33 mg, 0.06, 60%) was 
obtained as a colorless oil upon purification by flash chromatography on SiO2 (10 to 15% 
EtOAc/hex). 
1
H NMR (500 MHz, CDCl3) δ 4.96 (d, J = 4.0 Hz, 1H), 3.76-3.89 (m, 4H), 
3.61-3.68 (m, 3H), 3.40 (dt, J = 10.5, 4.0 Hz, 1H), 3.32 (s, 3H), 3.27 (s, 3H), 2.08-2.21 
(m, 2H), 1.91 (d, J = 10.5 Hz, 1H), 1.56-1.67 (m, 2H), 1.34-1.42 (m, 1H), 1.36 (s, 3H), 
1.24-1.32 (m, 1H), 1.31 (s, 3H), 0.76-1.05 (m, 6H), 0.91 (d, J = 7.0 Hz, 3H), 0.90 (d, J = 
6.5 Hz, 3H), 0.89 (s, 9H), 0.79 (d, J = 7.0, 3H), 0.06 (s, 3H), 0.05 (s, 3H); 
13
C NMR (100 
MHz, CDCl3) δ 99.65, 99.60, 99.40, 80.59, 70.74, 70.68, 70.41, 65.68, 61.50, 48.76, 
47.99, 47.94, 42.84, 34.21, 31.59, 25.93, 25.66, 22.96, 22.28, 21.14, 17.82, 17.70, 15.84, 
-5.09, -5.40; IR (film, cm
-1
) 3490, 2954, 2930, 2871, 1638, 1458, 1376, 1252, 1138, 
1035; HRMS (ES) m/z calcd for C28H40O8Si [M+Na]
+  
569.3480, found 569.3481. 
Thiophenyl Glucose Sugar Silane and Diol 90 6-Hydroxy Silyl-Linked (Scheme 2.17, 
compound 91) 
 
 Diol 90 (28 mg, 0.10 mmol) was dissolved in a 2:1 mixture of dry CH2Cl2 and 
toluene (0.066M) to this was added B(C6F5)3 (2.0 mg, 0.004 mmol) followed by dropwise 
addition of silane (78 mg, 0.13 mmol) over 20 min as a solution in 1.5 mL toluene, this 
was stirred at rt for 10 min.  The product (76 mg, 0.087 mmol, 87%, 14:1 regioisomeric 
ratio) was obtained as a white foam upon purification by flash chromatography on SiO2 
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(30 to 45% EtOAc/hex). 
1
H NMR (500 MHz, CDCl3) δ 7.57-7.61 (m, 2H), 7.26-7.40 (m, 
16 H), 7.12-7.16 (m, 2H), 5.04 (t, J = 9.5 Hz, 1H), 4.96 (d, J = 11.5 Hz, 1H), 4.86-4.94 
(m, 2H), 4.75 (d, J = 10.5 Hz, 1H), 4.54-4.68 (m, 4H), 4.35 (d, J = 7.5 Hz, 1H), 4.08 (dd, 
J = 11.5, 4.5 Hz, 1H), 4.00 (dd, J = 11.5, 4.0 Hz, 1H), 3.67-3.77 (m, 3H), 3.52-3.62 (m, 
2H), 3.46 (s, 3H), 3.33 (dt, J = 9.5, 4.5 Hz, 1H), 2.81 (br s, 1H), 2.09 (s, 3H), 2.07 (s, 
3H), 0.25 (s, 3H), 0.22 (s, 3H);  
Glucose and Glucose Diol 90 6-Hydroxy Glycoside (Scheme 2.17, compound 92) 
 
 Following the general procedure 4.4, compound 91 (49 mg, 0.056 mmol), NIS (18 
mg, 0.078 mmol), TMSOTf (24 μL, 0.134 mmol), and 2,6-DTBMP (46 mg, 0.224 mmol) 
were stirred for 20 min at -40 °C, then warmed to 0 °C and stirred for 40 min, then an 
excess of n-Bu4NF (0.56 mL, 0.56 mmol) was added as a 1M solution in THF and 
allowed to stir overnight at rt. The product (30 mg, 0.042, 75%) was obtained as a white 
foam upon purification by flash chromatography on SiO2 (50 to 70% EtOAc/hex). 
1
H 
NMR (500 MHz, CDCl3) δ 7.26-7.40 (m, 13H), 7.12-7.15 (m, 2H), 5.06 (t, J = 9.5 Hz, 
1H), 4.90-4.96 (m, 3H), 4.86 (d, J = 11.0 Hz, 1H), 4.82 (d, J = 11.0 Hz, 1H), 4.61 (d, J = 
12.0 Hz, 1H), 4.54 (d, J = 12.0 Hz, 1H), 4.49 (d, J = 11.0 Hz, 1H), 4.41 (d, J = 8.0 Hz, 
1H), 4.10 (dd, J = 10.5, 4.0 Hz, 1H), 3.86 (ddd, J = 10.5, 5.0, 2.0 Hz, 1H), 3.71-3.81 (m, 
4H), 3.69 (dd, J = 10.5, 2.0 Hz, 1H), 3.65 (dd, J = 10.5, 4.5 Hz, 1H), 3.50-3.59 (m, 3H), 
2.55 (br s, 1H), 2.09 (s, 3H), 2.07 (s, 3H); 
13
C NMR (100 MHz, CDCl3) δ 171.29, 169.67, 
138.57, 137.93, 137.55, 128.43, 128.39, 127.93, 127.91, 127.86, 127.81, 127.79, 127.69, 
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101.69, 98.83, 83.27, 75.69, 75.39, 75.00, 74.14, 73.44, 72.85, 71.32, 71.01, 69.78, 68.45, 
67.60, 57.03, 20.87, 20.76; IR (film, cm
-1
) 3437, 3064, 3031, 2927, 1753, 1454, 1364, 
1243, 1046; HRMS (ES) m/z calcd for C38H46O13 [M+Na]
+  
733.2831, found 733.2830. 
Thiophenyl Glucose Sugar Silane and Diol 93 6-Hydroxy Silyl-Linked (Scheme 2.18, 
compound 94) 
 
 Diol 93 (28 mg, 0.10 mmol) was dissolved in a 2:1 mixture of dry CH2Cl2 and 
toluene (0.066M) to this was added B(C6F5)3 (2.0 mg, 0.004 mmol) followed by dropwise 
addition of silane (78 mg, 0.13 mmol) over 20 min as a solution in 1.5 mL toluene, this 
was stirred at rt for 10 min.  The product (57 mg, 0.065 mmol, 65%) was obtained as a 
white foam upon purification by flash chromatography on SiO2 (30 to 45% EtOAc/hex). 
1
H NMR (500 MHz, CDCl3) δ 7.56-7.60 (m, 2H), 7.23-7.39 (m, 16H), 7.10-7.14 (m, 2H), 
5.19-5.21 (m, 1H), 5.17 (dd, J =10.0, 3.5 Hz, 1H), 4.93 (s, 2H), 4.73 (d, J = 10.5 Hz, 1H) 
4.52-4.66 (m, 5H), 4.12 (dd, J = 11.5, 4.0 Hz, 1H), 3.95-4.01 (m, 2H), 3.76-3.83 (m, 2H), 
3.72 (dd, J = 11.0, 5.0 Hz, 1H), 3.68 (t, J = 9.0 Hz, 1H), 3.51-3.65 (m, 3H), 3.33 (s, 3H), 
2.59 (br s, 1H), 2.07 (s, 6H), 0.26 (s, 3H), 0.21 (s, 3H); 
Glucose and Diol 93 6-Hydroxy Glycoside (Scheme 2.18, compound 95) 
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 Following general procedure 4.4, 
1
H NMR (500 MHz, CDCl3) δ 7.26-7.41 (m, 
13H), 7.13-7.17 (m, 2H), 5.23 (dd, J = 3.0, 1.5 Hz, 1H), 5.19 (dd, J = 10.0, 3.5 Hz, 1H), 
5.00 (d, J = 3.0 Hz, 1H), 4.95 (d, J = 11.0 Hz, 1H), 4.84 (d, J = 11.0 Hz, 1H), 4.83 (d, J = 
10.5 Hz, 1H), 4.67 (d, J = 1.5 Hz, 1H), 4.63 (d, J = 12.0 Hz, 1H), 4.54 (d, J = 12.5 Hz, 
1H), 4.50 (d, J = 10.5 Hz, 1H), 4.12-4.17 (m, 1H), 4.03 (t, J = 10.0 Hz, 1H), 3.59-3.92 
(m, 8H), 3.59 (s, 3H), 2.59 (br s, 1H), 2.11 (s, 3H), 2.08 (s, 3H). 
Thiophenyl Glucose Sugar Silane and Diol 90 (6-OSiEt3) 4-Hydroxy Silyl-Linked 
(Scheme 2.19, compound 96) 
 
 Diol 90 (28 mg, 0.10 mmol) was dissolved in a 2:1 mixture of dry toluene and 
CH2Cl2 (0.066M) to this was added B(C6F5)3 (2.0 mg, 0.004 mmol) and Et3SiH (16 μL, 
0.10 mmol) and allowed to stir for 3 hr 45 min followed by addition of silane (75 mg, 
0.125 mmol) as a solution in 0.5 mL toluene, this was stirred at rt overnight.  The product 
(42 mg, 0.042 mmol, 42%) was obtained as an off-white foam upon purification by flash 
chromatography on SiO2 (20 to 30% EtOAc/hex). 
1
H NMR (500 MHz, CDCl3) δ 7.55-
7.60 (m, 2H), 7.21-7.39 (m, 16H), 7.14-7.20 (m, 2H), 5.11 (t, J = 9.5 Hz, 1H), 4.74-4.87 
(m, 4H), 4.52-4.63 (m, 4H), 4.29 (d, J = 8.0 Hz, 1H), 3.98 (t, J = 9.0 Hz, 1H), 3.93 (d, J = 
11.5 Hz, 1H), 3.76-3.84 (m, 2H), 3.62-3.75 (m, 3H), 3.47-3.54 (m, 2H) 3.44 (s, 3H), 3.20 
(dd, J = 9.5, 4.0 Hz, 1H), 2.07 (s, 3H), 2.05 (s, 3H), 0.95 (t, J = 7.5 Hz, 9H), 0.59 (q, J = 
8.0 Hz, 6H), 0.23 (s, 3H), 0.09 (s, 3H). 
Thiophenyl Glucose Sugar Silane and Diol 90 (6-OSiPh3) 4-Hydroxy Silyl-Linked 
(Scheme 2.20, compound 97) 
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 Diol 90 (28 mg, 0.10 mmol) and Ph3SiH (27 mg, 0.105 mmol) were dissolved in a 
1:2 mixture of dry CH2Cl2 and toluene (0.066M) to this was added B(C6F5)3 (4.0 mg, 
0.008 mmol) and the reaction stirred at 75 °C for 90 min at which point the mixture was 
cooled to rt followed by dropwise addition of silane (78 mg, 0.13 mmol) over 10 min as a 
solution in 1 mL toluene, this was stirred at rt for 3.5 hr.  The product (80 mg, 0.07 
mmol, 70%) was obtained as a white foam upon purification by flash chromatography on 
SiO2 (20 to 30% EtOAc/hex). 
1
H NMR (500 MHz, CDCl3) δ 7.61-7.64 (m, 6H), 7.51-
7.54 (m, 2H), 7.37-7.42 (m, 2H), 7.25-7.36 (m, 18H), 7.15-7.22 (m, 6H), 5.09 (t, J = 9.5 
Hz, 1H), 4.84 (dd, J = 9.5, 7.5 Hz, 1H), 4.68-4.76 (m, 3H), 4.60 (d, J = 12.0 Hz, 1H), 
4.55 (d, J = 11.0 Hz, 1H), 4.53 (d, J = 12.5 Hz, 1H), 4.32 (d, J = 10.0 Hz, 1H), 4.27 (d, J 
= 8.0 Hz, 1H), 4.13 (dd, J = 11.0, 1.5 Hz, 1H), 4.05 (t, J = 9.5 Hz, 1H), 3.99 (dd, J = 
11.5, 5.0 Hz, 1H), 3.77 (dd, J = 11.0, 2.0 Hz, 1H), 3.70 (dd, J = 11.0, 5.0 Hz, 1H), 3.54 
(m, 2H), 3.39-3.44 (m, 1H), 3.40 (s, 3H), 3.24-3.32 (m, 2H), 2.06 (s, 3H), 2.04 (s, 3H), 
0.15 (s, 3H), 0.02 (s, 3H). 
Thiophenyl Glucose Sugar Silane and Diol 93 (6-OSiEt3) 4-Hydroxy Silyl-Linked 
(Scheme 2.21, compound 98) 
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 Diol 93 (38 mg, 0.14 mmol) and Ph3SiH (37 mg, 0.147 mmol) were dissolved in a 
1:2 mixture of dry CH2Cl2 and toluene (0.066M) to this was added B(C6F5)3 (5.5 mg, 
0.011 mmol) and the reaction stirred at 75 °C for 70 min at which point the mixture was 
cooled to rt followed by dropwise addition of silane (112 mg, 0.19 mmol) over 10 min as 
a solution in 1.4 mL toluene, this was stirred at rt overnight.  The product (114 mg, 0.10 
mmol, 71%) was obtained as a white foam upon purification by flash chromatography on 
SiO2 (15 to 20% EtOAc/hex). 
1
H NMR (500 MHz, CDCl3) δ 7.58-7.67 (m, 2H), 7.24-
7.42 (m, 21H), 7.18-7.24 (m, 4H), 7.13-7.16 (m, 2H), 5.26 (dd, J = 3.5, 1.5 Hz, 1H), 5.21 
(dd, J =10.0, 4.0 Hz, 1H), 4.77 (d, J = 11.0 Hz, 1H), 4.64 (m, 3H), 4.60 (d, J = 12.0 Hz, 
1H), 4.52-4.57 (m, 2H), 4.39 (t, J = 9.5 Hz, 1H), 4.29 (d, J = 10.0 Hz, 1H), 4.16 (dd, J = 
11.0, 1.5 Hz, 1H), 3.99 (dd, J = 11.0, 6.0 Hz, 1H), 3.77 (dd, J = 10.5, 1.5 Hz, 1H), 3.68-
3.74 (m, 2H), 3.58 (td, J = 9.0, 3.5 Hz, 1H), 3.41 (ddd, J = 10.0, 4.5, 2.0 Hz, 1H), 3.28 (s, 
3H), 3.24 (t, J = 8.5 Hz, 1H), 2.03 (s, 3H), 2.02 (s, 3H), 0.10 (s, 3H), 0.01 (s, 3H). 
Thiophenyl Glucose Sugar Silane and Diol 90 (6-OBn) 4-Hydroxy Silyl-Linked 
(Scheme 2.23, compound 101) 
 
 Following the general procedure 4.4, compound 100 (53 mg, 0.055 mmol), NIS 
(16 mg, 0.071 mmol), TMSOTf (12 μL, 0.066 mmol), and 2,6-DTBMP (23 mg, 0.11 
mmol) were stirred for 5 min at -40 °C, then warmed to 0 °C and stirred for 60 min, then 
an excess of n-Bu4NF (0.28 mL, 0.28 mmol) was added as a 1M solution in THF and 
allowed to stir overnight gradually warming to rt. The product (30 mg, 0.042, 77%) was 
obtained as a foam upon purification by flash chromatography on SiO2 (50 to 75% 
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EtOAc/hex). 
1
H NMR (500 MHz, CDCl3) δ 7.26-7.40 (m, 13H), 7.14-7.20 (m, 2H), 5.07 
(t, J = 9.0 Hz, 1H), 4.88-4.94 (m, 2H), 4.85 (d, J = 11.0 Hz, 1H), 4.82 (d, J = 11.0 Hz, 
1H), 4.60 (d, J = 12.0 Hz, 1H), 4.54 (d, J = 12.0 Hz, 1H), 4.53 (d, J = 11.0 Hz, 1H), 4.10 
(d, J = 8.0 Hz, 1h), 4.36-4.40 (m, 1H), 4.17 (dd, J = 11.5, 3.5 Hz, 1H), 3.94 (dd, J = 11.5, 
5.0 Hz, 1H), 3.65-3.80 (m, 5H), 3.46-3.62 (m, 5H), 3.49 (s, 3H), 3.30 (d, J = 4.5 Hz, 1H), 
2.07 (s, 3H), 2.06 (s, 3H). 
Thiophenyl Glucose Sugar Silane and Diol 90 (6-OSiPh3) Glycosylation to Form 108 
and 109 (Scheme 2.29, compounds 108 and 109) 
 and  
 Compound 97 (93 mg, 0.082 mmol), 2,6-DTBMP (34 mg, 0.164 mmol) were 
dissolved as a 0.02M solution in dry CH2Cl2 with and 3Å MS and cooled to -40 °C, 
Me2S2∙Tf2O
47
 (123 μL, 0.123 mmol) was added as a solution in CH2Cl2 and after 1 min, 
the reaction was warmed to 0 °C and stirred for 10 min when the reaction was quenched 
by an excess of NEt3 (250 μL, 1.8 mmol). The products glucal 108 (32 mg, 0.031 mmol, 
38%) and 1,6-anhydro 109 (31 mg, 0.026 mmol, 32%) were obtained upon purification 
by flash chromatography on SiO2. Compound 108 
1
H NMR (500 MHz, CDCl3) δ 7.62-
7.70 (m, 6H), 7.16-7.47 (m, 24H), 6.27 (s, 3H), 5.10 (t, J = 9.5 Hz, 1h), 4.88 (dd, J = 9.5, 
8.0 Hz, 1H), 4.67 (d, J = 11.0 Hz, 1H), 4.62 (d, J = 12.0 Hz, 1H), 4.59 (d, J = 12.0 Hz, 
1H), 4.51-4.59 (m, 3H), 4.39 (d, J = 8.0 Hz, 1H), 3.94-4.11 (m, 5H), 3.86 (dd, J = 6.5, 4.5 
Hz, 1H), 3.76 (dd, J = 10.5, 6.0 Hz, 1H), 3.66 (dd, J = 11.0, 4.0 Hz 1H), 3.37-3.45 (m, 
1H), 3.42 (s, 3H), 2.06 (s, 3H), 2.03 (s, 3H), 0.11 (s, 3H), 0.05 (s, 3H); 
13
C NMR (100 
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MHz, CDCl3) δ 107.13, 169.91, 138.28, 137.95, 135.45, 133.81, 132.61, 132.01, 130.03, 
128.36, 128.33, 128.29, 127.83, 127.76, 127.73, 127.62, 127.60, 127.53, 101.23, 76.75, 
76.36, 75.91, 75.30, 74.20, 73.40, 72.79, 72.28, 71.98, 69.15, 67.98, 62.45, 56.46, 20.91, 
-2.70, -2.78. Compound 109 
1
H NMR (500 MHz, CDCl3) δ 7.60-7.68 (m, 2H), 7.22-7.47 
(m, 24H), 5.25 (s, 1H), 5.09 (t, J = 9.5 Hz, 1H), 4.86 (dd, J = 9.5, 8.0 Hz, 1H), 4.50-4.58 
(m, 4H), 4.38 (d, J = 8.0 Hz, 1H), 4.05 (t, J = 9.5 Hz, 2H), 3.97 (dd, J = 11.0, 4.0 Hz, 
1H), 3.81 (d, J = 7.0 Hz, 1H), 3.65 (dd, J = 7.5, 5.5 Hz, 2H), 3.43-3.47 (m, 1H), 3.32-
3.42 (m, 2H), 2.40 (s, 3H), 2.08 (s, 3H), 2.05 (s, 3H), 0.11 (s, 3H), 0.01 (s, 3H); 
13
C NMR 
(100 MHz, CDCl3) δ 170.44, 169.94, 135.49, 133.84, 130.03, 128.42, 128.36, 127.82, 
127.75, 127.67, 127.62, 102.61, 101.21, 79.41, 78.20, 76.32, 75.53, 74.58, 72.52, 72.04, 
71.14, 68.90, 65.91, 62.43, 56.44, 21.02, 20.79, -2.14, -2.34. 
Thiophenyl Glucose Sugar Silane and Diol 93 4-Hydroxy Glycoside (Scheme 2.30, 
compound 110) 
 
 Following the general procedure 4.4, compound 97 (111 mg, 0.098 mmol), NIS 
(29 mg, 0.127 mmol), TMSOTf (21 μL, 0.118 mmol), and 2,6-DTBMP (40 mg, 0.196 
mmol) were stirred for 5 min at -40 °C, then warmed to 0 °C and stirred for 60 min, then 
an excess of n-Bu4NF (0.49 mL, 0.49 mmol) was added as a 1M solution in THF and 
allowed to stir overnight at rt. The product (8 mg, 0.011, 11%) was obtained as a 
yellowish foam upon purification by flash chromatography on SiO2 (50 to 80% 
EtOAc/hex). 
1
H NMR (500 MHz, CDCl3) δ 5.42 (dd, J = 9.5, 3.5 Hz, 1H), 5.20 (dd, J = 
3.5, 2.0 Hz, 1H), 5.19 (d, J = 3.5 Hz, 1H, glu α-anomer), 4.69 (s, 1H, man α-anomer). 
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Thiophenyl Glucose Sugar Silane and Compound 114 Silyl-Linked (Scheme 2.33, 
compound 116) 
 
 Following the general procedure 4.5, silane (45 mg, 0.08 mmol), alcohol 114 (39 
mg, 0.07 mmol) and B(C6F5)3 (1.5 mg, 0.003 mmol) were stirred for overnight at rt.  The 
product (42 mg, 0.036 mmol, 51%) was obtained as a viscous oil upon purification by 
flash chromatography on SiO2 (10 to 15% EtOAc/hex). 
1
H NMR (500 MHz, CDCl3) δ 
7.62-7.66 (m, 6H), 7.56-7.60 (m, 2H), 7.22-7.44 (m, 22H), 7.14 (m, 3H), 7.09-7.12 (m, 
2H), 4.92 (d, J = 12.0 Hz, 1H), 4.89 (d, J = 11.5 H, 1H), 4.85 (d, J = 3.5 Hz, 1H), 4.71 (d, 
J  10.5 Hz, 1H), 4.52-4.64 (m, 4H), 3.92-4.04 (m, 4H), 3.68-3.88 (m, 5H), 3.64 (t, J = 9.5 
Hz, 1H), 3.51-3.58 (m, 2H), 3.28 (s, 3H), 3.22 (s, 3H), 3.08 (s, 3H), 1.23 (s, 3H), 1.22 (s, 
3H), 0.22 (s, 3H), 0.20 (s, 3H). 
Glucose and Compound 114 Glycoside (Scheme 2.33, compound 117) 
 
Following the general procedure 4.4, compound 116 (42 mg, 0.036 mmol), NIS 
(11 mg, 0.047 mmol), TMSOTf (8 μL, 0.043 mmol), and 2,6-DTBMP (15 mg, 0.072 
mmol) were stirred for 5 min at -40 °C, then warmed to 0 °C and stirred for 60 min, then 
an excess of n-Bu4NF (0.29 mL, 0.29 mmol) was added as a 1M solution in THF and 
allowed to stir overnight at rt. The product (21 mg, 0.028, 79%) was obtained as a white 
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foam upon purification by flash chromatography on SiO2 (60 to 75% EtOAc/hex). 
1
H 
NMR (500 MHz, CDCl3) δ 7.24-7.39 (m, 13H), 7.15-7.19 (m, 2H), 4.98 (d, J = 11.0 Hz, 
1H), 4.98 (d, J = 4.0 Hz, 1H), 4.85(2H) (d, J = 11.0 Hz, 1H; d, J = 4.0 Hz, 1H), 4.80 (d, J 
= 11.0 Hz, 1H), 4.65 (d, J = 12.0 Hz, 1H), 4.54 (d, J = 11.5 Hz, 1H), 4.46 (d, J = 12.0 Hz, 
1H), 4.16-4.22 (m, 1H), 4.05 (t, J = 9.5 Hz, 1H), 3.82-3.89 (m, 2H), 3.65-3.81 (m, 8H), 
3.42 (s, 3H), 3.27 (s, 3H), 3.25 (s, 3H), 2.54 (br d, J = 6.0 Hz, 1H), 1.89 (br s, 1H), 1.30 
(s, 3H), 1.25 (s, 3H). 
Thiophenyl Glucose Sugar Silane and Diol 118 6-Hydroxy Silyl-Linked (Scheme 
2.34, compound 119) 
 
 Diol 118 (31 mg, 0.10 mmol) was dissolved in toluene (0.1M) to this was added 
B(C6F5)3 (2.0 mg, 0.004 mmol) followed by dropwise addition of silane (78 mg, 0.13 
mmol) over 5 min as a solution in 1.0 mL toluene, this was stirred at rt for 10 min.  The 
product (45 mg, 0.05 mmol, 50%) was obtained as a white foam upon purification by 
flash chromatography on SiO2 (30 to 45% EtOAc/hex). 
1
H NMR (500 MHz, CDCl3) δ 
7.56-7.60 (m, 2H), 7.22-7.40 (m, 16H), 7.08-7.12 (m, 2H), 4.95 (d, J = 11.0 Hz, 1H), 
4.89 (d, J = 11.5 Hz, 1H), 4.72 (d, J = 11.0 Hz, 1H), 4.68 (s, 1H), 4.51-4.66 (m, 4H), 
3.84-4.10 (m, 5H), 3.49-3.80 (m, 7H), 3.30 (s, 3H), 3.27 (s, 3H), 3.19 (s, 3H), 2.35 (br s, 
1H), 1.32 (s, 3H), 1.26 (s, 3H), 0.21 (s, 6H). 
Glucose and Diol 118 6-Hydroxy Glycoside (Scheme 2.34, compound 120) 
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 Following general procedure 4.4, compound 119 (45mg, 0.05 mmol), NIS (16 
mg, 0.07 mmol), TMSOTf (22 μL, 0.12 mmol), and 2,6-DTBMP (41 mg, 0.20 mmol) 
were stirred at -40 °C for 5 min then warmed to 0 °C and stirred for 2.5 h, then an excess 
of n-Bu4NF (0.50 mL, 0.50 mmol) was added as a 1M solution in THF and allowed to stir 
overnight at rt. The product (25 mg, 0.034, 67%) was obtained as a white foam upon 
purification by flash chromatography on SiO2 (60 to 75% EtOAc/hex).
 1
H NMR (500 
MHz, CDCl3) δ 7.37-7.40 (m, 2H), 7.25-7.36 (m, 11H), 7.13-7.17 (m, 2H), 5.07 (d, J = 
2.5 Hz, 1H), 4.96 (d, J = 11.5 Hz, 1H), 4.84 (d, J = 11.0 Hz, 1H), 4.83 (d, J = 11.0 Hz, 
1H), 4.72 (d, J = 1.0 Hz, 1H), 4.63 (d, J = 12.5 Hz, 1H), 4.51 (d, J = 12.5 Hz, 1H), 4.49 
(d, J = 11.0 Hz, 1H), 4.16 (t, J = 10.0 Hz, 1H), 3.95-4.03 (m, 2H), 3.81-3.92 (m, 3H), 
3.70-3.80 (m, 4H), 3.68 (dd, J = 11.0, 2.0 Hz, 1H), 3.59-3.66 (m, 1H), 3.35 (s, 3H), 3.28 
(s, 3H), 3.24 (s, 3H), 2.52 (br s, 2H), 1.33 (s, 3H), 1.29 (s, 3H); 
13
C NMR (100 MHz, 
CDCl3) δ 138.71, 138.36, 137.98, 128.35, 128.31, 128.00, 127.88, 127.77, 127.65, 
127.59, 127.56, 100.96, 100.31, 99.93, 99.80, 83.13, 77.24, 75.10, 74.89, 73.47, 73.36, 
70.72, 70.03, 69.58, 68.57, 67.95, 66.49, 63.03, 54.95, 48.07, 47.98, 17.72; IR (film, cm
-
1
) 3438, 3029, 2928, 1453, 1378, 1129, 1046 ; HRMS (ES) m/z calcd for C40H52O13 
[M+Na]
+  
763.3300, found 763.3299. 
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4.3 Chapter 3 Experimental Procedures and Spectral Data 
4.3.1 Chapter 3 Experimental Procedures 
All reagents were used as received unless otherwise noted. Solvents were purified 
under nitrogen using a solvent purification system (Innovative Technology, inc., Model # 
SPS-400-3 and PS-400-3). Ni(COD)2 (Strem Chemicals, Inc., used as received), and 1,3-
dimesitylimidazolium chloride (IMes·HCl) were stored and weighed in an inert 
atmosphere glovebox. Ti(O-i-Pr)4 and Me2Si(H)Cl were distilled and stored under inert 
atmosphere in Schlenk flasks. All nickel reactions were conducted in flame-dried 
glassware under a nitrogen atmosphere. 
1
H and 
13
C spectra were obtained in CDCl3 at rt, 
unless otherwise noted, on a Varian Mercury 400 or Varian Unity 500 MHz instrument. 
Chemical shifts of 
1H NMR spectra were recorded in parts per million (ppm) on the δ 
scale from an internal standard of residual chloroform (7.27 ppm). Chemical shifts of 
13
C 
NMR spectra were recorded in ppm from the central peak of CDCl3 (77.0 ppm) on the δ 
scale. High resolution mass spectra (HRMS) were obtained on a VG-70-250-s 
spectrometer manufactured by Micromass Corp. (Manchester UK) at the University of 
Michigan Mass Spectrometry Laboratory. 
General Procedure for Ni(0)-IMes Catalyzed Reductive Coupling of Aldehydes and 
Terminal Alkynes (General Procedure 4.7) 
A solid mixture of Ni(COD)2 (10%), IMes·HCl (10%), and KO-t-Bu (10%) was 
dissolved in dry THF (0.04M) at rt under an inert atmosphere (N2), and stirred for 10-15 
minutes until the catalyst mixture was a dark blue color.  Sugar silane (1.1 equiv.), and 
aldehyde (1.0 equiv., freshly distilled) were added to the catalyst as a solution in dry THF 
(0.2M) at the same instance the first drop of alkyne (1.5 equiv., freshly distilled) was 
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added to the catalyst via syringe drive addition.  The alkyne is added as a 0.6M solution 
in THF at a rate of 1 mL/50 min. Upon completion of the reaction, as monitored by TLC, 
the reaction mixture was filtered through a short plug of silica gel with a mixture of 
EtOAc/hexanes and concentrated by rotary evaporation.  The resulting residue was 
purified via flash chromatography (SiO2) to afford the desired product.   
General Procedure for Ni(0)-IMes Catalyzed Reductive Coupling of Aldehydes and 
Internal Alkynes (General Procedure 4.8) 
A solid mixture of Ni(COD)2 (10%), IMes·HCl (10%), and KO-t-Bu (10%) was 
dissolved in dry THF (0.02M) at rt under an inert atmosphere (N2), and stirred for 10-15 
minutes until the catalyst mixture was a dark blue color.  Ti(Oi-Pr)4 (1.1 equiv.) was then 
added to the catalyst mixture followed by the cannula addition of the sugar silane (1.1 
equiv.), and aldehyde (1.0 equiv, freshly distilled) and alkyne (1.2 equiv.) as a solution in 
dry  THF (0.2M).  Upon completion of the reaction, as monitored by TLC, the reaction 
mixture was filtered through a short plug of silica gel with a mixture of EtOAc/hexanes 
and concentrated by rotary evaporation.  The resulting residue was purified via flash 
chromatography (SiO2) to afford the desired product.  
General Procedure for Radical Cation Glycosylation (General Procedure 4.9) 
A solid mixture of NaHCO3 (20 equiv.) and 4Å MS was stirred in dry acetonitrile 
(70% total solvent volume) for 15 min, radical cation 171 (1.5 equiv.) was then added 
followed by drop wise addition over 3-5 min of the silyl-linked compound (1.0 equiv.) as 
a 0.067M solution in dry acetonitrile. Upon completion of the reaction, as monitored by 
TLC, the reaction mixture was quenched with nBu4NF (5.0 equiv.) as a 1M solution in 
THF. The reaction is then filtered through a short plug of silica gel with a mixture of 
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EtOAc/hexanes, and concentrated with SiO2 added. The resulting solid mixture was 
purified via flash chromatography (SiO2) to afford the desired product. Note – 
comparable yields were observed using 5.0 equiv. NaHCO3. 
Reductive Coupling of Heptanal and Phenylacetylene (Scheme 3.10, compound 146) 
 
Following the general procedure 4.8, without Ti(OiPr)4, silane (330 mg, 0.55 
mmol), heptanal (70 μL, 0.50 mmol), phenylacetylene (66 μL, 0.60 mmol), Ni(COD)2 
(14 mg, 0.05 mmol), IMes·HCl (17 mg, 0.05 mmol), and KO-t-Bu (6 mg, 0.05 mmol) 
were stirred overnight.  The product (148 mg, 0.18 mmol, 36%, 1:1 dr) was obtained as a 
colorless oil after purification by flash chromatography on SiO2 (5 to 10% EtOAc/Hex). 
1
H NMR (500MHz, CDCl3) δ 6.47 (d, J = 16.0 Hz, 0.5H), 6.44 (d, J = 16.5 Hz, 0.5H), 
6.09-6.17 (m, 1H) (diagnostic olefin protons), 4.40 (d, J = 9.5 Hz, 0.5H), 4.38 (d, J = 
9.5 Hz, 1H) (diagnostic anomeric proton). 
Reductive Coupling of Isobutyraldehyde and Phenylacetylene (Scheme 3.10, 
compound 147) 
 
Following the general procedure 4.8, without Ti(OiPr)4, silane (500 mg, 0.90 
mmol), isobutyraldehyde (85 μL, 0.82 mmol), phenylacetylene (135 μL, 1.23 mmol), 
Ni(COD)2 (23 mg, 0.08 mmol), IMes·HCl (28 mg, 0.08 mmol), and KO-t-Bu (9 mg, 0.08 
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mmol) were stirred overnight.  The product (175 mg, 0.24 mmol, 30%, 1:1 dr) was 
obtained as a colorless oil after purification by flash chromatography on SiO2 (10% 
EtOAc/Hex). 
1
H NMR (400MHz, CDCl3) δ 6.47 (d, J = 16.0 Hz, 0.5H), 6.45 (d, J = 16.0 
Hz, 0.5H), 6.14 (dt, J = 16.0, 7.0 Hz, 1H) (diagnostic olefinic protons), 4.40 (d, J = 9.6 
Hz, 0.5H), 4.37 (d, J = 9.6 Hz, 0.5H) (diagnostic anomeric proton). 
Reductive Coupling of Benzaldehyde and Phenylacetylene (Scheme 3.10, compound 
148) 
 
Following the general procedure 4.8, without Ti(OiPr)4, silane (182 mg, 0.33 
mmol), benzaldehyde (30 μL, 0.30 mmol), phenylacetylene (40 μL, 0.36 mmol), 
Ni(COD)2 (8 mg, 0.03 mmol), IMes·HCl (10 mg, 0.03 mmol), and KO-t-Bu (3.4 mg, 
0.03 mmol) were stirred overnight.  The product (77 mg, 0.10 mmol, 34%, 1:1 dr) was 
obtained as a colorless oil after purification by flash chromatography on SiO2 (5 to 10% 
EtOAc/Hex). 
Reductive Coupling of Heptanal and 1-Octyne (Scheme 3.12, compound 152) 
 
Following the general procedure 4.7, silane (122 mg, 0.22 mmol), heptanal (28 
μL, 0.20 mmol), 1-octyne (44 μL, 0.30 mmol), Ni(COD)2 (5.5 mg, 0.02 mmol), 
IMes·HCl (7 mg, 0.02 mmol), and KO-t-Bu (2.2 mg, 0.02 mmol) were stirred for 2 hr 
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after completion of syringe drive.  The product (115 mg, 0.15 mmol, 74%, 1:1 dr) was 
obtained as a colorless oil after purification by flash chromatography on SiO2 (5 to 10% 
EtOAc/Hex). 
1
H NMR (500MHz, CDCl3) δ 7.24-7.39 (m, 13H), 7.09-7.14 (m, 2H), 5.44-
5.55 (m, 1H), 5.30-5.40 (m, 1H), 5.00 (d, J = 11.5 Hz, 1H), 4.85 (d, J = 11.0 Hz, 0.5H), 
4.84 (d, J = 11.0 Hz, 0.5H), 4.75 (d, J = 10.5 Hz, 0.5H), 4.74 (d, J = 10.5 Hz, 0.5 H), 
4.50-4.63 (m, 3H), 4.35-4.42 (m, 1H), 4.20 (quint, J =7.0 Hz, 1H), 3.66-3.78 (m, 3H), 
3.47-3.61 (m, 3H), 2.67-2.81 (m, 2H), 1.96 (q, J = 7.5 Hz, 1H), 1.47-1.58 (m, 2H), 1.16-
1.45 (m, 19H), 0.86-0.91 (m, 6H), 0.19 (s, 3H), 0.17 (s, 1.5H), 0.16 (s, 1.5H). 
Reductive Coupling of Cyclohexylacetylene and 1-Octyne (Scheme 3.12, compound 
153) 
 
Following the general procedure 4.7, silane (122 mg, 0.22 mmol), 
cyclohexylcarboxaldehyde (24 μL, 0.20 mmol), 1-octyne (44 μL, 0.30 mmol), Ni(COD)2 
(5.5 mg, 0.02 mmol), IMes·HCl (7 mg, 0.02 mmol), and KO-t-Bu (2.2 mg, 0.02 mmol) 
were stirred for 2 hr 15 min after completion of syringe drive.  The product (133 mg, 0.17 
mmol, 86%, 1:1 dr) was obtained as a colorless oil after purification by flash 
chromatography on SiO2 (10% EtOAc/Hex). 
1
H NMR (500MHz, CDCl3) δ 7.23-7.40 (m, 
13H), 7.08-7.12 (m, 2H), 5.41-5.55 (m, 1H), 5.30-5.38 (m, 1H), 5.02 (d, J = 11.5 Hz, 
0.5H), 5.01 (d, J = 11.5 Hz, 0.5H), 4.82-4.88 (m, 1H), 4.74 (d, J = 10.5 Hz, 1H), 4.50-
4.62 (m, 4H), 4.39 (d, J = 9.5 Hz, 0.5H), 4.36 (d, J = 9.5 Hz, 0.5 H), 3.93 (t, J = 7.0 Hz, 
0.5H), 3.90 (t, J = 7.0 Hz, 0.5H), 3.66-3.78 (m, 3H), 3.46-3.61 (m, 3H), 2.67-2.80 (m, 
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2H), 1.94-2.02 (m, 2H), 1.81 (t, J = 11.5 Hz, 1H), 1.58-1.73 (m, 4H), 1.22-1.38 (m, 12H), 
1.05-1.20 (m, 3H), 0.80-0.95 (m, 5H), 0.173 (s, 3H), 0.167 (s, 1.5H), 0.14 (s, 1.5H). 
Reductive Coupling of Heptanal and Cyclohexylacetylene (Scheme 3.12, compound 
154) 
 
Following the general procedure 4.7, silane (122 mg, 0.22 mmol), heptanal (28 
μL, 0.20 mmol), cyclohexylacetylene (39 μL, 0.30 mmol), Ni(COD)2 (5.5 mg, 0.02 
mmol), IMes·HCl (7 mg, 0.02 mmol), and KO-t-Bu (2.2 mg, 0.02 mmol) were stirred for 
2 hr after completion of syringe drive.  The product (124 mg, 0.16 mmol, 80%, 1:1 dr) 
was obtained as a colorless oil after purification by flash chromatography on SiO2 (5 to 
10% EtOAc/Hex). 
1
H NMR (500MHz, CDCl3) δ 7.24-7.40 (m, 13H), 7.08-7.12 (m, 2H), 
5.40-5.49 (m, 1H), 5.26-5.34 (m, 1H), 5.00 (d, J = 11.5Hz, 1H), 4.85 (d, J = 11.5 Hz, 
0.5H), 4.84 (d, J = 11.0 Hz, 0.5H), 4.74 (d, J = 11.0 Hz, 1H), 4.50-4.62 (m, 3H), 4.39 (d, 
J = 9.5 Hz, 0.5H), 4.37 (d, J = 9.5 Hz, 0.5H), 4.14-4.22 (m, 1H), 3.66-3.78 (m, 3H), 3.46-
3.61 (m, 3H), 2.67-2.81 (m, 2H), 1.86-1.94 (m, 1H), 1.60-1.74 (m, 4H), 1.46-1.56 (m, 
2H), 0.98-1.42 (m, 16H), 0.85-0.90 (m, 3H), 0.183 (s, 1.5H), 0.180 (s, 1.5H), 0.17 (s, 
1.5H), 0.15 (s, 1.5H). 
Reductive Coupling of Heptanal and 4-Octyne (Scheme 3.13, compound 155) 
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Following the general procedure 4.8, silane (182 mg, 0.33 mmol), heptanal (42 
μL, 0.30 mmol), 4-octyne (53 μL, 0.36 mmol), Ti(OiPr)4 (98 μL, 0.33 mmol), Ni(COD)2 
(8 mg, 0.03 mmol), IMes·HCl (10 mg, 0.03 mmol), and KO-t-Bu (3.4 mg, 0.03 mmol) 
were stirred overnight.  The product (193 mg, 0.25 mmol, 83%, 1:1 dr) was obtained as a 
colorless oil after purification by flash chromatography on SiO2 (5% EtOAc/Hex). 
1
H 
NMR (500MHz, CDCl3) δ 7.23-7.40 (m, 13H), 7.07-7.11 (m, 2H), 5.24-5.32 (m, 1H), 
5.01 (d, J = 11.5 Hz, 0.5H), 5.00 (d, J = 11.5 Hz, 0.5H), 4.86 (d, J = 11.5 Hz, 0.5H), 4.85 
(d, J = 11.5 Hz, 0.5H), 4.74 (d, J = 10.5 Hz, 0.5H), 4.73 (d, J = 10.5 Hz, 0.5H), 4.60 (d, J 
= 12.5 Hz, 1H), 4.56 (d, J = 12.0 Hz, 1H), 4.52 (d, J = 11.0 Hz, 0.5H), 4.51 (d, J = 11.0 
Hz, 0.5H), 4.39 (d, J = 9.5 Hz, 0.5H), 4.37 (d, J = 9.5 Hz, 0.5H), 4.18 (t, J = 6.0 Hz, 
0.5H), 4.14 (t, J = 5.5 Hz, 0.5H), 3.66-3.88 (m, 3H), 3.46-3.61 (m, 3H), 2.67-2.80 (m, 
2H), 1.90-2.00 (m, 4H), 1.10-1.53 (m, 17H), 0.84-0.92 (m, 9H), 0.16 (s, 1.5H), 0.15 (s, 
3H), 0.12 (s, 1.5H). 
Reductive Coupling of Heptanal and 3-Hexyne (Scheme 3.13, compound 156) 
 
Following the general procedure 4.8, silane (182 mg, 0.33 mmol), heptanal (42 
μL, 0.30 mmol), 3-hexyne (41 μL, 0.36 mmol), Ti(OiPr)4 (98 μL, 0.33 mmol), Ni(COD)2 
(8 mg, 0.03 mmol), IMes·HCl (10 mg, 0.03 mmol), and KO-t-Bu (3.4 mg, 0.03 mmol) 
were stirred overnight.  The product (195 mg, 0.26 mmol, 87%, 1:1 dr) was obtained as a 
colorless oil after purification by flash chromatography on SiO2 (5% EtOAc/Hex). 
1
H 
NMR (500MHz, CDCl3) δ 7.23-7.40 (m, 13H), 7.08-7.12 (m, 2H), 5.26 (t, J = 7.5 Hz, 
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0.5H), 5.23 (t, J = 7.5 Hz, 0.5H), 5.01 (d, J = 11.0 Hz, 0.5H), 5.00 (d, J = 11.0 Hz, 0.5H), 
4.86 (d, J = 11.0 Hz, 0.5H), 4.85 (d, J =11.5 Hz, 0.5H), 4.75 (d, J = 10.5 Hz, 0.5H), 4.74 
(d, J = 10.5 Hz, 0.5H), 4.61 (d, J =12.5 Hz, 1H), 4.50-4.58 (m, 2H), 4.39 (d, J = 9.5 Hz, 
0.5H), 4.37 (d, J = 10.0 Hz, 0.5H). 4.12-4.19 (m, 1H), 3.66-3.78 (m, 3H), 3.47-3.62 (m, 
3H), 1.94-2.05 (m, 4H), 1.42-1.54 (m, 2H), 1.10-1.34 (m, 11H), 0.84-1.00 (m, 9H), 0.16 
(s, 1.5H), 0.153 (s, 1.5H), 0.147 (s, 1.5H), 0.13 (s, 1.5H). 
Reductive Coupling of Isobutyraldehyde and 3-Hexyne (Scheme 3.13, compound 
157) 
 
Following the general procedure 4.8, silane (365 mg, 0.66 mmol), 
isobutyraldehyde (55 μL, 0.60 mmol), 3-hexyne (82 μL, 0.72 mmol), Ti(OiPr)4 (195 μL, 
0.66 mmol), Ni(COD)2 (17 mg, 0.06 mmol), IMes·HCl (20 mg, 0.06 mmol), and KO-t-
Bu (7 mg, 0.06 mmol) were stirred overnight.  The product (316 mg, 0.45 mmol, 75%, 
1:1 dr) was obtained as a colorless oil after purification by flash chromatography on SiO2 
(5 to 10% EtOAc/Hex). 
1
H NMR (500MHz, CDCl3) δ 7.23-7.40 (m, 13H), 7.08-7.12 (m, 
2H), 5.23 (q, J = 6.0 Hz, 1H), 5.03 (d, J = 11.0 Hz, 0.5H), 5.01 (d, J = 11.5 Hz, 0.5H), 
4.87 (d, J = 11.5 Hz, 0.5H), 4.86 (d, J = 11.5 Hz, 0.5H), 4.74 (d, J = 10.5 Hz, 0.5H), 4.73 
(d, J = 11.0 Hz, 0.5H), 4.61 (d, J = 12.5 Hz, 1H), 4.56 (d, J = 12.5 Hz, 1H), 4.53 (d, J = 
11.0 Hz, 0.5H), 4.52 (d, J = 10.5 Hz, 0.5H), 4.37 (q, J = 9.0 Hz, 1H), 3.66-3.81 (m, 4H), 
3.46-3.62 (m, 3H), 2.67-2.80 (m, 2H), 1.94-2.06 (m, 4H), 1.66-1.76 (m, 1H), 1.29-1.34 
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(m, 3H), 0.88-1.01 (m, 8H), 0.77 (t, J = 7.0 Hz, 3H), 0.16 (s, 1.5H), 0.15 (s, 1.5H), 0.14 
(s, 1.5H), 0.11 (s, 1.5H). 
Reductive Coupling of Benzaldehyde and 3-Hexyne (Scheme 3.13, compound 158) 
 
Following the general procedure 4.8, silane (365 mg, 0.66 mmol), benzraldehyde 
(61 μL, 0.60 mmol), 3-hexyne (82 μL, 0.72 mmol), Ti(OiPr)4 (195 μL, 0.66 mmol), 
Ni(COD)2 (17 mg, 0.06 mmol), IMes·HCl (20 mg, 0.06 mmol), and KO-t-Bu (7 mg, 0.06 
mmol) were stirred overnight.  The product (407 mg, 0.55 mmol, 92%, 1:1 dr) was 
obtained as a colorless oil after purification by flash chromatography on SiO2 (5 to 10% 
EtOAc/Hex). 
1
H NMR (500MHz, CDCl3) δ 7.15-7.37 (m, 18H), 7.07-7.11 (m, 2H), 5.51 
(q, J = 7.5 Hz, 1H), 5.35 (d, J = 11.5 Hz, 1H), 4.81-4.94 (m, 2H), 4.69-4.75 (m, 1H), 
4.50-4.62 (m, 3H), 4.37 (d, J = 9.5 Hz, 0.5H), 4.34 (d, J = 9.5 Hz, 0.5H), 3.65-3.78 (m, 
3H), 3.44-3.61 (m, 3H), 2.60-2.78 (m, 2H), 1.99-2.10 (m, 3H), 1.79-1.96 (m, 2H), 1.24-
1.29 (m, 4H), 0.99 (t, J = 7.0 Hz, 1.5H), 0.98 (t, J = 7.0 Hz, 1.5H), 0.71 (t, J = 7.5 Hz, 
1.5H), 0.70 (t, J = 7.5 Hz, 1.5H), 0.171 (s, 1.5H), 0.166 (s, 3H), 0.12 (s, 3H).  
Reductive Coupling of Benzaldehyde and 4-Octyne (Scheme 3.13, compound 159) 
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Following the general procedure 4.8, silane (182 mg, 0.33 mmol), benzaldehyde 
(30 μL, 0.30 mmol), 4-octyne (53 μL, 0.36 mmol), Ti(OiPr)4 (98 μL, 0.33 mmol), 
Ni(COD)2 (8 mg, 0.03 mmol), IMes·HCl (10 mg, 0.03 mmol), and KO-t-Bu (3.4 mg, 
0.03 mmol) were stirred overnight.  The product (173 mg, 0.22 mmol, 75%, 1:1 dr) was 
obtained as a faint pink oil after purification by flash chromatography on SiO2 (5 to 10% 
EtOAc/Hex). 
1
H NMR (500MHz, CDCl3) δ 7.14-7.36 (m, 18H), 7.06-7.10 (m, 2H), 5.54-
5.58 (m, 1H), 5.34 (d, J = 14.0 Hz, 1H), 4.80-4.93 (m, 2H), 4.72 (t, J = 11.5 Hz, 1H), 
4.49-4.69 (m, 3H), 4.36 (d, J = 9.5 Hz, 0.5H), 4.33 (d, J = 10.0 Hz, 0.5 H), 3.64-3.77 (m, 
3H), 3.44-3.61 (m, 3H), 2.59-2.76 (m, 2H), 1.74-2.04 (m, 2H), 1.72-1.90 (m, 2H), 1.35-
1.44 (m, 2H), 1.23-1.29 (m, 4H), 1.12-1.22 (m, 1H), 0.99-1.09 (m, 1H), 0.88-0.94 (m, 
3H), 0.72-0.77 (m, 3H), 0.163 (s, 3H), 0.157 (s, 1.5H), 0.11 (s, 1.5H). 
Reductive Coupling of Benzaldehyde and 1-Phenyl-1-propyne (Scheme 3.13, 
compound 160) 
 
Following the general procedure 4.8, silane (182 mg, 0.33 mmol), benzaldehyde 
(30 μL, 0.30 mmol), 1-phenyl-1-propyne (45 μL, 0.36 mmol), Ti(OiPr)4 (98 μL, 0.33 
mmol), Ni(COD)2 (8 mg, 0.03 mmol), IMes·HCl (10 mg, 0.03 mmol), and KO-t-Bu (3.4 
mg, 0.03 mmol) were stirred overnight.  The product (149 mg, 0.19 mmol, 64%, 1:1 dr, 
95:5 regioselectivity) was obtained as a colorless oil after purification by flash 
chromatography on SiO2 (5 to 15% EtOAc/Hex). 
1
H NMR (300MHz, CDCl3) δ 6.69 (br 
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s, 1H) (diagnostic olefin proton), 4.39 (d, J = 9.3 Hz, 0.5H), 4.37 (d, J = 9.3 Hz, 0.5H) 
(diagnostic anomeric proton). 
Reductive Coupling of Heptanal and 1-Phenyl-1-propyne (Scheme 3.13, compound 
161) 
 
Following the general procedure 4.8, silane (122 mg, 0.22 mmol), heptanal (28 
μL, 0.20 mmol), 1-phenyl-1-propyne (30 μL, 0.24 mmol), Ti(OiPr)4 (65 μL, 0.22 mmol), 
Ni(COD)2 (5.5 mg, 0.02 mmol), IMes·HCl (7 mg, 0.02 mmol), and KO-t-Bu (2.2 mg, 
0.02 mmol) were stirred overnight.  The product (155 mg, 0.20 mmol, 99%, 1:1 dr, 93:7 
regioselectivity) was obtained as a colorless oil after purification by flash 
chromatography on SiO2 (5 to 10% EtOAc/Hex). 
1
H NMR (500MHz, CDCl3) δ (major 
regioisomer) 7.15-7.40 (m, 18H), 7.06-7.12 (m, 2H), 6.41 (s, 0.5H), 6.37 (s, 0.5H), 4.97-
5.02 (m, 1H), 4.85-4.90 (m, 1H), 4.73 (t, J = 10.0 Hz, 1H), 4.48-4.62 (m, 3H), 4.40 (t, J = 
9.5 Hz, 1H), 4.34 (t, J = 7.0 Hz, 0.5H), 4.31 (t, J = 7.0 Hz, 0.5H), 3.64-3.80 (m, 3H), 
3.47-3.62 (m, 3H), 2.68-2.81 (m, 2H), 1.789 (d, J = 13.0 Hz, 1.5H), 1.786 (d, J = 13.0 
Hz, 1.5H), 1.50-1.66 (m, 2H), 1.20-1.35 (m, 11H), 0.85-0.91 (m, 3H), 0.22 (s, 1.5H), 
0.204 (s, 1.5H), 0.199 (s, 1.5H), 0.17 (s, 1.5H). (diagnostic olefin proton for minor 
regioisomer) 5.72-5.81 (m, 0.04H). 
Macrocyclization of 14-Membered Ynal 136 (Scheme 3.14, compound 163) 
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Following general procedure,
56
 silane (199 mg, 0.36 mmol), ynal (63 mg, 0.30 mmol), 
Ni(COD)2 (17 mg, 0.06 mmol), IMes·HCl (20 mg, 0.06 mmol), and KO-t-Bu (7 mg, 0.06 
mmol) were stirred for 13.5 hr. The product (114 mg, 0.015 mmol, 50%) was obtained as 
a colorless oil after purification by flash chromatography on SiO2 (5 to 15% EtOAc/hex). 
1
H NMR (500MHz, CDCl3) δ 7.23-7.40 (m, 13H), 7.08-7.13 (m, 2H), 5.24-5.44 (m, 2H), 
4.994 (d, J = 11.5 Hz, 0.5H), 4.988 (d, J = 11.5 Hz, 0.5H), 4.87 (d, J = 11.0 Hz, 0.5H), 
4.86 (d, J = 11.0 Hz, 0.5H), 4.75 (d, J = 11.0 Hz, 0.5H), 4.74 (d, J = 11.0 Hz, 0.5H), 
4.50-4.63 (m, 3H), 4.40 (d, J = 9.5 Hz, 0.5H), 4.38 (d, J = 9.5 Hz, 0.5H), 4.21-4.27 (m, 
1H), 3.66-3.78 (m, 3H), 3.47-3.62 (m, 3H), 2.67-2.81 (m, 2H), 2.10-2.17 (m, 1H), 1.87-
1.97 (m, 1H), 1.10-1.47 (m, 23H), 0.19 (s, 3H), 0.174 (s, 1.5H), 0.165 (s, 1.5H). 
Macrocyclization Ynal 164 (Scheme 3.14, compound 165) 
 
Following the general procedure,
56
 silane (194 mg, 0.36 mmol), ynal 164 (58 mg, 
0.30 mmol), 3-hexyne (41 μL, 0.36 mmol), Ni(COD)2 (17 mg, 0.06 mmol), IMes·HCl 
(20 mg, 0.06 mmol), and KO-t-Bu (7 mg, 0.06 mmol) were stirred overnight at rt.  The 
product (18 mg, 0.02 mmol, 8%, 1:1 dr) was obtained as a colorless oil after several 
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purifications by flash chromatography on SiO2 (10 to 20% EtOAc/Hex). 
1
H NMR 
(500MHz, CDCl3) δ 5.16-5.36 (m, 2H) (diagnostic olefin protons), 4.38 (d, J = 9.0 Hz, 
0.5H), 4.37 (d, J = 9.5 Hz, 0.5H) (diagnostic anomeric proton). 
Asymmetric Reductive Coupling of Heptanal and 3-Hexyne (Scheme 3.15, 
compound 166) 
 
Following the general procedure 4.8, silane (122 mg, 0.22 mmol), heptanal (28 
μL, 0.20 mmol), 3-hexyne (27 μL, 0.24 mmol), Ti(OiPr)4 (65 μL, 0.22 mmol), Ni(COD)2 
(5.5 mg, 0.02 mmol), 54·HBF4 (16 mg, 0.02 mmol), and KO-t-Bu (2.2 mg, 0.02 mmol) 
were stirred overnight.  The product (140 mg, 0.19 mmol, 93%, 3:1 dr) was obtained as a 
colorless oil after purification by flash chromatography on SiO2 (7.5 to 10% EtOAc/Hex). 
1
H NMR (500MHz, CDCl3) δ 5.26 (t, J = 7.0 Hz, 0.75 H), 5.22 (t, J = 7.5 Hz, 0.25H) 
(diagnostic olefin proton) all other spectral data matched that of the non-selective 
reaction to produce 156. 
Asymmetric Reductive Coupling of Cyclohexylcarboxaldehyde and 3-Hexyne 
(Scheme 3.15, compound 167) 
 
Following the general procedure 4.8, silane (61 mg, 0.11 mmol), 
cyclohexylcarboxaldehyde (12 μL, 0.10 mmol), 3-hexyne (14 μL, 0.12 mmol), Ti(OiPr)4 
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(33 μL, 0.11 mmol), Ni(COD)2 (3 mg, 0.01 mmol), 54·HBF4 (8 mg, 0.01 mmol), and 
KO-t-Bu (1 mg, 0.01 mmol) were stirred overnight.  The product (57 mg, 0.07 mmol, 
76%, ~5.3:1 dr) was obtained as a colorless oil after purification by flash chromatography 
on SiO2 (5 to 8% EtOAc/Hex). 
1
H NMR (500MHz, CDCl3) δ (major diastereomer) 
7.23-7.40 (m, 13H), 7.07-7.10 (m, 2H), 5.17 (t, J = 7.5 Hz, 1H), 5.03 (d, J = 11.5 Hz, 
1H), 4.85 (d, J = 11.5 Hz, 1H), 4.73 (d, J = 11.0 Hz, 1H), 4.60 (d, J = 12.5 Hz, 1H), 4.55 
(d, J = 12.5 Hz, 1H), 4.52 (d, J = 10.5 Hz, 1H), 4.36 (d, J = 9.5 Hz, 1H), 3.71-3.77 (m, 
2H), 3.68 (dd, J = 11.0, 4.5 Hz, 1H), 3.47-3.61 (m, 3H), 2.67-2.80 (m, 2H), 1.92-2.08 (m, 
5H), 1.58-1.74 (m, 3H), 1.42-1.48 (m, 1H), 1.25-1.40 (m, 4H), 1.03-1.20 (m, 3H), 0.99 (t, 
J = 8.0 Hz, 3H), 0.95 (t, J = 7.0 Hz, 3H), 0.77-0.90 (m, 2H), 0.14 (s, 3H), 0.13 (s, 3H), 
(diagnostic peak for minor diastereomer) 4.39 (d, J = 10.0 Hz, 0.19 H). 
Thioethyl Glucose Sugar Silane and Allylic Alcohol 173 Silyl-Linked (Scheme 3.20, 
compound 174) 
 
Following the general procedure 4.6, silane (427 mg, 0.77 mmol), alcohol 173 
(143 mg, 0.70 mmol), CuCl (3.5 mg, 0.035 mmol), IMes·HCl (12 mg, 0.035 mmol), and 
NaO-t-Bu (7 mg, 0.07 mmol) were stirred at rt overnight.  The product (400 mg, 0.53 
mmol, 76%) was obtained as a colorless oil upon purification by flash chromatography 
on SiO2 (10% EtOAc/hex). 
1
H NMR (500MHz, CDCl3) δ 7.21-7.40 (m, 15H), 7.08-7.18 
(m, 5H), 5.36-5.51 (m, 2H), 4.97 (d, J = 11.0 Hz, 0.5H), 4.93 (d, J = 11.5 Hz, 0.5H), 4.85 
(d, J = 11.5 Hz, 1H), 4.75 (d, J = 11.0 Hz, 0.5H), 4.73 (d, J = 10.5 Hz, 0.5H), 4.51-4.63 
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(m, 3H), 4.40-4.47 (m, 1H), 4.343 (d, J = 9.5 Hz, 0.5H), 4.340 (d, J = 9.5 Hz, 0.5H), 
3.73-3.38 (m, 1H), 3.63-3.71 (m, 2H), 3.46-3.60 (m, 3H), 2.64-2.88 (m, 4H), 1.88-1.98 
(m, 2H), 1.19-1.33 (m, 7H), 0.84-0.88 (m, 3H), 0.07 (s, 1.5H), 0.06 (s, 1.5H), 0.03 (s, 
1.5H), 0.01 (s, 1.5H). 
Compound 174 Glycoside (Table 3.3, entry 9, compound 175) 
 
  Following the general procedure 4.9, silyl-linked compound 174 (78 mg, 0.10 
mmol), radical cation 171 (127 mg, 0.15 mmol), NaHCO3 (173 mg, 2.06 mmol) were 
stirred at rt for 30 min. nBu4NF (0.50 mL, 0.50 mmol) was added as a 1M solution in 
THF and the reaction was allowed to stir overnight. The product (46 mg, 0.07 mmol, 
70%) was obtained as an oil upon purification by flash chromatography on SiO2 (10 to 
20% EtOAc/hex). 
1
H NMR (500MHz, CDCl3) δ (more polar diastereomer) 7.36-7.40 
(m, 2H), 7.19-7.35 (m, 16H), 7.12-7.16 (m, 2H), 5.61 (dt, J = 15.5, 6.5 Hz, 1H), 5.48 (dd, 
J = 15.5, 8.0 Hz, 1H), 4.91 (d, J = 11.0 Hz, 1H), 4.81 (d, J = 10.5 Hz, 1H), 4.79 (d, J = 
3.5 Hz, 1H), 4.77 (d, J = 11.0 Hz, 1H), 4.63 (d, J = 12.0 Hz, 1H), 4.47 (d, J = 12.0 Hz, 
1H), 4.46 (d, J = 10.5 Hz, 1H), 4.15-4.21 (m, 1H), 3.84 (d, J = 9.0 Hz, 1H), 3.74 (dd, J = 
10.5, 3.0 Hz, 1H), 3.52-3.67 (m, 4H), 2.82-2.89 (m, 2H), 1.92-2.02 (m, 2H), 1.42 (d, J = 
10.5 Hz, 1H), 1.22-1.35 (m, 4H), 0.88 (t, J = 7.0 Hz, 3H). 
Glycoside of Reductive Coupling Product From Cyclohexylcarboxaldehyde and 1-
Octyne (Scheme 3.23, compound 176) 
182 
 
 
Following the general procedure 4.9, silyl-linked compound 153 (100 mg, 0.11 
mmol), radical cation 171 (159 mg, 0.20 mmol), NaHCO3 (108 mg, 1.29 mmol) were 
stirred at rt for 15 min. nBu4NF (0.65 mL, 0.65 mmol) was added as a 1M solution in 
THF and the reaction was allowed to stir overnight. The product (43 mg, 0.065 mmol, 
50%) was obtained as an oil upon purification by flash chromatography on SiO2 (8 to 
12% EtOAc/hex).   
Glycoside of Reductive Coupling Product From Heptanal and Cyclohexylacetylene 
(Scheme 3.23, compound 177) 
 
Following the general procedure 4.9, silyl-linked compound 154 (100 mg, 0.13 
mmol), radical cation 171 (159 mg, 0.20 mmol), NaHCO3 (218 mg, 2.60 mmol) were 
stirred at rt for 2 hr. nBu4NF (0.65 mL, 0.65 mmol) was added as a 1M solution in THF 
and the reaction was allowed to stir overnight. The product (39 mg, 0.06 mmol, 46%) 
was obtained as an oil upon purification by flash chromatography on SiO2 (10% 
EtOAc/hex). 
1
H NMR (500MHz, CDCl3) δ (more polar diastereomer) 7.39-7.42 (m, 
2H), 7.25-7.36 (m, 11H), 7.14-7.18 (m, 2H), 5.54 (dd, J = 16.0, 7.0 Hz, 1H), 5.33 (dd, J = 
15.5, 8.0 Hz, 1H), 5.00 (d, J = 3.0 Hz, 1H), 4.97 (d, J = 11.5 Hz, 1H), 4.85 (d, J = 11.0 
Hz, 1H), 4.83 (d, J = 10.5 Hz, 1H), 4.64 (d, J = 12.5 Hz, 1H), 4.51 (d, J = 10.5 Hz, 1H), 
4.50 (d, J = 12.5 Hz, 1H), 3.96 (q, J = 7.0 Hz, 1H), 3.81-3.86 (m, 1H), 3.65-3.77(m, 4H), 
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3.58 (dd, J = 10.5, 1.5 Hz, 1H), 2.04 (d, J = 8.5 Hz, 1H), 1.86-1.95 (m, 1H), 1.60-1.75 
(m, 6H), 1.42-1.50 (m, 1H), 0.97-1.34 (m, 16H). 
Glycoside of Reductive Coupling Product From Ynal 136 (Scheme 3.23, compound 
178) 
 
Following the general procedure 4.9, silyl-linked compound 163 (75 mg, 0.10 
mmol), radical cation 171 (121 mg, 0.15 mmol), NaHCO3 (41 mg, 0.49 mmol) were 
stirred at rt for 30 min. nBu4NF (0.50 mL, 0.50 mmol) was added as a 1M solution in 
THF and the reaction was allowed to stir overnight. The product (32 mg, 0.05 mmol, 
50%) was obtained as an oil upon purification by flash chromatography on SiO2 (10% 
EtOAc/hex). 
1
H NMR (500MHz, CDCl3) δ 5.44-5.62 (m, 1H), 5.34 (dd, J = 15.5, 8.0 Hz, 
0.5H), 5.18 (dd, J = 15.0, 8.5 Hz, 0.5H) (diagnostic olefin protons), 5.03 (d, J = 3.5 Hz, 
1H) (diagnostic anomeric proton).  
Glycoside of Reductive Coupling Product From Corresponding Diisopropyl Silyl-
Linked Compound (Scheme 3.23, compound 179) 
 
Following the general procedure 4.9, silyl-linked compound (80 mg, 0.12 mmol), 
radical cation 171 (141 mg, 0.17 mmol), NaHCO3 (193 mg, 2.30 mmol) were stirred at rt 
for 15 min. nBu4NF (0.60 mL, 0.60 mmol) was added as a 1M solution in THF and the 
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reaction was allowed to stir overnight. The product (23 mg, 0.037 mmol, 31%) was 
obtained as an oil upon purification by flash chromatography on SiO2 (10 to 20% 
EtOAc/hex).  Note - the product was isolated as the diisopropylsilanol at the 2-hydroxy 
position. 
Glycoside of Reductive Coupling Product From Heptanal and 3-Hexyne (Scheme 
3.23, compound 180) 
 
Following the general procedure 4.9, silyl-linked compound 156 (75 mg, 0.10 
mmol), radical cation 171 (122 mg, 0.15 mmol), NaHCO3 (168 mg, 2.0 mmol) were 
stirred at rt for 100 min. nBu4NF (0.50 mL, 0.50 mmol) was added as a 1M solution in 
THF and the reaction was allowed to stir overnight. The product (18 mg, 0.03 mmol, 
30%) was obtained as an oil upon purification by flash chromatography on SiO2 (5 to 
10% EtOAc/hex). 
1
H NMR (500MHz, CDCl3) δ 7.25-7.42 (m, 13H), 7.14-7.18 (m, 2H), 
5.37 (t, J = 7.5 Hz, 0.5H), 5.32 (t, J = 7.5 Hz, 0.5H), 4.94-5.01 (m, 1.5H), 4.91 (d, J = 4.0 
Hz, 0.5H), 4.80-4.87 (m, 2H), 4.65 (t, J = 13.0 Hz, 1H), 4.45-4.54 (m, 2H), 3.98 (t, J = 
7.5 Hz, 0.5H), 3.92 (t, J = 7.0 Hz, 0.5H), 3.62-3.84 (m, 5.5H), 3.53-3.57 (m, 0.5H), 1.92-
2.13 (m, 5H), 1.50-1.70 (m, 3H), 1.20-1.36 (m, 3H), 0.86-1.05 (m, 9H). 
Glycoside of Reductive Coupling Product From Heptanal and 1-Phenyl-1-Propyne 
(Scheme 3.23, compound 181) 
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Following the general procedure 4.9, silyl-linked compound 161 (78 mg, 0.10 
mmol), radical cation 171 (122 mg, 0.20 mmol), NaHCO3 (168 mg, 2.0 mmol) were 
stirred at rt for 60 min. nBu4NF (0.50 mL, 0.50 mmol) was added as a 1M solution in 
THF and the reaction was allowed to stir 1 hr. The product (23 mg, 0.035 mmol, 35%) 
was obtained as an oil upon purification by flash chromatography on SiO2 (5 to 20% 
EtOAc/hex). 
1
H NMR (500MHz, CDCl3) δ 7.21-7.42 (m, 18H), 7.12-7.19 (m, 2H), 6.49 
(s, 0.5), 6.45 (s, 0.5H), 5.07 (d, J = 3.0 Hz, 0.5H), 4.95-5.00 (m, 1.5H), 4.79-4.89 (m, 
2H), 4.69 (d, J = 12.0 Hz, 0.5H), 4.59 (d, J = 12.0 Hz, 0.5H), 4.42-4.56 (m, 2H), 4.19 (t, J 
= 7.0 Hz, 0.5H), 4.07 (t, J = 7.0 Hz, 0.5H), 3.85-3.89 (m, 0.5H), 3.64-3.83 (m, 5H), 3.53 
(dd, J = 10.5, 2.0 Hz, 0.5H), 1.840 (dd, J = 6.5 Hz, 1.5H), 1.837 (d, J = 6.0 Hz, 1.5H), 
1.58-1.79 (m, 2H), 1.22-1.38 (m, 12H). 
Hydrogenation of Compound 166 (Scheme 3.24, compound 182) 
 
 Compound 166 (41 mg, 0.05 mmol), and Pd/C (8 mg, 0.008 mmol), were allowed 
to stir 26 hr as a 0.05M soln in wet EtOAc at 40 °C under an atmosphere of hydrogen 
gas. The product (41 mg, 0.05 mmol, 85%, ~15% starting material remained, dr 
undetermined) was obtained as an oil after filtration through a plug of SiO2 and celite. 
1
H 
NMR (500MHz, CDCl3) δ 5.00 (d, J = 11.5 Hz, 1H), 4.85 (d, J = 11.0 Hz, 1H), 4.74 (d, J 
= 10.5 Hz, 1H), 4.61 (d, J = 12.0 Hz, 1H), 4.56 (d, J = 12.5 Hz, 1H), 4.37 (d, J = 9.5 Hz, 
1H) (diagnostic benzylic and anomeric protons). 
Glycoside of Hydrogenation Product 182 (Scheme 3.24, compound 183) 
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Following the general procedure compound for NIS/TMSOTf glycosylation 182 
(37 mg, 0.05 mmol), NIS (15 mg, 0.065 mmol), TMSOTf (11 μL, 0.06 mmol), and 2,6-
DTBMP (21 mg, 0.10 mmol) were stirred at -40 °C for 10 min,  then warmed to 0 °C and 
stirred for 30 min, then excess n-Bu4NF (0.25 mL, 0.25 mmol) was added as a 1M 
solution in THF, warmed to rt and allowed to stir overnight.  The product (12 mg, 0.022 
mmol, 44%, dr undetermined) was obtained as a colorless oil upon purification by flash 
chromatography on SiO2 (10 to 15% EtOAc/hex). 
1
H NMR (500MHz, CDCl3) δ 7.16-
7.20 (m, 2H), 7.25-7.44 (m, 13H), 4.96 (m, 2H), 4.82-4.86 (m, 2H), 4.66 (d, J = 12.5 Hz, 
1H), 4.51 (d, J = 11.0 Hz, 1H), 4.50 (d, J = 12.0 Hz, 1H), 3.77-3.91 (m, 2H), 3.62-3.75 
(m, 5H), 2.00 (d, J = 10.0 Hz, 1H), 1.15-1.58 (m, 17H), 0.84-0.95 (m, 9H). 
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